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ABSTRACT  
 
Ageing is defined as an age-related increase in susceptibility to diseases and death and 
is a complex process that affects every major system at the molecular, cellular and 
organ level. Although the exact cause of ageing is unknown, there is significant 
evidence that oxidative stress plays a major role in the ageing process.  
 
Skeletal muscle produces oxidants from a variety of different sources with nitric oxide 
and superoxide being the primary radical species. Nitric oxide is regulated by the 
activity of nitric oxide synthases, however the sites that modulate changes in superoxide 
remain unclear. Skeletal muscle ageing is associated with a reduction in muscle mass 
and strength and leads to a significant vulnerability that opposes healthy ageing. Reports 
have indicated a positive correlation between tissue concentrations of oxidised 
macromolecules in skeletal muscle of old individuals, which implies the possible 
involvement of reactive species in the processes of skeletal muscle ageing. The role of 
oxidants in skeletal muscle ageing has also been extensively examined in different 
model organisms, which have undergone genetic manipulations and reports have shown 
that absence of Cu, Zn superoxide dismutase (SOD1) in homozygotic SOD1 knockout 
mice, induces an acceleration of skeletal muscle ageing phenotypic changes which 
further provides support for the implication of radical species in the processes of muscle 
ageing. 
 
The overall aim of the work carried out in this thesis was; i) to develop specific 
techniques to determine changes in superoxide within the cytosolic and mitochondrial 
compartment of skeletal muscle, ii) to identify the major sites for superoxide generation 
in skeletal muscle and iii) to identify the reactive species that are involved in the 
accelerated loss of muscle mass in the homozygotic SOD1 knockout mouse model and 
to characterize the changes in redox status and adaptive responses that occur in muscles 
from the SOD1 knockout mice.  
 
The results of carried out in this thesis indicated that the superoxide sensitive 
fluorescent probes dihydroethidium and MitoSOX Red were capable of selectively 
detecting changes in superoxide within the cytosolic and mitochondrial matrix of 
skeletal muscle, respectively. Specific pathway inhibitors and immunolocalisation 
techniques showed that the major sub-cellular sites contributing to cytosolic superoxide 
changes in skeletal muscle both at rest and during contractions were the NAD(P)H 
oxidases. Finally with the use of single isolated muscle fibres from the flexor digitorum 
brevis muscle, it was concluded that formation of peroxynitrite in muscle fibres was a 
major effect of lack of SOD1 in SOD1 null mice, which may contribute to fibre loss in 
this model. 
 
Techniques developed in this study to monitor real-time changes in superoxide in the 
mitochondrial and cytosolic compartment of muscle fibres provided a useful tool to i) 
examine the sub-cellular pathways that are involved in the regulation of superoxide at 
rest and during contractile activity in skeletal muscle and to ii) determine the role of 
superoxide in skeletal muscle degeneration observed in SOD1 knockout mice. These 
results may have widespread implications for the understanding of diverse scientific 
areas, including the responses of muscle to exercise training, age-related loss of muscle 
mass and function, as well as inflammatory or degenerative muscle diseases, such as the 
muscular dystrophies that are associated with increased levels of oxidative damage. 
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Skeletal muscle is the largest pool of proteins in humans and exhibits a complex 
structure and architecture. Skeletal muscle ageing is associated with a reduction in 
muscle mass and strength and is a contributor to frailty and loss of independence in the 
elderly. The problem is universal and leads to a significant vulnerability that opposes 
healthy ageing, but the mechanisms underlying the muscle loss during ageing remain to 
be defined. Skeletal muscle produces oxidants from a variety of different sources and 
oxidative damage has been suggested to be among the factors contributing to the 
initiation and progression of muscle atrophy that occurs during ageing. The overall aim 
of the work carried out in this thesis was to identify the major sources of reactive 
oxygen species in skeletal muscle and to investigate their effect in skeletal muscle age-
related degeneration.  
This introductory chapter details the features of skeletal muscle, the sources and 
reactive species produced by skeletal muscle as well as the role that oxidants have been 
reported to play in skeletal muscle metabolism. 
 
1.1.      FEATURES OF SKELETAL MUSCLE 
1.1.1    Skeletal muscle 
Skeletal muscle, also known as striated muscle is one of three major muscle 
types in the human body, the others being cardiac (heart) muscle and smooth muscle 
(Martini, 2005). Skeletal muscle is considered an organ of the muscular system, is the 
largest protein store and is under the control of the peripheral nervous system. There are 
640 individually named skeletal muscles and they comprise 42% of total body mass in 
an average adult male and 36% in an adult female (Marieb and Hoehn, 2010). Skeletal 
muscle, as its name implies, is attached to the skeleton by bundles of collagen fibres 
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known as tendons (Figure 1.1), which function to transmit forces, thus effecting skeletal 
movement such as locomotion and maintaining posture. Although the basis for motion 
mediated by all three types of muscle cells is the conversion of chemical energy into 
mechanical energy, skeletal muscle exhibits a complex structure and architecture, which 
is essential and directly related to its primary function, contraction. 
 
Figure 1.1 Schematic representation of skeletal muscle structure (from Hemmings and 
Hopkins, 2005).  
 
1.1.2 Skeletal muscle structure  
Skeletal muscles vary considerably in size and shape, are extremely specialized 
and exhibit unique structural features. Starting with the largest structure of skeletal 
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muscle, the epimysium, a layer of connective tissue that sheaths the entire muscle 
(Figure 1.1). Connective tissue from the epimysium extends into the muscle, dividing 
the tissue into compartments, the fascicles. Individual fascicles are also surrounded by a 
layer of connective tissue, the perimysium and contain bundles of individual muscle 
fibres (muscle cells) (Figure 1.1). Finally a delicated network of loose connective tissue, 
the endomysium, is found between the muscle fibres of a fascicle. This sheath is very 
important in the physiology of muscle contraction because it electrically insulates the 
individual muscle cells from each other (Mougios, 2006). 
 
1.1.3 Structural features of muscle fibres 
Skeletal muscles consist of hundreds, or possibly thousands of individual muscle 
fibres (Marieb and Hoehn, 2010; Martini, 2005). Skeletal muscle fibres are long, 
cylindrical cells which present densely packed striations, perpendicular to their 
longitudinal axis. An example of a single isolated muscle fibre is presented in figure 
1.2. The striations consist of alternative dark and light areas. Every dark area is called A 
band and every light area the I band. More about the alternations of A and I band will be 
discussed in Sections 1.1.4 and 1.1.5 of this chapter. 
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Figure 1.2 Single isolated skeletal muscle fibre presents intense transverse stripes under 
a light microscope. Dark stripes are called A bands and light stripes I bands. 63X 
original magnification, scale bar = 30 µm  (picture from Palomero et al, 2008). 
 
Muscle fibres are multinucleated cells (Figure 1.3) that are bound by a plasma 
membrane, the sarcolemma (Figure 1.4) and an overlying basal lamina (Marieb and 
Hoehn, 2010; Martini, 2005). There are specialized invaginations of the sarcolemma 
that run transversely across the cell (Figure 1.4). These invaginations are known as 
transverse tubules (T-tubules) and are essential for carrying the depolarisation brought 
to the cell by a motor nerve impulse  (Figure 1.5) into the muscle cell (Mougios, 2006).  
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Figure 1.3 Cross section of an EDL skeletal muscle showing individual fibres along 
with the nuclei (image provided by Dr A. Vasilaki)  
 
 
Figure 1.4 Schematic representation of the structure of a skeletal muscle fibre (from 
Davies and Nowak, 2006). 
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Skeletal muscles must have neuronal innervation to function and a microscopy 
image of the synapse (neuromuscular junction) between the end of the axon (a long 
slender projection of the neuron that conducts electrical impulses away from the neuron 
cell body) and the plasma membrane of a muscle cell is shown in Figure 1.5 (Ruff, 
2011). The motor end plate represents the final synapse in the motor pathway, between 
a nerve cell and the individual fibre it controls. Each skeletal muscle fibre irrespective 
of its size has only one neuromuscular junction (Ruff, 2011) and evidence has shown 
that if the axons to a myofibre fail to develop, or are damaged, the muscle cells will 
wither in the process known as neurogenic atrophy (Wong and Martin, 2010). 
 
The sarcoplasm is the specialised cytoplasm of a muscle cell that surrounds 
organelles and other insoluble cytoplasmic components including the Golgi apparatus, 
the sarcoplasmic reticulum (a network which acts as a calcium (Ca2+) storage site), 
mitochondria, myoglobin (a 17kDa protein which receives oxygen from the blood, 
stores it and transports it inside the muscle cells) the endoplasmic reticulum and 
abundant myofibrils (Mougios, 2006). 
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Figure 1.5 Confocal images showing the synapse (neuromuscular junction) between the 
axons and a group of motor endplates in skeletal muscle. (i) Fibres were stained with 
phalloidin (blue), (ii) Axons from mice overexpressing YFP in the nerve (green), (iii) 
Motor endplate stained with bungarotoxin (red), (iv) merged image of i-ii-iii (image 
provided by Dr A. Vasilaki) 
 
1.1.4 Myofibril structure  
Skeletal muscle fibres consist of parallel myofibrils, which are embedded in the 
sarcoplasm of the cell and comprise the basic unit of the muscle (Figure 1.6). The 
alternation of A and I bands mentioned in Section 1.1.3 persist in every myofibril and 
the striations on skeletal muscle fibres are due to the alignment of A bands in adjacent 
myofibrils (Martini, 2005; Mougios, 2006).  
 
A and I bands are not uniform. The A band has a stripe in the middle, the H zone 
which is less dense than the rest of the band (Figures 1.6 and 1.7). In the middle of the 
H zone, the dense line is called the M line. The I band also has a dense line in the 
middle called the Z line or Z disc (Figures 1.6 and 1.7). This symmetrical pattern is 
i ii iii iv 
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repeated along the entire myofibril and permits the definition of a minimal complete 
functional unit, the sarcomere, which is defined as the segment of a myofibril between 
two Z lines (Figures 1.6 and 1.7) (Martini, 2005; Mougios, 2006).   
 
 
Figure 1.6 Schematic representation of myofibril structure (from Marieb, 2001).  
 
1.1.5 Sarcomere architecture  
The sarcomere has a filamentous appearance and is approximately 2.3um long in 
the myofibrils of fibres under resting conditions. Electron micrographs of cross sections 
of myofibrils have revealed that sarcomeres consist of two kinds of filaments, the thick 
filaments with a diameter of 15nm and the thin filaments with a diameter of 9nm 
(Figure 1.7), (Mougios, 2006). The I band consists of thin filaments while the A band 
presents a mixed make up of both thin and thick filaments. The H zone consists of thick 
filaments and the rest of the band by both kinds of filaments in a symmetrical 
arrangement (Figure 1.7).  
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Thick filaments are composed mainly of myosin while the thin filaments of 
actin, tropomyosin and troponin proteins. The data in figure 1.7 show that thick and thin 
filaments interdigitate at the two ends of the A bands which interact through cross 
bridges. The cross bridges are part of the myosin molecules and protrude from the 
surface of each thick filament and point toward the surrounding thin filaments 
(Harrington and Rodgers, 1984). It is essential to mention that the interaction of the 
myosin cross-bridges with actin is what generates the force for contractions and further 
details on sarcomere contraction will be mentioned in the following Section (1.1.6) of 
this chapter. 
 
Figure 1.7 Electron micrograph of a sarcomere. (A) A longitudinal section of a 
myofibril presents repetitive symmetrical pattern. The part between two Z lines shown 
here is called a sarcomere. (B) Cross sections at different points along the sarcomere 
reveals its structural details (from Mougios, 2006). 
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1.1.6 The mechanism of muscle contraction  
Sarcomeres are the fundamental contractile units of skeletal muscle, which 
shorten in proportion to the whole muscle. Studies on the mechanism of muscle 
contraction have shown that there is no proportional shortening in the parts of the 
sarcomere and examination by electron microscopy revealed that the I band and H zone 
shorten, whereas the A band does not change. This observation has made it clear that 
the lengths of both the thin and thick filaments are constant during contraction but their 
overlap increases, which suggests that sarcomere contraction is caused by the active 
sliding of thick and thin filaments past each other. This has been proposed as the 
sliding-filament model that is widely accepted as the theory for muscle contraction 
(Huxley and Niedergerke, 1954). 
The major proteins involved in force generation are myosin and actin. As 
mentioned in previous Section (1.1.5), thick filaments consist of myosin, the most 
abundant protein of muscle tissue which accounts half of its protein mass. On the other 
hand, thin filaments consist mainly of actin, tropomyosin and troponin. Actin is the 
main component of the thin filaments and it exists in two forms, globular actin (G-actin) 
and fibrous actin (F-actin) (Mougios, 2006). F-actin forms the trunk to which 
tropomyosin and troponin attach in the thin filaments. Tropomyosin consists of two 
similar stringlike subunits in an α-helical conformation. Molecules of tropomyosin join 
in a row to form fibres which run along each thin filament while following the twisting 
of the actin monomers (Figure 1.8). Troponin is a complex of three different subunits 
(TnC, TnI, TnT) and is attached to tropomyosin. TnT subunit binds to tropomyosin, TnI 
to actin and TnC to Ca2+.  
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Figure 1.8 Thin-filament proteins. A thin filament consists of an F-actin fibre, two 
tropomyosin molecules, and troponin (Tn) complexes places at regular intervals. Every 
troponin complex consists of TnC, TnI and TnT (from Mougios, 2006). 
 
The interaction of the myosin cross-bridges with actin is what generates the force for 
contractions. Under resting conditions (when a muscle is at rest), the interaction among 
actin-tnI-TnT-tropomyosin hold tropomyosin close to the actin monomers where the 
myosin heads bind, thus tropomyosin hinders the interaction on thin and thick filaments 
(Harrington and Rodgers, 1984). However, under contracting conditions, muscle 
excitation by the nervous system results in the release of Ca2+ from the sarcoplasmic 
reticulum to the sarcoplasm of myofibres. The increased Ca2+ ions bind on the TnC 
subunit and elicit a change in its conformation. As a result, TnC detaches TnI from 
actin, moving tropomyosin away from the binding sites of myosin on actin (Harrington 
and Rodgers, 1984). Cross-bridges of myosin bind to actin and the muscle contracts. 
Contractile activity will seize when the Ca2+ ions are sequestered in the sarcoplasmic 
reticulum by the calcium ATPases (calcium pumps that transfer cytosolic Ca2+ into the 
sarcoplasmic reticulum during muscle relaxation) and the actin-TnI-TnT-tropomyosin 
interaction is then restored (Mougios, 2006).   
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1.2.  REACTIVE OXYGEN AND NITROGEN SPECIES PRODUCED BY  
           SKELETAL MUSCLE  
1.2.1  Skeletal muscle produces reactive species 
Molecular oxygen is one of the most abundant elements in the atmosphere 
(nearly 21% by volume), and its ability to accept electrons makes it vital for a variety of 
physiological processes. Aerobic organisms including humans have adapted well to the 
atmosphere, using atmospheric oxygen by respiration and to obtain energy efficiency. 
Resting and contracting skeletal muscles require energy and in biological systems, the 
energy is accumulated as ATP and released by its hydrolysis (Marieb and Hoehn, 2010; 
Martini, 2005). Skeletal muscle mitochondria are implicated in the processes of ATP 
production via the mitochondrial oxidative phosphorylation, a metabolic pathway that 
takes place in the inner mitochondrial membrane and results in the production of ATP 
by reducing molecular oxygen to water (Scheffler, 1999; Kemp, 2004). Although 
oxidative phosphorylation is a vital part of metabolism, it produces reactive oxygen 
intermediates, which can lead to the propagation of free radicals, molecules that contain 
one unpaired electron and are capable of independent existence (Radak, 2000). Other 
metabolic pathways unrelated to mitochondrial oxidative phosphorylation are also 
implicated in the production of reactive species and a detailed description of the main 
sources of reactive molecules are discussed in Section 1.2.3.  
More than 50 years ago, reports showed that oxygen toxicity caused cellular 
damage by the generation of reactive oxygen species (Fenn et al., 1957; Gerschman et 
al., 1954) and the first studies to report that reactive species are produced in skeletal 
muscle appeared in the 1980s (Davies et al., 1982b; Dillard et al., 1978; Jackson et al., 
1985). It is now widely accepted that resting and contracting skeletal muscles produce 
reactive oxygen and nitrogen species (RONS). Reactive oxygen species (ROS) is a 
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general term that refers to molecular oxygen-derived molecules that are reactive species 
including oxygen-centered radicals but also non-radical species which are reactive 
derivatives of oxygen (Halliwell and Gutteridge, 2007). Similarly, the term reactive 
nitrogen species (RNS) refers to both nitrogen radicals along with other reactive 
molecules where the reactive centre is nitrogen (Jackson, 2008; Jackson, 2009; 
Palomero and Jackson, 2010).  
RONS are constantly produced by skeletal muscle in both humans and animals 
and their generation is augmented during contractile activity (Close et al., 2005; 
Palomero et al., 2008). The first studies identified an increase in end-point indicators of 
the reactions of oxidants in tissues during and following exercise and claimed that the 
increase in reactive species appeared to be in major part due to generation by 
contracting skeletal muscle (Davies et al., 1982b; Dillard et al., 1978; Jackson et al., 
1985). Now, the field of redox biology has advanced significantly and with the 
development of analytical approaches, researchers have been able to confirm previous 
reports by detecting real time changes in RONS generation during and following 
contractile activity (Palomero et al., 2008; Pye et al., 2007; Vasilaki et al., 2010). 
Free radical generation by skeletal muscle has been detected and quantified by a 
wide array of methods including spectrophotometry, fluorescence, chemiluminescence 
and spin traps (Balon and Nadler, 1994; Close et al., 2007; Diaz et al., 1993; Jackson et 
al., 1985; Palomero et al., 2008; Pattwell et al., 2003; Phung et al., 1994; Pye et al., 
2007; Reid et al., 1992) and it is widely accepted that the primary radical species 
generated by skeletal muscle include nitric oxide (NO) and superoxide (McArdle and 
Jackson, 2000; Jackson and McArdle, 2011; Palomero and Jackson, 2010). Both NO 
and superoxide are reactive and can readily react to form a series of other RONS. 
Details on the chemistry of the main radical species (NO and superoxide) as well as the 
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sources that are produced from in skeletal muscle are presented in detail in the 
following two Sections (1.2.2 and 1.2.3, respectively). 
 
1.2.2     Chemistry of reactive oxygen and nitrogen species  
Skeletal muscles produce reactive species including radical species but also non-
radical species, which are reactive derivatives of oxygen and nitrogen. The main 
reactive molecules produced in biological species are presented in table 1.1. 
 
 
Table 1.1 Reactive oxygen and nitrogen species relevant to biological species (from 
Radak, 2000). 
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1.2.2.1 Superoxide radical  
Superoxide anion, is considered a primary radical (i.e the first radical to be 
produced) and arises either through incomplete reduction of oxygen in electron 
transport systems or as a specific product of enzymatic systems (Powers and Jackson, 
2008). It is produced from one electron reduction of oxygen and has a negative charge. 
Due to its negative charge, superoxide is an anion radical and can pass through 
biomembranes only through an anion channel (Lynch and Fridovich, 1978). Superoxide 
has a relatively long half life and does not react directly with polypeptides, sugars, or 
nucleic acids but can further interact with other molecules to generate secondary ROS, 
either directly or prevalently through enzyme or metal-catalyzed processes (Fridovich, 
1986). In aqueous solutions, superoxide can be protonated to produce hydroperoxyl 
radical (HOO.) or depleted undergoing a dismutation reaction to produce hydrogen 
peroxide (H2O2); (2O2. + 2H+ → H2O2 + O2) (Valko et al., 2007). However, this 
dismutation is considered to be very slow because superoxide radicals electrostatically 
repel each other and the rate constant of the dismutation of superoxide to H2O2 is 
approximately 2 x 109 M-1 s-1 (Beckman and Koppenol, 1996). 
 
1.2.2.2 Nitric oxide radical 
Nitric oxide (NO) also known as nitrogen monoxide is considered a primary 
radical species and arises through the conversion of arginine to citrulline by the nitric 
oxide synthases, utilising nicotinamide adenine dinucleotide phosphate (NADPH) as a 
cofactor (Moncada et al., 1991; Szabo et al., 2007). NO is a weak reducing agent, reacts 
with oxygen to form nitric dioxide (NO2), and reacts very rapidly with superoxide to 
produce peroxynitrite (ONOO-) and subsequently other RNS (Droge, 2002). NO is a 
small reactive molecule, containing one unpaired electron and its half-life in vivo is 
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thought to be less than 10 seconds (Chiueh, 1999; Moncada et al., 1991). Although it 
reacts rapidly with many radicals, NO is generally unreactive and does not react rapidly 
with most biomolecules (Radak, 2000). NO stability is greater in an environment with a 
lower oxygen concentration (halflife > 15 seconds) and is soluble in both aqueous and 
lipid media. NO readily diffuses through the cytoplasm and plasma membranes and in 
the extracellular milieu, it reacts with oxygen and water to form nitrate and nitrite 
anions (Halliwell and Gutteridge, 2007; Powers and Jackson, 2008). In addition, NO 
reacts with free and bound transition metal ions such as the ferrous ion in guanyl 
cyclase thus activating this enzyme and resulting in the formation of cGMP, a second 
messenger for relaxing blood vessels (Valko et al., 2006; Wink et al., 1996). Due to this 
property, NO released from the endothelium is called the endothelium-derived relaxing 
factor (EDRF) (Stamler and Meissner, 2001). Heme proteins are intimately associated 
with the biological action of NO and binding of NO to Fe2+ plays a major role in its 
inactivation and removal through binding to the iron (Fe) in hemoglobin (Powers and 
Jackson, 2008). The toxicity of NO is linked to its ability to generate highly reactive 
species when combined with other reactive species such as superoxide anions. 
 
1.2.2.3 Hydrogen peroxide 
Hydrogen peroxide (H2O2) belongs to the family of ROS, has no unpaired 
electrons, thus it is a non-radical molecule. H2O2 is a relatively stable compound, it is 
not very reactive and acts as either a mild oxidising or weak reducing agent. H2O2 is 
permeable to membranes and has a relatively long half-life (Powers and Jackson, 2008; 
Radak, 2000). In addition to formation by dismutation of superoxide, a number of 
enzyme systems also generate H2O2 including urate, amino acid oxidases and 
nicotinamide adenine dinucleotide phosphate oxidases (Valko et al., 2006; von 
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Lohneysen et al., 2008). H2O2 is unable to oxidise DNA or lipids directly but can 
inactivate some enzymes by oxidation of essential thiol groups, compounds that contain 
the functional group composed of sulphur-hydrogen (S-H) (Halliwell and Gutteridge, 
2007; Brodie and Reed, 1987). For instance, evidence has shown that high 
concentrations of H2O2 can inactivate glyceraldehyde-3-phosphate dehydrogenase, thus 
inhibit glycolysis (Brodie and Reed, 1987). The generation of various free radicals is 
closely linked with the participation of redox-active metals and the cytotoxicity of H2O2 
occurs through its ability to generate highly reactive species such as the hydroxyl 
radical through metal-catalyzed reactions (Valko et al., 2006; Jackson, 2011).  
 
1.2.2.4 Hydroxyl radical 
Hydroxyl radicals are the most highly reactive radical species present in 
biological systems and are generated from the reductive decomposition of H2O2 with 
reduced transition metal ions, Fe or copper (Cu); (H2O2 + Fe2+ → Fe3+ + ·OH + -OH) 
and (H2O2 + Cu1+ → Cu2+ + ·OH + -OH) a reaction called the Fenton reaction (Powers 
and Jackson, 2008; Halliwell and Gutteridge, 2007). There is controversy about whether 
Fenton reactions can occur in vivo due to a) its small rate constant and b) from the fact 
that the concentration of Fenton reaction reactive transition metal ions is very low 
(Radak, 2000). It has been suggested that Fe regulation ensures that there is no free 
intracellular Fe, but it has been shown that a rapid increase in superoxide production can 
oxidise Fe cluster-containing enzymes (Fe-containing molecules) thus releasing “free 
iron” which facilitates hydroxyl radical production from H2O2 (Valko et al., 2006). 
Superoxide radical can also participate in the Haber-Weiss reaction, where Fe or Cu is 
maintained in a reduced form by superoxide; (O2. + Fe3+ → Fe2+ + O2) and (O2. + Cu2+ 
→ Cu1+ + O2) and hence capable of catalyzing the formation of the hydroxyl radical 
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from H2O2; (O2. + H2O2 → ·OH + -OH + O2) (Valko et al., 2007). Hydroxyl ions have a 
strong oxidizing potential with a half-life in aqueous solution of less than 1ns (Valko et 
al., 2006) and react rapidly with almost any biomolecule that is near its formation site 
(Powers and Jackson, 2008). Thus, the oxidative damage will depend on its formation 
site, for example generation of hydroxyl ions close to DNA could modify the DNA 
bases or cause strand breakage (Mello Filho et al., 1984). Hydroxyl radicals are 
membrane impermeant and can initiate lipid peroxidation through hydrogen abstraction 
and to produce peroxyl radicals, which derive from the one electron oxidation of 
hydroperoxides (Radak, 2000).  
 
1.2.2.5 Peroxynitrite 
Peroxynitrite is an oxidatively active molecule and is formed through the 
reaction of superoxide with NO thus reducing their bioavailability; (O2. + NO → 
ONOO-), (Jackson et al., 2007; Szabo et al., 2007; Trujillo et al., 2008). This reaction 
has received considerable attention as a potentially deleterious reaction or as a 
detoxification mechanism for ROS. This reaction occurs approximately three times 
faster than the dismutation of superoxide and even faster than the reaction of NO with 
heme proteins (Powers and Jackson, 2008) and has one of the highest rate constants 
known for reactions of NO, 7.0 x 109 M−1 s−1 (Valko et al., 2006; Beckman and 
Koppenol, 1996). Peroxynitrite anion is a relatively long-lived toxic compound and it 
reacts with thiol compounds forming disulfides (Radi et al., 1991). Peroxynitrite and its 
protonated form, peroxynitrous acid (ONOOH); (ONOO− + H+ → ONOOH) can oxidise 
various biological molecules including, nucleic acids, proteins and phospholipids 
(Powers and Jackson, 2008; Valko et al., 2006). Another potentially important reaction 
of peroxynitrite is nitration of tyrosine residues in the presence of transition metal ions 
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(Ischiropoulos et al., 1992). This reaction is a prerequisite for the cyclic interconvertion 
between the phosphorylated and the unphosphorylated forms of tyrosine (Hunter, 1995), 
which is crucial for signal transduction in the cell. However overproduction of 
peroxynitrite can cause oxidative damage to molecular components of the cell, alter the 
structure of proteins and inhibit their normal function (Valko et al., 2007; Szabo et al., 
2007).  
 
1.2.3    Sources of RONS in skeletal muscle 
Since the initial observations that skeletal muscle produces RONS (Davies et al., 
1982b; Jackson et al., 1983), a great deal of research has been undertaken to identify the 
sources that contribute to RONS production. It has been shown that resting and 
contracting skeletal muscles produce oxidants from a variety of cellular locations and 
Figure 1.9 shows an updated schematic representation from a recent report of the 
various sites and mechanisms that have been proposed for RONS generation 
(intracellular and extracellular) in skeletal muscle (Jackson, 2011).  
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Figure 1.9 Schematic representation of the sites and mechanisms proposed for RONS 
generation in skeletal muscle fibres (from Jackson, 2011). 
 
1.2.3.1 Sources of NO in skeletal muscle 
The production of NO is mediated by a series of specific enzymes, the nitric 
oxide synthases (NOS) which are regulated by calcium and calmodulin (a calcium-
binding messenger protein) (Davidson and Duchen, 2006) and catalyse the production 
of NO from the amino acid L-arginine by utilizing NADPH (Jackson, 2008; Palomero 
and Jackson, 2010). There are three different isoforms of NOS; the neuronal (type I or 
nNOS), the endothelial (type III or eNOS) and the inducible isoform of NOS (type III or 
iNOS) (Kobzik et al., 1994; Silvagno et al., 1996; Thompson et al., 1996), (Table 1.2). 
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Studies have shown that skeletal muscles express nNOS, which was originally found in 
neural tissue but is also present in most cell types. Neuronal nNOS is expressed along 
the sarcolemma of skeletal muscle fibres together with the dystrophin–glycoprotein 
complex via a linkage to α1-syntrophin (Brenman et al., 1996; Brenman et al., 1995). 
Type III isoenzyme (eNOS) was originally described in endothelial cells but also 
localised to the muscle mitochondria (Stamler and Meissner, 2001; Kobzik et al., 1994) 
(see figure 1.9). The third isoform of NOS (iNOS) is involved in the immune response, 
and is also expressed in skeletal muscle in response to a septic challenge or 
inflammatory conditions (Powers and Jackson, 2008), and evidence has shown that 
expression of NO from iNOS has been implicated in skeletal muscle dysfunction (Gath 
et al., 1996; Krause et al., 1998). From the three NOS isoenzymes, nNOS has been 
reported to be the prime source of the NO release from skeletal muscle and is strongly 
expressed in fast twitch muscle fibres (Hirschfield et al., 2000). NO can diffuse through 
the plasma membrane, thus the intracellular sources of NO may play a role in the 
extracellular release.  
Autoregulation of blood flow refers to the continuous adjustment in blood 
supply to various organs that is individualized in relation to metabolic demand and NO 
has been implicated in the microvascular response to muscle contractions (Stamler and 
Meissner, 2001). Studies in rat and human skeletal muscles have addressed the question 
of “NO involvement” by infusion of NOS inhibitors and it is believed that NO or 
nitrosothiol derived from microvascular endothelial cells factors importantly in control 
of skeletal muscle blood flow (Hickner et al., 1997; Thomas and Victor, 1998). In 
relations to this, increased blood flow during contractile activity is critical in providing 
L-arginine to skeletal muscle, the substrate of NOS isoenzymes (Stamler and Meissner, 
2001). 
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NOS 
ISOFORMS 
SUBCELLULAR 
LOCATION 
CHARACTERISTICS REFERENCES 
nNOS Plasma membrane 
i) interacts with α1-syntrophin in the 
membrane cytoskeleton-dystrophin 
complex of skeletal muscle, ii) has 
been reported to be the major site of 
NO release from skeletal muscle. 
(Brenman et al., 1996; 
Brenman et al., 1995; 
Powers and Jackson, 
2008) 
eNOS Mitochondria 
Activated through association with the 
90-kDa heat shock protein. 
(Garcia-Cardena et al., 
1998; Stamler and 
Meissner, 2001) 
iNOS Extracellular space 
i) expressed in skeletal muscle under 
inflammatory conditions, ii) activity is 
directly coupled to O2 concentration. 
(Powers and Jackson, 
2008) (Dweik et al., 
1998) 
 
Table 1.2 Characteristics of nitric oxide synthase (NOS) isoforms expressed in skeletal 
muscle.  
 
1.2.3.2 Sources of superoxide in skeletal muscle 
Superoxide anion is generated through either incomplete reduction of oxygen in 
electron transport systems or as a specific product of enzymatic systems. A variety of 
different potential sources of superoxide in skeletal muscle have been recognized such 
as generation by the mitochondria (Davies et al., 1982b; Halliwell and Gutteridge, 2007; 
Murphy, 2009; Loschen et al., 1974), the nicotinamide adenine dinucleotide phosphate 
(NADPH) oxidase enzymes (Xia et al., 2003; Hidalgo et al., 2006; Mofarrahi et al., 
2008; Whitehead et al., 2010), enzymes of the phospholipase A2 family (PLA2) (Gong 
et al., 2006; Nethery et al., 1999) and xanthine oxidase (Gomez-Cabrera et al., 2010; 
Gomez-Cabrera et al., 2003), (see figure 1.9).  
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1.2.3.2.1 Mitochondrial sources 
    Skeletal muscle consists of oxidative (type I), fast oxidative (Type llα) and 
fast glycolytic (llβ and llx) muscle fibers of which slow type I myofibers are rich in 
mitochondria. Mitochondria have generally been cited as the major source of ROS in 
muscle cells (Davies et al., 1982a; Davies et al., 1982b; Kanter, 1994; Urso and 
Clarkson, 2003) and the mechanisms of mitochondrial superoxide formation within 
skeletal muscle have been extensively studied for over 30 years. The mitochondrial 
electron transport chain is the main source of ATP in the mammalian cell (Mougios, 
2006; Scheffler, 1999; Kemp, 2004) and during energy transduction, 2-5% of the 
oxygen (the final electron acceptor of the electron transport chain) consumed by 
mitochondria may undergo one electron reduction, forming superoxide (Boveris and 
Chance, 1973; Loschen et al., 1974). Studies investigating mitochondria at the 
ultrastructural level have reported that the main sites of mitochondrial superoxide 
generation are complexes I (NADH dehydrogenase) and III (cytochrome bc1) of the 
electron transport chain (Barja, 1999; Muller et al., 2004). The mechanism of complex I 
dependent superoxide release involves a high NADH/NAD+ ratio in the mitochondrial 
matrix leading to increased superoxide production from the flavin mononucleotide 
(FMN) cofactor in complex I (Murphy, 2009). FMN cofactor accepts electrons from the 
NADH and passes them through the iron-sulfur clusters chain to the Coenzyme Q 
(CoQ) reduction site and the proportion of the FMN that is fully reduced is thought to 
be set by the NADH/NAD+ ratio (Kussmaul and Hirst, 2006; Murphy, 2009). 
Mitochondrial complex III has also shown to produce superoxide (Cadenas et al., 1977) 
and catalyzes the transfer of electrons from reduced CoQ to cytochrome c, with a 
concomitant translocation of protons across the inner mitochondrial membrane (Baum 
et al., 1967). Studies using the complex III inhibitor antimycin A have shown this 
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compound to enhance superoxide production in skeletal muscle mitochondria (Muller et 
al., 2004) which derives from the reaction of O2 with a ubisemiquinone bound to the Qo 
site (Turrens et al., 1985; Murphy, 2009).  
Superoxide anion is a membrane impermeant radical thus it is highly 
compartmentalized and research has been undertaken to identify the side of the inner 
mitochondrial membrane (those being the mitochondrial intermembrane space and the 
mitochondrial matrix), to which complex I and III release superoxide. With the 
development of analytical approaches, studies have delineated the x-ray structure of 
both complexes I and III and have concluded that complex I derived superoxide is 
exclusively released into the mitochondrial matrix whereas complex III dependent 
superoxide is released to both the mitochondrial matrix and the mitochondrial 
intermembrane space (Muller et al., 2004). The mitochondrial electron transport chain 
was the first source of superoxide to be suggested in skeletal muscle (Davies et al., 
1982a; Davies et al., 1982b), however other metabolic pathways have also been 
identified and contribute to the intracellular/extracellular generation of superoxide. 
These are described in detail in the following Sections of this chapter.  
 
1.2.3.2.2 Nicotinamide adenine dinucleotide phosphate oxidase enzymes 
    Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX) was 
fist discovered in phagocytes (Babior, 1978) and is considered a multi-component 
enzyme system that functions to generate superoxide. During the respiratory burst of 
phagocytic cells (neutrophils, macrophages and lymphocytes), NADPH oxidase 
catalyses the reduction of oxygen to superoxide by utilizing NADH and/or NADPH as a 
substrate (Babior, 1995; Bedard and Krause, 2007). NADPH oxidase localizes on the 
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plasma membrane of phagocytic cells and is a major component in immune defence 
since NOX-dependent superoxide production is used for the bactericidal action of these 
cells (Babior, 1995; Vazquez-Torres et al., 2000). The multicomponent enzyme system 
consists of catalytic and regulatory subunits which have distinct roles to initiate 
assembly and activation of the enzyme system (Bedard and Krause, 2007). There are 
five catalytic/membrane NOX isoforms (NOX1, NOX2, NOX3, NOX4 and NOX5) and 
two dual oxidase enzymes (DUOX1 and DUOX2), a small membrane-bound integral 
subunit (p22phox) localized to the membrane and three regulatory/cytosolic subunits; 
p40phox, p47phox and p67phox (Bedard and Krause, 2007; Lambeth et al., 2007), (Figure 
1.10). In addition, phagocyte NOX has been suggested to require the participation of a 
small GTP binding protein Rac (Rac1 and Rac2), for enzyme activation (Takeya and 
Sumimoto, 2003; Groemping and Rittinger, 2005), Rac has been shown to regulate a 
number of cell signaling pathways (Groemping and Rittinger, 2005). Under non-
activating conditions (resting phagocytes), p47phox, p67phox and p40phox proteins form a 
complex within the cytosolic compartment of phagocytic cells in which p67phox tethers 
p47phox to p40phox (Kuribayashi et al., 2002). However, upon cell stimulation, the 
cytosolic complex p47phox-p67phox-p40phox translocates to the membrane and rapidly 
assembles with the membrane bound NOX2/p22phox complex to form the active NOX2 
enzyme complex (Robinson, 2008; Robinson, 2009). This interaction occurs due to a 
conformational change of p47phox during cell activation, which renders p47phox capable 
of binding on p22phox (Kuribayashi et al., 2002). NOX2 contains binding sites for the 
co-enzymes flavin adenine dinucleotide (FAD) and NADPH and following assembly, 
electrons from NADPH are transferred across the membrane with the use of two haem 
groups and accepted by molecular O2 to generate superoxide, which is released on the 
outer side of the phagocytic membrane (Lambeth, 2004).  
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NADPH oxidases have recently been shown to be more widespread and studies 
have identified NADPH oxidase expression in skeletal muscle (Hidalgo et al., 2006; 
Javesghani et al., 2002; Xia et al., 2003; Espinosa et al., 2006; Mofarrahi et al., 2008; 
Whitehead et al., 2010). Although little information is available regarding the role and 
regulation of this complex in generation of superoxide in skeletal muscle, evidence 
suggests that skeletal muscle cells contain NADPH oxidase enzymes on the muscle 
fibre plasma membrane (Whitehead et al., 2010; Javesghani et al., 2002), the 
sarcoplasmic reticulum (SR) (Sun et al., 2011; Xia et al., 2003) and transverse tubules 
(T-Tubules) (Hidalgo et al., 2006). Pharmacological studies have indicated that skeletal 
muscle NADPH oxidase can alter the intracellular (Whitehead et al., 2010) and 
extracellular (Pattwell et al., 2004) content of superoxide. NOX expression on the SR 
and T tubules seems unlikely to contribute to the extracellular release since superoxide 
is a membrane impermeable anion. Recent reports have shown that skeletal muscle 
membrane depolarization may increase the activity of the complex and can influence 
calcium release by the SR through oxidation of the ryanodine receptor (Cherednichenko 
et al., 2004; Hidalgo et al., 2006). In addition, NADPH oxidases can also be stimulated 
by the activation of the phospholipase A2 enzymes (Zhao et al., 2002). 
NADPH oxidases are also expressed in endosomes and studies have shown that 
NOX-dependent superoxide production is important in the redox-dependent activation 
of NF-κB transcription factor (Mumbengegwi et al., 2008; Oakley et al., 2009) (see 
Section 1.7). Reports have examined how superoxide produced within the endosomes 
can facilitate redox-dependent signaling events in the cytoplasm and have provided 
evidence that the chloride channels located on the endosomal surface mediate the 
release of superoxide from the endosomes to the cytosolic compartment of epithelial 
(Mumbengegwi et al., 2008) and vascular smooth muscle cells (Lassegue, 2007). 
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Research in skeletal muscle has shown that recycling of endosomes is important for 
trafficking and maintenance of proteins at the neuromuscular junction and recent reports 
have shown that endocytic recycling regulators localise to the primary synaptic clefts of 
the neuromuscular junction (Mate et al., 2012). However, to my knowledge there is no 
evidence in the literature to suggest that endosomes are expressed in the intracellular 
compartment of skeletal muscle and contribute to superoxide changes. 
 
 
Figure 1.10 Schematic representation of the NADPH oxidase isoforms. Despite their 
similar structure and enzymatic function, NOX family enzymes differ in their 
mechanism of activation. NOX1 activity requires p22phox, NOXO1 (or possibly 
p47phox in some cases) and NOXA1, and the small GTPase Rac. NOX2 requires 
p22phox, p40phox, p47phox, p67phox, and Rac. NOX3 requires p22phox and NOXO1. NOX4 
requires p22phox, but in reconstitute systems it is constitutively active without the 
requirement for other subunits. NOX5, DUOX1, and DUOX2 are activated by Ca2+ and 
do not appear to require subunits (from Bedard and Krause, 2011). 
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1.2.3.2.3 Phospholipase A2 enzymes 
    Phospholipase A2 enzymes (PLA2) is a family of enzymes that cleave 
membrane phospholipids to release arachidonic acid, which also acts as a substrate for 
ROS-generating enzyme systems such as the lipoxygenases (Zuo et al., 2004). There are 
two forms of PLA2 enzymes present in skeletal muscle, the calcium-dependent (sPLA2) 
isoform which is located within the mitochondria and has been reported to stimulate the 
intracellular ROS generation during contractile activity (Nethery et al., 1999) and the 
calcium-independent form (iPLA2) which is expressed in the cytosolic compartment of 
skeletal muscle cells and has been shown to modulate cytosolic oxidant changes in 
skeletal muscle (Gong et al., 2006). In addition, the cytosolic isoform (cPLA2), which is 
not expressed in muscle cells is activated by micromolar concentrations of calcium and 
has also been claimed to stimulate ROS generation (Muralikrishna Adibhatla and 
Hatcher, 2006; Powers and Jackson, 2008). Although the contribution of PLA2 enzymes 
to superoxide production has not been extensively studied in skeletal muscle, other 
studies suggest that this family of enzymes might not directly produce superoxide but 
that it can regulate the activity of the lipoxygenases by modulating the release of 
arachidonic acid (Zuo et al., 2004).  
 
1.2.3.2.4 Xanthine oxidase 
    Xanthine oxidase (XO) has been identified as a source for superoxide 
generation based on the effects of XO inhibitors (allopurinol or oxypurinol) (Gomez-
Cabrera et al., 2003; Heunks et al., 2001). XO catalyzes the oxidation of hypoxanthine 
to xanthine and can further catalyze the oxidation of xanthine to uric acid. It is highly 
expressed in endothelial cells (Friedl et al., 1990; Cross and Jones, 1991) and recent 
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studies in skeletal muscle have show that XO activity may contribute to the increased 
extracellular superoxide release observed during contractile activity (Gomez-Cabrera et 
al., 2010).  
 
1.2.4    Which is the major intracellular source for superoxide in skeletal muscle? 
Considerable research has been undertaken to identify the major sites that 
contribute to superoxide production in skeletal muscle both at rest and during 
contractile activity. As mentioned earlier (Section 1.2.3.2), superoxide anion is 
generated through either incomplete reduction of oxygen in electron transport systems 
or as a specific product of enzymatic systems. Although there is little consensus on the 
prime intracellular sources for superoxide production in muscle, early studies suggested 
that the mitochondrial respiratory chain was the predominant source during contractile 
activity (Davies et al., 1982a; Koren et al., 1983). These studies supported early reports 
published in the 1970’s which suggested that 2–5% of the total oxygen consumed by 
mitochondria may undergo one-electron reduction with the generation of superoxide 
(Boveris and Chance, 1973; Loschen et al., 1974) and based on this observation, a large 
number of publications relate the increase in superoxide to the elevated oxygen 
consumption that occurs with increased mitochondrial activity, implying potentially a 
50–100 fold increase in superoxide generation in skeletal muscles subjected to aerobic 
contractions. 
However, recent studies examining the major contributors to superoxide 
production in skeletal muscle have produced inconsistent findings. Reports from this 
group have shown that the intracellular ROS changes in skeletal muscle increased by 
only 2 to 4-fold during contractile activity (McArdle et al., 2005; Palomero et al., 2008; 
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Pye et al., 2007; Vasilaki et al., 2010). Further studies investigating mitochondrial 
superoxide production failed to observe changes in MitoSOX Red fluorescence (a 
mitochondrial superoxide sensitive fluorescent probe) upon tetanic stimulation of single 
muscle fibres suggesting that superoxide production was not altered with increased 
contractile activity (Aydin et al., 2009). In relation to this, recent assessments of the rate 
of superoxide production by mitochondria indicate that only ∼0.15% of the total oxygen 
consumed by mitochondria is reduced to superoxide (St-Pierre et al., 2002), a value that 
is an order of magnitude lower than the original estimates of 2-5%. Moreover, recent 
reports have demonstrated that mitochondrial ROS generation is higher during the basal 
respiration state (state 4) compared with state 3 (maximal ADP-stimulated respiration) 
(Adhihetty et al., 2005; Kozlov et al., 2005), which further limits the mitochondrial 
generation of ROS during contractions since skeletal muscle mitochondria during 
aerobic contractions are predominantly in State 3.  
Collectively, these findings imply that mitochondria might not generate 
superoxide to the extent that was previously estimated. The possibility that other 
sources unrelated to mitochondria might contribute to superoxide in skeletal muscles 
has not been examined extensively although non-mitochondrial sites for superoxide 
production including NADPH oxidases and PLA2 enzymatic systems have been 
identified (Section 1.2.3.2). Hence, additional research is required to determine the sites 
that contribute to superoxide in skeletal muscle both at rest and during contractile 
activity.  
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1.3.      THE REGULATION OF RONS IN SKELETAL MUSCLE  
Skeletal muscle has a well-developed system to regulate the cellular production 
of RONS and protect the myocytes from oxidative injury (the term oxidative stress and 
the effect of reactive species in inducing oxidative damage has been described in detail 
in Section 1.3). The antioxidant network (the system that functions to prevent oxidative 
injury) consists of enzymatic and non-enzymatic antioxidants that work in a coordinated 
fashion to resist redox disturbances in the muscle cell. 
 
1.3.1  Enzymatic systems 
The main antioxidant enzymes include the superoxide dismutases, glutathione 
peroxidases, and catalase. There are however additional enzymes such as 
peroxiredoxins, glutaredoxins, and thioredoxin reductases, which also contribute 
significantly to preventing RONS toxicity in muscle fibres. In addition, a number of 
enzymes are involved in the supply of substrates for primary antioxidant enzymes such 
as glutathione reductase and glucose-6-phosphate dehydrogenase but they do not 
directly scavenge oxidants.  
 
1.3.1.1 Superoxide dismutase 
Superoxide dismutase (SOD) was discovered in 1969 (McCord and Fridovich, 
1969) and represents a family of metalloenzymes that catalyze the one electron 
dismutation of superoxide radical to H2O2 and oxygen (Jackson and McArdle, 2011; 
Palomero and Jackson, 2010). This reaction is considered to be very slow since 
superoxide radicals electrostatically repel each other (see Section 1.2.2.1). SOD 
metalloenzymes require a redox active transition metal bound to its active site to 
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accomplish the catalytic dismutation of superoxide anion (Culotta et al., 2006), which 
activity is also pH dependent (Radak, 2000). There are three SOD isoenzymes 
depending on the metal ion in the active site. Skeletal muscle expresses copper-zinc 
SOD (CuZnSOD or SOD1), which is a highly stable enzyme located within the cytosol 
and the mitochondrial intermembrane space, and manganese SOD (MnSOD or SOD2), 
which is not as stable as SOD1 and is found in the mitochondrial matrix (Powers and 
Jackson, 2008; Radak, 2000). There is however an additional isoform of SOD, the 
extracellular SOD isoenzyme (ecSOD or SOD3) which is present in the interstitial 
spaces of tissues and extracellular fluids of many cell types and tissues (Zelko et al., 
2002; Culotta et al., 2006), thus SOD3 accounts for the majority of the SOD activity in 
plasma, lymph and synovial fluid (Mates and Sanchez-Jimenez, 1999). Reports have 
also shown that SOD3 can be bound to heparin and its primary function is to reduce 
superoxide that is formed outside cell membranes due to inflammation and ischemia-
reperfusion (Fridovich, 1995). SOD provides the first line of enzymatic defence against 
superoxide and studies have shown that exercise can induce an increase in both SOD1 
and SOD2 activities (Leeuwenburgh et al., 1997; Oh-ishi et al., 1997). SOD1 protein 
has a half-life of 6 to 10 min whereas SOD2 5 to 6 hours (Gorecki et al., 1991) and table 
1.3 shows the antioxidant enzyme activity of SOD1 and SOD2 in a variety of tissues 
including fast and slow skeletal muscles. Oxidative muscle fibres have shown to have a 
higher mRNA and protein expression of SOD1 and SOD2 compared with fast 
glycolytic fibres (Radak, 2000). In skeletal muscle, 15-35% of the total SOD activity is 
in the mitochondria with the SOD2 isoenzyme accounting for 15-20% (Leeuwenburgh 
et al., 1997) and the remaining 65-85% is in the cytosol (Powers et al., 1994; Ji et al., 
1988). Although superoxide is not considered a highly reactive molecule, the 
importance of SOD as an important cellular redox system regulator is best illustrated in 
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studies using homozygotic SOD1 knockout mice, which will be described in detail in 
Section 1.5.  
 
Table 1.3 Antioxidant enzyme activity of superoxide dismutase (SOD), glutathione 
peroxidase (GPX), catalase (CAT) and glutathione reductase (GR) in various rat tissues 
including the liver, heart, soleus, deep vastus lateralis (DVL), superficial vastus lateralis 
(SVL) and erythrocytes; n.d., not determined  (from Radak, 2000). 
 
1.3.1.2 Glutathione peroxidase 
Glutathione peroxidase (GPX) is a homotetramer with each 22kDa subunit 
containing a selenium atom in the form of a selenocysteine and catalyzes the reduction 
of H2O2 to H2O or organic hydroperoxide (ROOH) to alcohol (ROH) by using reduced 
glutathione (GSH) or in some cases thioredoxin (TRX) or glutaredoxin (GRX) as the 
electron donor (Bjornstedt et al., 1994; Holmgren et al., 2005). In addition, recent 
reports also suggest that GPX is also implicated in the reduction of hydroxyl radical 
activity by elimination of H2O2 (Landis and Tower, 2005). When GSH provides the 
electrons to GPX to catalyse the reduction of ROS, GSH is oxidised to glutathione 
disulfide (GSSG) and further details regarding the regulation of GSH-GSSG are 
discussed in Section 1.3.2.1.1. GPX is highly specific for its hydrogen donor GSH and 
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its kinetic characteristics make it a versatile hydroperoxide remover in the cell thus 
inhibiting lipid peroxidation, DNA and RNA damage (Radak, 2000). Mammalian cells 
express five isoforms of GPX (GPX1-GPX5), which differ in substrate specificity and 
cellular localization (Brigelius-Flohe, 1999) with GPX1 as the cytosolic form (Frey et 
al., 2009) and GPX4 as the most widely expressed. GPX2 and GPX3 are rarely 
detectable in most tissues and GPX5 is the least described isoenzyme (Mates and 
Sanchez-Jimenez, 1999). The expression of the GPX genes is controlled by different 
mechanisms including oxygen tension, metabolic rate (Radak, 2000), toxins and 
xenobiotics (Halliwell and Gutteridge, 2007) as well as growth and development 
(Moscow et al., 1992). Similarly to SOD, type I muscle fibres express higher amounts 
of GPX compared with type IIb fibres (Powers et al., 1994) and its expression and 
activity increases with endurance exercise (Sen et al., 1992; Leeuwenburgh et al., 1997; 
Leeuwenburgh et al., 1994). Exercise-induced increase in GPX depends on both the 
duration and the intensity of the training regime, with moderate and high intensity 
exercise producing the largest increase in GPX activity (Powers et al., 1994). Table 1.3 
shows the antioxidant enzyme activity of GPX in a variety of tissues including fast and 
slow skeletal muscles. 
 
1.3.1.3 Catalase 
Catalase (CAT) is a homotetramer with a molecular mass of 240kDa and its 
antioxidant property is to catalyze the breakdown of H2O2 into H2O and O2 (Jackson, 
2008; Jackson, 2009). CAT requires heme (Fe3+) as a cofactor, bound at the enzyme’s 
active site for its catalytic function (Zamocky and Koller, 1999). As mentioned earlier, 
GPX is also a H2O2 regulator, and has a much higher affinity for H2O2 at low 
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concentrations (Km = 1µM) compared with CAT (Km = 1mM) (Powers and Jackson, 
2008). However, under conditions where H2O2 is significantly increased, CAT becomes 
more significant in protecting biological systems and its catalytic function prevails since 
it cannot be saturated under any H2O2 concentration since there is no apparent Vmax 
(Mates and Sanchez-Jimenez, 1999). In addition, CAT does not require reducing 
equivalents to function as a H2O2 reducer and is therefore considered an energy efficient 
antioxidant (Vetrano et al., 2005). The cellular location of CAT is different in 
comparison with GPX as it is mainly found in the cytosolic compartment of the muscle 
fibres. CAT activity increases with increased H2O2 and reports have shown that 
similarly to SOD and GPX, CAT protein expression and enzymatic activity is higher in 
highly oxidative fibres (Laughlin et al., 1990; Leeuwenburgh et al., 1994). 
 
1.3.1.4 Additional RONS regulatory enzymes 
In addition to SODs, GPXs and CAT, skeletal muscles express additional 
enzymes such as peroxiredoxins, thioredoxin reductases and glutaredoxins which have 
significant antioxidant defense properties and can further contribute to maintain the 
redox homeostasis in skeletal muscle cells.  
 
1.3.1.4.1 Thioredoxin system 
    The thioredoxin (TRX) system consists of thioredoxins (TRXs) and 
thioredoxin reductases (TRXRs) (Dimauro et al., 2012). TRXs are a class of small 
multifunctional proteins that are present in all eukaryotic and prokaryotic organisms and 
are susceptible to oxidation/reduction in the presence of oxidants (Powis and Montfort, 
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2001). TRXs are present in various cellular compartments; Trx1 isoform is found in the 
nucleus and cytosol (Trx1 can be imported into the nucleus from the cytoplasm during 
various forms of oxidative stress (Wei et al., 2000)) and TRX2 is localized in the 
mitochondria (Spyrou et al., 1997). The oxidised form of TRXs is reduced by TRXRs, 
by utilizing electrons from NADPH (Holmgren, 1985). Similarly to the TRXs there are 
two isoforms of TRXRs; the cytosolic and nuclear isoform (TRXR1) and the 
mitochondrial isoform (TRXR2) (Dimauro et al., 2012). TRXs are key intracellular 
regulators of redox signaling and evidence has shown that the TRX system is 
responsible for maintaining proteins in their reduced state and the control of apoptosis 
(Arner and Holmgren, 2000). 
 
1.3.1.4.2 Glutaredoxins 
    Glutaredoxins (GRXs) share many of the functions of TRXs but are reduced 
by GSH rather than a specific reductase (Berndt et al., 2007). GRXs are small redox 
enzymes that exist in either a reduced or oxidised form and are involved in the 
protection and repair of protein and non-protein thiols during periods of oxidative stress 
(Berndt et al., 2007). Human cells express three types of GRX; GRX1 is found in the 
cytosol, GRX2 and GRX5 are located in the mitochondria (Powers and Jackson, 2008). 
GRXs show overlapping functions with the TRX system and have been reported to 
inhibit apoptosis and reduce protein disulfides at the expense of GSH (Enoksson et al., 
2005). 
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1.3.1.4.3 Peroxiredoxins 
    Peroxiredoxins (PRXs) were discovered in the late 80’s (Kim et al., 1988; 
Kim et al., 1985) and have recently received much attention. PRXs, initially know as 
thiol-specific antioxidants (Chae et al., 1993) are a family of cysteine-dependent 
thioredoxin peroxidases (Wood et al., 2003). PRXs are considered important antioxidant 
enzymes, which are capable of reducing both hydroperoxides and H2O2 (Rhee et al., 
2005b; Rhee et al., 2005c) with the use of electrons provided by TRXs (Rhee et al., 
2005a). Following detoxification of H2O2, the oxidised form of PRX is inactive, 
requiring the donation of electrons from reduced TRX to restore its catalytic activity 
(Pillay et al., 2009). Skeletal muscles express six isoforms of PRX, which are present in 
the cytosol (PRX I, II, VI), the mitochondrion (PRX III) and the extracellular space 
(PRX IV) (Powers and Jackson, 2008). An additional isoform of PRX, (PRXV) is 
expressed in the cytosol, mitochondria, nuclei and perixosomes (Rhee et al., 2005a) and 
is considered a peroxynitrite reductase (Dubuisson et al., 2004; Trujillo et al., 2008). 
 
1.3.2  Non-Enzymatic systems 
In addition to the antioxidant enzyme defence network, skeletal muscle also 
contains non-enzymatic systems, which regulate reactive species and protect muscle 
cells from oxidative injury. These are water soluble and fat soluble (Halliwell and 
Gutteridge, 2007) and are classified into two categories: i) the endogenously produced 
and ii) dietary antioxidants which cannot be synthesized or induced and must be taken 
from the diet.  
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1.3.2.1 Endogenous non-enzymatic antioxidants 
The most important non-enzymatic endogenously produced antioxidants are 
glutathione, uric acid, bilirubin and coenzyme Q10.  
 
1.3.2.1.1 Glutathione 
    Reduced glutathione (GSH) is the most abundant endogenous antioxidant in 
eukaryotic cells and is a major player in the regulation of the cellular redox state (Kim 
and Vaziri, 2010). GSH a tripeptide and is synthesized in the liver, by GSH synthetase 
(Radak, 2000). The release of GSH from the liver is stimulated by catecholamines, 
glycagon and vasopressin and is transported to tissues via the circulation (Lu et al., 
1992; Sies and Graf, 1985). GSH is the most abundant non-protein thiol in cells and 
plays an important role in converting disulfides to thiols as well as maintaining substrate 
levels for GPX to eliminate H2O2 and hydroperoxides (Meister and Anderson, 1983). 
Glutamate cysteine ligase (GCL) catalyzes the rate-limiting step in the formation of 
GSH (Krejsa et al., 2010). The GCL holoenzyme consists of two separately coded 
proteins, a catalytic subunit (GCLC) and a modifier subunit (GCLM). Both GCLC and 
GLCM are controlled transcriptionally by a variety of cellular stimuli, including 
oxidative stress (Krejsa et al., 2010). Expression of GCL is regulated by the redox-
sensitive transcription factor Nrf2 (Kim and Vaziri, 2010) (see Section 1.7) and 
experimental evidence undertaken in Nrf2-null mice has shown that regulation of GSH 
in cardiomyocytes is linked to the Nrf2 regulated pathway (Brewer et al., 2011). By 
donating a pair of hydrogen ions, GSH is oxidised to glutathione disulfide (GSSG) 
(Powers and Jackson, 2008). Although GSSG levels in most tissues are very low (de la 
Asuncion et al., 1996), the reduction of GSSG is catalyzed by glutathione reductase 
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(GR), a flavin containing enzyme, where NADPH is used as the reducing agent 
(Halliwell and Gutteridge, 2007; Radak, 2000). In many tissues, NADPH is produced 
by glucose-6-phosphate dehydrogenase, however studies in skeletal muscle have 
identified that NADPH is primarily supplied by isocitrate dehydrogenase (Vetrano et 
al., 2005). GSH can react directly with a variety of radicals by donating a hydrogen 
atom (Yu, 1994) and has been shown to reduce vitamin C and E radicals derived in 
chain breaking reactions with alkoxyl or lipid peroxyl radicals (Powers and Jackson, 
2008; Radak, 2000). The GSH concentration varies from tissue to tissue and studies in 
skeletal muscle have shown that type I muscle fibres contain a higher GSH content than 
type IIb although the ratio GSH/GSSG (an additional indicator of redox status) appears 
to be consistent across various fibre types (Ji, 1995). Intracellular GSH levels are 
regulated by GSH utilization and GSH synthesis and due to the large muscle mass of the 
body, the relatively high concentration of GSH in skeletal muscle can influence plasma 
GSH levels (Kretzschmar et al., 1992; Sen et al., 1992). High intracellular levels of 
GSSG have shown to inactivate enzymes and cause damage to the cell (Halliwell and 
Gutteridge, 2007), however skeletal muscle fibres are capable of exporting GSSG to 
maintain the GSH/GSSG ratio (Meister and Anderson, 1983).    
 
1.3.2.1.2 Uric acid 
    Uric acid (UA) may also function to protect muscle fibres against oxidative 
injury and is a strong reducing agent by acting as an electron donor (Halliwell and 
Gutteridge, 2007). UA is a by-product of purine metabolism and has shown properties 
in scavenging peroxyl and hydroxyl radicals as well as singlet oxygen (Davies et al., 
1986; Sevanian et al., 1985). In humans, over half of the antioxidant capacity of blood 
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plasma derives from UA (Maxwell et al., 1997). Contractile activity of high intensity 
has shown to increase plasma UA levels due to increased release of hypoxanthine and 
xanthine from the muscle into the circulation and the subsequent convertion of these 
products to UA by xanthine oxidase, which is present in endothelial cells of blood 
vessels (Samra et al., 1991). At physiological pH, uric acid exists mainly as urate 
(Powers and Jackson, 2008), which has also been shown to protect against oxidative 
damage by acting as an electron donor (Halliwell and Gutteridge, 2007). Urate is also 
capable of preventing hydroxyl radical formation by hindering the Fenton reaction as it 
is considered a metal ion chelator (Halliwell and Gutteridge, 2007).  
 
1.3.2.1.3 Bilirubin and Coenzyme Q10 
    Bilirubin is the final product of hemoprotein catabolism, and similarly to UA 
it possesses antioxidant properties against peroxyl radicals and lipid peroxidation 
(Stocker et al., 1987a; Stocker et al., 1987b). Contractile activity has shown to increase 
blood levels of bilirubin and evidence suggests that is can protect cells from the toxic 
levels of H2O2 (Baranano et al., 2002). Upon oxidation, bilirubin is converted to 
biliverdin and then recycled back to bilirubin, a reaction catalysed by biliverdin 
reductase (Liu et al., 2006; Baranano et al., 2002). Coenzyme Q10 (CoQ10) also known 
as ubiquinone contributes to peroxyl radical scavenging and inhibits lipid peroxidation 
(Sena et al., 2008). CoQ10 is abundant on the inner mitochondrial membrane and plays 
an essential role in mitochondrial electron transport as an electron carrier (Halliwell and 
Gutteridge, 2007). Although few data are available regarding the role of CoQ10 as an 
antioxidant in vivo, evidence has shown that exercise can increase the CoQ10 content in 
skeletal muscle (Gohil et al., 1987). 	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1.3.2.2 Dietary antioxidants 
Nutrition significantly impacts the cellular antioxidant system and research has 
identified that dietary antioxidants such as vitamin C, vitamin E and carotenoids also 
exert defensive properties and protect muscle cells from RONS toxicity. Vitamin E is a 
lipid-soluble antioxidant and possesses strong membrane-stabilizing effects, thus it 
protects cells from lipid peroxidation (Dillard et al., 1978; Jackson et al., 2007). 
Intervention studies have shown that vitamin E deficiency can disturb cell membrane 
fluidity (Dillard et al., 1978), alter GSH/GSSG (Anzueto et al., 1993) and exacerbate 
mitochondrial dysfunction and lipid peroxidation in skeletal muscle (Davies et al., 
1982b). Carotenoids which are also located in the membranes of tissues show 
significant antioxidant defence properties by protecting myocytes from lipid 
peroxidation (Krinsky, 1998). Due to their structural arrangement, carotenoids are 
efficient biological antioxidants and can scavenge superoxide and peroxyl radicals 
(Krinsky, 1998). In contrast, vitamin C is a hydrophilic vitamin and therefore functions 
in a aqueous environment, the cytosolic cellular compartment and extracellular fluid 
(Beyer, 1994). Vitamin C scavenges superoxide, hydroxyl radical, and lipid 
hydroperoxide radicals (Carr and Frei, 1999) and can additionally play an important role 
in the recycling of vitamin E (Packer et al., 1979). Most mammalian species synthesize 
vitamin C. High doses can have a prooxidant effect (Yu, 1994) and induce hydroxyl 
radical formation due to reaction with transition metal ions (Halliwell and Gutteridge, 
2007). 
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1.4.    RONS METABOLISM IN GLYCOLYTIC AND OXIDATIVE SKELETAL 
MUSCLE FIBRES 
Reports have demonstrated the existence of differences between glycolytic and 
oxidative skeletal muscle fibres in RONS metabolism (Picard et al., 2012). 
Experimental evidence in both permeabilised fibres and in isolated mitochondria have 
shown that H2O2 release was two - to threefold higher from mitochondria in white 
gastrocnemius (fast glycolytic) compared with the soleus muscle (oxidative) under basal 
state 2 respiration in the presence of complex I or complex II substrates (Picard et al., 
2011; Anderson and Neufer, 2006). As a consequence, superoxide leak expressed as a 
percentage of total electron flux through the respiratory chain was 3.5-fold greater in 
mitochondria from the white gastrocnemius compared with that of the soleus muscle 
(Picard et al., 2008). Although the mechanisms underlying this substantial difference in 
H2O2 release are not fully understood, there is evidence of fibre type differences in the 
subcellular H2O2 scavenging systems (Treberg et al., 2010). Direct measurements in 
muscle fibres have shown that the capacity of mitochondria from fast-glycolytic fibres 
to scavenge an exogenous H2O2 load is approximately 40–50% lower compared with 
mitochondria from slow-oxidative fibres (Anderson and Neufer, 2006). This can be 
attributed to the activities of important antioxidant enzymes, which are significantly 
lower in glycolytic muscle compared with oxidative muscle. Reports have shown that 
glutathione peroxidase and catalase, the main H2O2 reducing systems are on average 
88% lower in glycolytic compared with oxidative muscles (Picard et al., 2012). Overall, 
current evidence suggests that oxidative muscle fibres, fibres which contain a large 
mitochondrial biomass are more protected against ROS toxicity whereas fast glycolytic 
muscles exhibit a greater ROS production. In relation to this, it has been suggested that 
the higher intracellular ROS content in fast-twitch muscles may be required to maintain 
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redox-dependent signaling pathways such as the control of redox-sensitive transcription 
factors (see Section 1.7).  
 
1.5.  RONS INDUCE OXIDATIVE DAMAGE TO SKELETAL MUSCLE  
            CELLS  
Oxidative stress is defined as an imbalance between oxidants and antioxidants 
(Sohal and Weindruch, 1996) and early studies that examined the effect of oxidant 
production during contractile activity suggested that these species were inevitably 
damaging to muscle cells (Davies et al., 1982b). The first evidence that contracting 
skeletal muscles produce free radicals appeared in the early 80’s and it was suggested 
that oxidants are essentially by-products of metabolism and deleterious to cells and 
tissues (Davies et al., 1982b). Excess RONS production and accumulation can induce 
severe cellular damage, leading to physiological dysfunction and cell death, 
contributing to chronic disease development (Zelko et al., 2002) and it is clear that 
oxidants can act as mediators of contraction-induced damage to skeletal muscle 
(Jackson et al., 1985; Reid et al., 1992) in situations where RONS are excessively 
augmented or when antioxidant defenses are compromised (Jackson et al., 2007; 
McArdle et al., 1999; Powers and Jackson, 2008). Elevated oxidants can result in 
oxidative damage to virtually all macromolecules including proteins, carbohydrates, 
lipids and nucleic acids (mitochondrial and nuclear) leading to mutagenesis and loss of 
function (Pulliam et al., 2012). The sensitivity of a particular target is defined by the 
local redox state and the intrinsic sensitivity of the molecule to oxidation-reduction 
(Halliwell and Gutteridge, 2007; Radak, 2000) and studies in skeletal muscle have 
identified that oxidants can induce oxidative damage to redox sensitive contractile 
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proteins such as myosin heavy chain proteins (Coirault et al., 2007; Yamada et al., 
2006) and troponin C (Kaneko et al., 1992; Plant et al., 2000), see Sections 1.1.5 and 
1.1.6 for a detailed description of muscle contractile proteins. In particular, in vitro 
experiments have shown that peroxynitrite can mediate the oxidation of myosin heavy 
chains as shown by the increase in protein carbonylation in purified myosin fractions 
(Coirault et al., 2007). Further reports have also examined the functional consequences 
of myosin oxidation on motor function and have reported that the velocity of actin 
sliding over myosin is significantly reduced following myosin heavy chain oxidation 
indicating that oxidative modification of myosin may impair actin-myosin binding 
(Coirault et al., 2007; Yamada et al., 2006). Skeletal muscle mitochondria were 
suggested to be the major sources of oxidative damage in skeletal muscle but it is now 
clear that there are endogenous sources of reactive species other than mitochondria (see 
Section 1.2.3.2). Inflammatory and degenerative muscle diseases, such as muscular 
dystrophies (Whitehead et al., 2010) or immobilization of skeletal muscle (Kondo et al., 
1991; Kondo et al., 1993) are associated with increased levels of oxidative damage and 
muscle weakness. Oxidative stress can contribute to the rate of muscle atrophy by 
promoting the activation of calpain (Kondo et al., 1992; Powers et al., 2007) and/or 
capsase-3 (Du et al., 2004; McClung et al., 2007) and the magnitude of the change in 
redox state determines the biological effect.  
 
1.6.  RONS ARE IMPLICATED IN THE PROCESSES OF SKELETAL  
            MUSCLE AGEING 
Ageing is defined as an age-related increase in susceptibility to diseases and 
death (Maynard Smith, 1962). Ageing is a complex process that affects every major 
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system at the molecular, cellular and organ levels and although the exact cause of 
ageing is unknown, there is significant evidence that oxidative stress plays a major role 
in the ageing process. As early as 1956, Denham Harman suggested that free radicals 
are likely to be involved in ageing and proposed the free radical theory of ageing 
(Harman, 1956). This theory has gained considerable momentum in recent years due to 
the ability of reactive species to modulate a variety of intracellular signal transduction 
processes that are linked to widespread biological processes. The basis of the oxidative 
stress hypothesis is that ageing occurs as a result of an imbalance between oxidants and 
antioxidants, which leads to the accrual of damaged proteins, lipids and DNA 
macromolecules with age (Harman, 1956), resulting in a progressive loss in the 
functional efficiency of various cellular processes (Muller et al., 2007). 
Studies in the 70’s suggested that mitochondrial organelles could generate a 
disproportionately large amount of reactive oxygen species (Boveris and Chance, 1973). 
Based on this finding, Harman proposed a modification of the free radical theory 
(Harman, 1956) and described the mitochondrial theory of ageing (Harman, 1972) 
giving a central role to mitochondria. Over the last 4 decades, there has been an 
enormous increase in information concerning the effect of oxidants with age and 
although there is evidence in support of the oxidative stress theory of ageing, there are 
also studies that do not directly support this theory (Muller et al., 2007; Perez et al., 
2009a; Perez et al., 2009b; Sohal and Orr, 2012).  
The causes of ageing can be divided into exogenous/extrinsic (including 
environmental stresses such as pollution, exercise and nutrition) and 
endogenous/intrinsic (including genetically associated processes and passive random 
biochemical processes which may involve reactive species associated damage) (Radak, 
2000). The extrinsic factors can influence intrinsic causes and reactive species reactions 
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can affect ageing extrinsically and intrinsically, in active and passive ways (Radak, 
2000). Many studies have indicated a positive correlation between tissue concentration 
of oxidised macromolecules and life span including an increase in DNA damage (Wang 
et al., 2010; Mecocci et al., 1999), accumulation of oxidised proteins (Mecocci et al., 
1999; Goto et al., 1995) and increased levels of lipid peroxidation (Reckelhoff et al., 
1998; Miro et al., 2000) with age. Increased DNA damage has been shown to alter 
genetic stability and may induce the expression of genes that regulate cell proliferation 
and/or block the expression of certain genes, thus permit damage with increasing age 
(Simic, 1992). RONS induced DNA sequence changes or mutations have been 
suggested to affect the cellular state of differentiation (Cutler, 1991; Halliwell and 
Gutteridge, 2007) and in relation to the mitochondrial theory of ageing (Harman, 1972), 
the accumulation of mitochondrial DNA damage (Wang et al., 2010) has been proposed 
to prevent the rejuvenation of the mitochondrial population and lead to bionergetic 
decline and cellular death (Miquel et al., 1998). The accumulation of altered/oxidised 
proteins in aged tissues further implies the possible involvement of RONS in the 
processes of ageing (Goto et al., 1995; Simic, 1992). Aged tissues show an 
accumulation of catalytically inactive or less active forms of enzymes and the observed 
age-related changes in catalytic activity have been suggested to occur due to oxidative 
modifications induced by reactive species (Goto et al., 1995; Simic, 1992). Age-related 
changes in lipid peroxidation have also been observed with tissues from aged rodents 
showing higher levels of lipid peroxidation and intervention studies have shown that 
vitamin E supplementation can reduce lipid peroxidation and LDL oxidation in tissues 
from aged rodents (Yu et al., 1998; Reckelhoff et al., 1998) 
The role of oxidants in ageing has also been extensively examined in different 
model organisms, which have undergone genetic manipulations with inconsistent 
	   48	  
findings (Muller et al., 2006; Vasilaki et al., 2010; Jakupoglu et al., 2005; Conrad et al., 
2004; Ran et al., 2007). Transgenic and knockout mouse studies have provided insight 
into the function of RONS regulatory enzymes in ageing and it has been shown that 
homozygotic mice lacking SOD2 (Li et al., 1995), TRX1 (Matsui et al., 1996), TRX2 
(Nonn et al., 2003), TRXR1 (Jakupoglu et al., 2005) and TRXR2 (Conrad et al., 2004) 
are embryonically lethal, suggesting that these enzymes are required for embryonic 
development. Mouse models with a shorten lifespan include PRX1-/- (Neumann et al., 
2003), PRX2-/- (Lee et al., 2003) and SOD1-/- mice (Muller et al., 2006; Vasilaki et al., 
2010) whereas GPX1-/- (Perez et al., 2009a; Perez et al., 2009b) and SOD3-/- (Carlsson 
et al., 1995; Sentman et al., 2006) knockout mouse studies showed not effect on 
lifespan. In contrast, transgenic mouse studies which included overexpression of RONS 
protective enzymes have failed to provide evidence of increased lifespan with the 
exception of mitochondrial catalase overexpressing mice which showed a 21% increase 
in lifespan (Schriner et al., 2005). As mentioned earlier (Section 1.3.1.3), catalase is not 
expressed in mitochondria and the effect on lifespan is likely to be related to a reduction 
in H2O2.   
The reduction in lifespan shown in PRX1-/- and PRX2-/- mice is much more 
pronounced in SOD1-/- mice (30% reduction) and provides support for the oxidative 
theory of ageing. In addition, homozygotic SOD1 knockout mice show an accelerated, 
age-related loss of skeletal muscle mass, which mimics the loss that occurs in wild type 
control mice past median lifespan and in older humans (Larkin et al., 2011; Jang et al., 
2010). Studies in humans have shown that by the age of 70, the cross-sectional area of 
skeletal muscle is reduced by 25–30%, and muscle strength is reduced by 30–40% 
(Porter et al., 1995). Oxidative damage has been claimed to be involved in the loss of 
tissue function that occurs during ageing, and skeletal muscle of old rodents has been 
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reported to contain increased amounts of the products of oxidative damage to 
biomolecules such as lipid, DNA, and proteins in comparison with young or adult 
rodents (Broome et al., 2006; Sastre et al., 2003; Vasilaki et al., 2007). Elevated 
oxidative stress has also been observed in skeletal muscles from SOD1 knockout mice, 
thus this mouse model may potentially provide a useful model to study the role of a 
chronic oxidative stress in loss of skeletal muscle and to uncover potential targets for 
intervention for preventing sarcopenia in humans.  
As mentioned earlier in Section 1.3.1.1, SOD1 is present in the cytosol and 
mitochondrial intermembrane space and catalyzes the autocatalytic oxidation and 
reduction of superoxide to molecular oxygen and H2O2. Hence, the skeletal muscle 
ageing phenotypic changes seen in SOD1 knockout mouse model are hypothesised to be 
related to elevated superoxide content. However, superoxide can react rapidly with NO 
to form peroxynitrite (see Section 1.2.2.5), thus alternative species might play a key role 
in the observed muscle atrophy. Hence, to identify the reactive species that are 
implicated in skeletal muscle degeneration it is essential to monitor specific radical 
species and further research is warranted to assess the changes in RONS and adaptive 
responses that occur in skeletal muscles from SOD1 knockout mice.  
 
1.7.  RONS ARE IMPORTANT REGULATORY MOLECULES IN  
            SKELETAL MUSCLE  
Although high levels of reactive species can induce cellular oxidative damage 
(see Sections 1.3 and 1.4), recent data indicate that RONS play multiple regulatory roles 
and influence the biology of skeletal muscles by fulfilling important cellular functions 
(Droge, 2002; Jackson et al., 2007; Powers and Jackson, 2008; Reid et al., 1993; 
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Jackson et al., 2002; Go and Jones, 2010; Gong et al., 2006). The concept that oxidants 
are essential in the physiology of skeletal muscles contrasts starkly with previous 
evidence that RONS were inevitably damaging to cellular components of muscle cells. 
Due to recent advances in the field of muscle redox status there is evidence that the 
cellular redox balance can be harnessed and changed to better suit specific metabolic 
needs, and that it can be considered as a dynamic condition, fluctuating from a 
relatively reduced state to relative oxidation, depending on functional requirements 
(Hwang et al., 1992; Ziegler, 1985). Indeed, for some cellular processes, a particular 
redox state “optimal redox state” is required for optimal function and changes to the 
oxidised or reduced state might be detrimental (Andrade et al., 1998; Aghdasi et al., 
1997; Radak, 2000). 
 
1.7.1  RONS regulate Ca2+ release from the sarcoplasmic reticulum  
Recent reports have shown that oxidants control Ca2+ release in skeletal muscle 
by controlling the opening of calcium release channels (ryanodine receptor) in the 
sarcoplasmic reticulum (Hidalgo et al., 2006; Sun et al., 2011). This has been suggested 
to occur via oxidative modification of the ryanodine receptor in which, critical thiol 
groups are oxidised (Abramson and Salama, 1989; Hidalgo et al., 2006). This implies 
the existence of an optimal redox state for ryanodine receptor in which the state of the 
redox sensitive thiol groups modulates the channel activity. In relation to this, 
sarcoplasmic Ca2+ ATPases are also redox sensitive and exposure to oxidants has shown 
to inhibit the enzymatic activity of these proteins (Andrade et al., 1998).  
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1.7.2  RONS regulate the activation of enzymes and protein kinases   
Oxidants and reductants have shown to modulate the activity of a variety of 
enzymes including enzymes involved in glycolysis, tricarboxylic acid cycle and 
oxidative phosphorylation (Stamler and Meissner, 2001; Ziegler, 1985; Gardner et al., 
1995). Nitric oxide increases during periods of contractile activity (Pye et al., 2007) and 
it has shown to increase the supply of glucose to the exercised muscles by dilating the 
arterioles and by inhibiting the enzymatic activity of creatine phosphokinase, 
glyceraldehyde-3-phosphate dehydrogenase, cytochrome c oxidase and aconitase 
(Balon and Nadler, 1994; Stamler and Meissner, 2001). As mentioned earlier in Section 
1.2.2.2, NO can stimulate guanylyl cyclases thus increase the cGMP content which can 
in turn activate a number of protein kinases, phosphodiesterases and ion channels 
(Stamler and Meissner, 2001; Schmidt et al., 1993; Lucas et al., 2000).  
 
1.7.3  RONS regulate redox-sensitive transcription factors  
Recent reports also suggest that reactive species are important signaling 
molecules as they can initiate and mediate signal transduction pathways (Droge, 2002; 
Jackson, 2008; Powers and Jackson, 2008). Studies in skeletal muscle have shown that 
changes in cell signaling following contractile activity are likely to be mediated by the 
increased RONS production observed during contractions (Vasilaki et al., 2006; 
McArdle et al., 2001). Studies from this group have showed that the exercise dependent 
increase in Heat Shock Protein (HSP) 60 and 70 (proteins that are associated with 
significant protection against subsequent cellular damage) as well as SOD and CAT 
activity (McArdle et al., 2001) was attenuated following pre-supplementation with 
antioxidant vitamin C, supporting the possibility that these responses were regulated by 
reactive species (Jackson et al., 2004; Khassaf et al., 2003). One mechanism by which 
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cells respond to RONS is through activation of redox sensitive transcription factors 
(Jackson et al., 2002; Go and Jones, 2010; Mann et al., 2007a) which are involved in the 
upregulation of antioxidant enzymes such as nuclear factor erythroid 2-related factor 
(Nrf2), Nuclear Factor κB (NFκB) and Activator Protein -1 (AP-1) (Jackson et al., 
2002; Powers and Jackson, 2008; Mann et al., 2007a; Mann et al., 2007b; Pamplona and 
Costantini, 2011; Kim and Vaziri, 2010), HSPs are primarily regulated by the 
transcription factor Heat Shock Factor (HSF1) (Cotto and Morimoto, 1999). Additional 
studies from this group have confirmed that an isometric protocol that increased 
oxidants generation in mouse skeletal muscle, activated the transcription factors NFκB, 
AP-1 and HSF1 which resulted in increased content of SOD, CAT and HSPs (Vasilaki 
et al., 2006).  
 
The ability of cells and tissues from old mammals to respond to a variety of 
stresses by an increased content of HSPs and RONS protective enzymes is severely 
attenuated (Demirel et al., 2003; Hall et al., 2000). Reports in skeletal muscle have 
shown that the increase in the protein expression of antioxidant enzymes and HSPs that 
is evident in muscles of adult rodents following isometric contractions was abolished in 
muscles of old rodents and this inability to adapt was due to the lack of complete 
activation of the appropriate transcription factors (Vasilaki et al., 2006). Recent 
experimental evidence suggest a molecular cross-talk between Nrf2 and NFκB signaling 
pathways (Stepkowski and Kruszewski, 2011) and studies have demonstrated that the 
age-related inability to activate the redox-sensitive transcription factors including Nrf2, 
NFκB, AP-1 and HSF1 and the subsequent failure of HSP and antioxidant protective 
enzyme upregulation plays a critical role in the development of functional deficits that 
occur with ageing in skeletal muscle (Vasilaki et al., 2010; Steinbaugh et al., 2012; 
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Safdar et al., 2010). Transgenic studies have shown that overexpression of HSP70 in 
mouse skeletal muscle provided protection against the fall in specific force associated 
with ageing and facilitated rapid and successful regeneration following contraction-
induced damage in muscles of old HSP70 overexpressor mice compared with the 
impaired regeneration and recovery normally observed in old WT mice (McArdle et al., 
2004). This protection was associated with prevention of oxidative damage and 
importantly, maintenance of the ability of muscles of old HSP70 overexpressor mice to 
activate NFκB following contractions (Broome et al., 2006) indicating a close 
relationship between retention of the ability of muscle from old mice to regenerate and 
the ability of those muscles to activate transcription factors (Safdar et al., 2010). A 
schematic figure of how reactive species can activate the Nrf2 pathway and 
subsequently the expression of RONS protective enzymes is shown in figure 1.11. 
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Figure 1.11 Schematic representation of Nrf2 activation by reactive species. Under 
normal conditions, Nrf2 is sequestered in the cytoplasm via binding to its repressor 
molecule, Keap1. Oxidants cause dissociation of Nrf2-Keap1 complex, which 
culminates in ubiquitination of Keap1 and nuclear translocation of Nrf2. After 
heterodimerization with other transcription factors such as small Maf, within the 
nucleus, Nrf2 promotes transcriptional activation of antioxidant and detoxifying 
enzymes by binding to the antioxidant responsive elements (ARE) in the promoter 
regions of the target genes (from Ramplona and Costantini, 2011). 
 
1.7.4  RONS regulate skeletal muscle force production  
The physiological importance of oxidants as regulators of skeletal muscle 
metabolism is further implied from the strong relationship between reactive species and 
skeletal muscle force production. Studies have identified that muscle redox status has an 
important influence on force production in unfatigued skeletal muscle. It has been 
shown that a modest increase in oxidants in skeletal muscle fibres resulted in an 
increase in force production (Reid et al., 1993) whereas muscles exposed to higher or 
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lower ROS concentrations, the force production was lower, indicating that skeletal 
muscle force production is likely mediated by reactive species production (Reid and 
Moody, 1994). A potential pathway that might be involved in modification of skeletal 
muscle force production is the effect of oxidants on the calcium sensitivity of 
myofilaments (Smith and Reid, 2006).   
 
1.8.  SUMMARY  
In summary, RONS are constantly produced by resting and contracting skeletal 
muscle fibres from a variety of cellular locations. The generation of oxidants is 
augmented during contractile activity and this increase may induce oxidative damage to 
muscle cells when antioxidant defenses are compromised or when RONS production is 
grossly excessive. Although the field of muscle redox biology has advanced rapidly and 
many sources have been identified to contribute to this apparent increase, there is still 
however considerable debate regarding the major sites that contribute to the increased 
rate of muscle superoxide generation during contractile activity (see Section 1.2.4). 
Recent advances in redox biology have shown that reactive species production under 
physiological conditions plays important roles in the physiological adaptations of 
muscle to contractions. It has become clear that low-to-moderate levels of oxidants are 
essential in the physiology of skeletal muscle as they are implicated in the control of 
gene expression, regulation of cell signaling pathways, and modulation-optimization of 
skeletal muscle force production.  In contrast, excess RONS production can induce 
severe cellular damage, leading to physiological dysfunction and cell death. In addition, 
oxidative stress is implicated in the processes of skeletal muscle ageing and genetic 
interventions (SOD1-/- mice) have provided evidence that increased levels of oxidative 
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damage contribute to the rate of muscle atrophy, though the specific oxidants that play a 
key role in skeletal muscle ageing are yet to be examined. 
 
1.9.  AIMS  
Hence, the main aims of this thesis were: 
 
• Develop specific techniques to examine cytosolic and mitochondrial superoxide 
in single isolated mature skeletal muscle fibres. 
• Identify the major sites that regulate cytosolic superoxide in both resting and 
contracting isolated fibres. 
• Identify the reactive species that are involved in the accelerated loss of muscle 
mass in the homozygotic SOD1 knockout mouse model and to characterize the 
changes in redox status and adaptive responses that occur in muscles from the 
SOD1 knockout mice. 
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CHAPTER 2 
EXPERIMENTAL METHODS 
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2 EXPERIMENTAL METHODS 
2.1 CHEMICALS AND REAGENTS  
Unless stated otherwise, all chemicals used in this study were obtained from 
Sigma Chemical Company, Dorset, UK. 
 
2.2 ISOLATION OF SINGLE MATURE SKELETAL MUSCLE FIBRES  
Single muscle fibres were isolated from the FDB muscles of mice as previously 
described (Palomero et al., 2008; Pye et al., 2007). FDB is a small and thin muscle 
located in the midline of the sole of the foot and in the presence of collagenase, single 
viable intact myofibres are dissociated from the muscle. Mice (males and females) were 
killed by cervical dislocation and the flexor digitorum brevis (FDB) muscles were 
dissected. The selection of gender of mice for each study was based entirely on the 
available mice at that time. Studies have shown that on average, the skeletal muscle of 
women typically has 60–80% of the strength, muscle fibre cross sectional area and 
whole muscle anatomical cross-sectional area of men (Folland and Williams, 2007). 
However, there is no evidence in the literature to suggest that skeletal muscles from 
female mice show a different pattern in RONS activation in comparison to skeletal 
muscles from male mice hence it was assumed that single muscle fibres from male and 
female mice would respond in the same way.  
 
Single muscle fibres were isolated from the FDB muscles of mice according to 
the method of Shefer & Yablonka-Reuveni (Shefer and Yablonka-Reuveni, 2005). FDB 
muscles were incubated for 1.5 h at 37oC in 0.4% (w/v) sterile Type I collagenase in 
minimum essential medium eagle (MEM) which contained all 21 amino acids, 
ribonucleosides, deoxyribonucleosides, sodium bicarbonate and was additionally 
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supplemented with 2mM glutamine, 50 i.u. penicillin, 50µg ml-1 streptomycin and 10% 
foetal bovine serum (FBS) (Invitrogen Ltd, Paisley, UK). Muscles were agitated every 
20 min to improve digestion of the connective tissue. Single myofibres were released by 
gentle trituration with a wide-bore pipette and were washed three times in MEM 
containing 10% FBS. Free single muscle fibres were separated from damaged fibres and 
contaminating cells by centrifugation at low speed (600 g for 30 s at 25°C). Single 
fibres were plated onto pre-cooled 35 mm cell culture dishes pre-coated with Matrigel 
(BD Biosciences, Oxford, UK) and were allowed to attach for 45 min before adding 2 
ml of MEM containing 10% FBS. Pre-cooling was necessary to prevent premature 
solidification of the collagen before fibre attachment. Fibres were incubated for 16 h at 
37oC, 21% O2 in 5% CO2 tissue culture incubator. It has recently been shown that fibres 
prepared and cultured in this manner are viable for up to 6 days in culture (Palomero et 
al., 2008), but they have routinely been used at 16 h following isolation. Experiments 
were only performed on fibres that displayed excellent morphology and exhibited 
intense transverse striations along the sarcolemma. All experiments were undertaken in 
the presence of 21% O2 environment.  
 
2.3 USE OF ROS SENSITIVE FLUORESCENT DYES TO STUDY 
INTRACELLULAR CHANGES IN ROS IN SINGLE SKELETAL 
MUSCLE FIBRES 
2.3.1 Use of CM-DCFH DA to monitor changes in ROS production in single 
isolated fibres 
To monitor changes in ROS production, single FDB muscle fibres were loaded 
with CM-DCFH DA as previously described (Palomero et al., 2008). Fibres were 
loaded by incubation in 2ml Dulbecco’s phosphate-buffered saline (D-PBS) containing 
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10µM 5- (and 6-) chloromethyl-2’,7’-dichlorodihydrofluorescein diacetate (CM-DCFH 
DA) (Molecular Probes, OR, USA) for 30 min at 37oC. Cells were washed twice with 
D-PBS and were maintained in MEM without Phenol Red containing	  10%	  FBS during 
the experimental period. MEM contained 19 amino acids; the essential amino acids and 
the non-essential amino acids including L-ala, L-asn, L-asp, L-glu, L-gly, L-pro and L-
ser. CM-DCFH DA readily diffuses into cells and within the cytoplasm the acetate 
group is cleaved by cytosolic esterases to yield CM-DCFH, a hydrophilic non-
fluorescent molecule that is retained by the cell. Intracellular ROS, particularly 
hydrogen peroxide, convert CM-DCFH to its fluorescent derivate, CM-DCF. 
 
2.3.2 Use of DAF-FM DA to monitor intracellular NO activity in isolated fibres 
The method used was described in detail in a previous study by Pye et al. 
(2007). Fibres were loaded by incubation in 2ml Dulbecco’s phosphate-buffered saline 
(D-PBS) containing 10µM 4-amino-5-methylamino-2′,7′-difluorofluorescein diacetate 
(DAF-FM DA) (Molecular Probes, OR) for 30 min at 37oC. Cells were then washed 
twice with D-PBS and were maintained in MEM containing 10% FBS without Phenol 
Red during the experimental period. MEM contained 19 amino acids; the essential 
amino acids and the non-essential amino acids including L-ala, L-asn, L-asp, L-glu, L-
gly, L-pro and L-ser. DAF-FM DA readily diffuses into cells and within the cytoplasm 
releases DAF-FM by the action of intracellular esterases. DAF-FM is essentially non-
fluorescent until it is nitrosylated by products of oxidation of NO, resulting in DAF-FM 
triazole which exhibits about a 160-fold greater fluorescence quantum efficiency 
(Kojima et al., 1999). 
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2.3.3 Use of dihydroethidium (DHE) to monitor cytosolic superoxide changes in 
isolated fibres 
For the detection of cytosolic superoxide, fibres were loaded with 5µM 
dihydroethidium (DHE) (Molecular Probes, OR), in a similar manner to CM-DCFH DA 
and DAF-FM DA. DHE is a non charged fluorescent probe specifically sensitive to 
superoxide (Bindokas et al., 1996; Zuo et al., 2004) and displays “blue” fluorescence” 
(Zielonka and Kalyanaraman, 2010) in the cytoplasm of single muscle fibres. Upon 
oxidation, the oxidised form of DHE becomes positively charged, contributing to its 
tendency to accumulate in the nucleus and intercalate with the negatively charged DNA 
phosphate backbone, producing Ethidium (E+) and 2-hydroxyethidium (2-OH-E+) 
fluorescence (Zielonka and Kalyanaraman, 2010). DHE is not targeted to mitochondria 
and its oxidation is likely to be influenced by cytosolic sources of superoxide 
production (Johnson-Cadwell et al., 2007; Gao and Wolin, 2008). Application of the 
technique to the study of single isolated mature skeletal muscle fibres is examined in 
detail in Chapter 3. 
 
2.3.4 Use of MitoSOX Red to monitor mitochondrial superoxide changes in 
isolated fibres 
Fibres were loaded with 250nM MitoSOX Red (Invitrogen), using the same 
protocol as for CM-DCFH DA, DAF-FM DA and DHE. MitoSOX Red is a derivative 
of DHE designed for highly selective detection of superoxide in mitochondria and 
exhibits fluorescence (MitoSOX Red fluorescence) on oxidation and subsequent 
binding to mitochondrial DNA (Robinson et al., 2006).  
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2.4 MICROSCOPY AND FLUORESCENT IMAGING  
The imaging system consisted of a Zeiss Axiovert 200M epifluorescence 
microscope equipped with X10 and X20 objectives. Different excitation/ emission 
filters were used according to the fluorescent probe: 
A 500/20 nm excitation, 535/30 nm emission filter set was used for DAF-FM 
fluorescence, a 510–560 nm excitation/590 nm emission filter set was used for E+ and 
MitoSOX Red fluorescence and a 450–490 nm excitation/515–565 nm emission filter 
set was used for the detection of CM-DCF fluorescence.  
Using a ×20 objective and exposures as indicated for individual experiments, 
fluorescence images were captured with a computer-controlled Zeiss MRm charged-
coupled device (CCD) camera (Carl Zeiss GmbH) and analysed with Axiovision 4.0 
image capture and analysis software (Carl Zeiss Vision, GmbH). All experiments were 
carried out at 25°C. 
Exposure of fibres loaded with DAF-FM to ultraviolet (UV) light was minimised by use 
of a 200 ms exposure time. In DHE and CM-DCFH loaded fibres, the image capture 
was limited to 50 and 100 ms, respectively. 
CM-DCF, DAF-FM, E+ and MitoSOX Red fluorescence was determined from user-
defined segments of single muscle fibres and the background fluorescence (from areas 
of the field containing no fibres) was subtracted from fibre measurements. Data were 
recorded in grayscale units. 
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2.5 CONTRACTILE ACTIVITY INDUCED BY ELECTRICAL  
STIMULATION  
Using established techniques (Palomero et al., 2008; Pye et al., 2007), 
contractile activity of single isolated muscle fibres was induced by electrical field 
stimulation in 35mm dishes using platinum electrodes (Harvard Apparatus, Kent, UK). 
Following 10 min at rest, fibres were electrically stimulated with trains of bipolar 
square wave pulses of 2ms in duration for 0.5 of a sec every 5 sec at 50 Hz and 30 
V/well. A schematic illustration of the standard contractile activity protocol is shown 
below (Figure 2.1). The total stimulation time was 10 min and the stimulation period 
commenced at 10 min following the beginning of the experiment and it was followed by 
a further 10 min period at rest. 
 
 
Scheme 2.1 Schematic illustration of the contractile activity protocol.  
 
2.6  SAMPLE PREPARATION FOR THE QUANTIFICATION OF MUSCLE 
PROTEINS  
Prior to analysis, tissues (muscles and organs) from the mice were ground under 
liquid nitrogen and the resulting powder was homogenised (Sartorius BBI Systems, 
Model POTTER S, Germany) in 800µl of 1% sodium dodecyl sulphate (SDS) 
containing protease inhibitors (1mM iodoacetimide, 1mM benzithonium chloride, 
5.7mM Phenylmethylsulphonyl fluoride). Samples were then centrifuged at 10,000 g 
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for 10 min at 4oC (Eppendorf Centrifuge 5402, London, U.K.) and the supernatants 
were stored at –80oC until analysis. 
 
2.7 BICINCHONINIC ACID (BCA) ASSAY 
Total protein content was quantified for each sample using a BCA assay 
according to the manufacturer’s protocol.  
Reagents 
Reagent A: Bicinchoninic acid (BCA) solution comprised of 160mM 
NaCO3.H2O, 25mM BCA-Na, 7mM Na2 tartrate & 0.95% NaHCO3.  Reagent B: 
160mM CuSO4.5H2O, c) Bovine serum albumin (BSA) 1mg/ml. Reagent C prepared by 
adding 12.5ml of Reagent A to 250µl of Reagent B.  
Samples were analysed against a range of standards 50-500 µg/ml from a 
1mg/ml stock solution of BSA. Samples and standards were added to a 96-well 
microplate at a volume of 20 µl. Reagent C was added to each well (180µL) and the 
microplate was incubated at 50oC for 30 minutes. The absorbance of both the samples 
and standards was then read using a microplate reader at 570nm and the protein content 
was determined by using the standard curve. 
 
2.8 WESTERN BLOTTING OF MUSCLE PROTEINS 
For assessment of specific proteins in muscle, 30-100µg of total protein was 
combined with equal volumes of protein loading buffer (National Diagnostics) and 
boiled for 5 min. Samples were allowed to cool for 15 min and then applied to a 8-15% 
polyacrylamide gel via a 4% stacking gel. Proteins were separated by electrophoresis at 
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a constant current of 40 mA. Once separated, the proteins were transferred to a 
nitrocellulose membrane by a Multiphore continuous blotting system (Pharmacia, 
Uppsala, Sweden). Over approximately a 90 min period a constant current over 0.8 mA 
cm-2 was applied to the gel to allow the successful transfer of proteins. Ponceau S 
solution was used to determine whether proteins had been transferred successfully on 
the nitrocellulose membrane. Membranes were blocked for 2h in a 3% milk solution at 
room temperature and probed overnight using antibodies against the proteins of interest 
as previously described (McArdle et al., 2001). Glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH) protein content was also determined and served the control-
loading sample. Though GAPDH is one of the most commonly used loading controls in 
skeletal muscle, recent reports suggest that the use of GAPDH as a “housekeeping  
protein” must be carefully evaluated (Gilda and Gomes, 2013). For such reason, all 
blots were ponceau S stained following transfer to evaluate equivalent loading of the 
samples. Horseradish peroxidase conjugated anti-mouse IgG, anti-rabbit IgG (Cell 
Signaling, Hitchin, UK), anti-goat IgG, or anti-chicken IgY (Thermo Scientific, 
Loughborough, UK) were used as the secondary antibody. Peroxidase activity was 
detected using an ECL kit (Amersham International Cardiff, UK), and band intensities 
were analysed using Quantity One Software (Biorad, US). The specificity of the bands 
were identified in comparison with a sample that had not been exposed to the primary 
antibody and the molecular weight was determined by using rainbow coloured protein 
markers (Amersham International). 
 
Details regarding the antibodies used in the present study are shown in the 
results chapters (Chapters 3,4 and 5) “Experimental Procedures”.  
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2.9 SUBCELLULAR FRACTIONATION   
Mitochondrial and cytosolic fractions from GTN skeletal muscle were isolated 
as described recently by Dimauro et al. 2012 (Dimauro et al., 2012). Fresh GTN 
muscles were washed with cold PBS, and placed in a pre-chilled glass Petri dish and 
minced on ice using sharp scissors. The PBS was aspirated and samples were 
resuspended in 300-500µl of STM buffer (comprising: 250mM sucrose, 50mM Tris-
HCl pH 7.4, 5mM MgCl2), protease and phosphatase inhibitor cocktails and 
homogenized for 1 minute on ice using a tight-fitting Teflon pestle attached to a Potter 
S homogeniser (set to 600-1,000 rpm) by slowly stroking the pestle up and down. 
Thereafter, the homogenate was decanted into a centrifuge tube and maintained on ice 
for 30 minutes, vortexed at maximum speed for 15 seconds and then centrifuged at 
800g for 15 minutes at 4°C. The pellet (labeled as P1) was discarded and the 
supernatant was kept (labeled as S1) and used for subsequent isolation of mitochondrial 
and cytosolic fractions.  
 
Cytosolic and mitochondrial fractions were extracted from S1 by centrifugation 
at 800g for 10 minutes. The supernatant (S2) was saved and the pellet (P2) was 
discarded. S2 was then centrifuged at 11,000g for 10 minutes 4°C and the supernatant 
(S3) was precipitated in cold 100% acetone at -20°C for at least 1 hour followed by 
centrifugation at 12,000g for 5 minutes, the pellet (P3) was then resuspended in 100-
300μL STM buffer and labelled as “cytosolic fraction”. Pellet P3 was resuspended in 
50-100μL SOL buffer (comprising: 50mM Tris HCl pH 6.8, 1mM EDTA, 0.5% 
Triton-X-100, protease and phosphatase inhibitors) by sonication on ice at high setting 
for 5-10 seconds with 30 seconds pauses and labelled as “mitochondrial fraction”. The 
purity of the different sample fractions, representing the cytoplasmic, and mitochondrial 
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compartments was validated by western blot analysis of “house-keeper” marker proteins 
that are specific for each cellular compartment. 
 
2.10 RNA EXTRACTION, DNase TREATMENT AND cDNA SYNTHESIS  
2.10.1 RNA isolation  
RNA from single muscle cells and tissues was extracted using Tri Reagent 
(Qiagen, Sussex, UK). Muscles were ground and placed into Tri Reagent (1ml per 50-
100mg of tissue) and centrifuged at 12,000g for 10mins at 4oC to remove insoluble 
material. Samples were then allowed to stand for 5mins at room temperature. 
Chloroform (200µL) was then added to the supernatants, samples were shaken 
vigorously for 15sec and allowed to stand for 15mins at room temperature. Samples 
were then centrifuged at 12,000g for 15mins at 4oC. Centrifugation separated the 
mixtures into 3 phases: a red organic phase (containing protein), an interphase 
(containing DNA) and a colourless upper aqueous phase (containing RNA). 
The aqueous phase was transferred to a fresh tube and 0.5ml of isopropanol was 
added to each sample. The samples were allowed to stand for 5-10mins at room 
temperature and centrifuged at 12,000g for 10mins at 4oC. The supernatants were then 
discarded and the RNA pellets were washed by adding 1mL of 75% ethanol. Samples 
were then centrifuged at 7,500g for 5mins at 4oC. Following centrifugation, the RNA 
pellets were briefly dried for 5-10mins by air-drying and 100µL of RNase-free H2O was 
added to each RNA pellet. The samples were then mixed by repeated pipetting.    
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2.10.2 Purification and DNase treatment of total RNA  
All RNA samples were DNase-treated and purified using the RNeasy MinElute 
cleanup-kit (Qiagen) as described below.  
Reagents 
• Buffer RLT 
• Buffer RPE 
• RNase- Free water 
• RNeasy MinElute Spin Columns 
• Collection tubes (1.5 & 2ml) 
 
RNA samples were adjusted to a volume of 100µl with RNase-free water. RTL 
buffer (350uL) was added, followed by 250µL Ethanol (100%) and mixed well by 
pipetting. Samples were transferred to an RNeasy MinELute Spin column, placed in a 
2mL collection tube. Samples were centrifuged for 15sec at 8,000g and the flow-
through was discarded. RNeasy MinELute Spin column were placed in a new 2ml 
collection tube and RPE buffer (500µl) was added to the spin columns and centrifuged 
for 15sec at 8,000g to wash the spin column membrane. The flow-through was 
discarded as previously. Addition of 80% Ethanol (500µL) to the RNeasy MinELute 
Spin column followed and samples were centrifuged for 2min at 8,000g to wash the 
spin column membrane. The flow-through and collection tube were discarded. RNeasy 
MinELute Spin columns were placed in a new collection tube (2mL) and centrifuged at 
full speed (20,800g) for 5 min. The flow-though and collection tubes were discarded. 
Finally, the spin column was placed in a new collection tube (1.5mL) and 14µL of 
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RNase-free water was added directly to the centre of the spin column membrane. 
Columns were centrifuged for 1min at full speed (20,800g) to elute the RNA.  
A schematic illustration of the steps described above is shown below (Figure 
2.1).   
 
 
Figure 2.1 RNeasy MinElute Cleanup Procedure used to DNAse and purify RNA 
samples (from the product specification sheet provided by the company).  
 
2.10.3 RNA content of samples using the RiboGreen RNA quantitation assay 
The RNA content of the samples was measured using the RiboGreen RNA 
quantitation assay kit (Molecular probes, Leiden, The Netherlands).  
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Reagents 
• RiboGreen RNA quantitation reagent (Component A).  
• 20X TE (Component B), 25ml of 200mM Tris-HCl, 20mM EDTA, pH 7.5 (20X 
TE) in DEPC-treated water. 
• Ribosomal RNA standard (Component C), 100µg/ml in TE.  
 
 A range of standards between 0-1µg/ml was prepared from a stock solution of 
100µg/ml Component C in 1X TE solution. 100µL from the standard, blank or sample 
and 100µl of Component A were placed in a 96 well plate. Samples were then incubated 
at room temperature for 2-5mins. The fluorescence of standards and samples was 
measured (excitation 480nm, emission 520nm) using a fluorescence microplate reader 
(Fluostar optima, BMG, Germany). The RNA content of each sample was calculated 
from the standard curve.  
 
2.10.4 Generation of first-strand cDNA 
Purified RNA was utilised to generate first-strand cDNA using the iScript 
cDNA Synthesis kit (Bio-Rad, Hertfordshire, UK).  
Reagents 
• 5 x iScript reaction mix 
• iScript reverse transcriptase 
• Nuclease-free water 
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Purified RNA (1ug/sample) was added in DNAse-RNAse free eppendorfs along 
with 5µL of master mix, which consisted of 4µL of 5 x iScript reaction mix and 1µL of 
iScript reverse transcriptase. To reach a final volume of 20µL, Nuclease-free water was 
added in each sample. To confirm the absence of genomic DNA, additional samples 
were prepared in which iScript reverse transcriptase was not added. For cDNA 
synthesis, the complete reaction mix was incubated in a PCR thermal cycler (Bio Gene 
Rapid cycler, Idaho Technology, Idaho Falls, USA) using the protocol: 
5 minutes at 25 oC, 30 minutes at 42 oC, 5 minutes at 85 oC, 5 minutes at 4 oC. 
 
Following first strand synthesis, cDNA was transferred into new DNAse-RNAse 
free eppendorfs and stored in -20 oC until further analysis.  
 
2.10.5 Assessing the optimal annealing temperature for each primer set 
Primers for real-time PCR analyses were designed (primer sets are described in 
“Experimental procedures” of the results chapters) and the optimal annealing 
temperature for each primer set was determined by using an annealing temperature 
gradient between 55 and 62°C. An example is shown in figure 2.3. Real-time PCR 
reactions were performed on an iCycler Detection System using iQ SYBR Green 
Supermix (Bio-Rad, Hertfordshire, UK) and the specificity of the PCR products was 
determined by melt curve analysis and agarose gel electrophoresis. 
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Figure 2.2 Experimental determination of optimal annealing temperature for p67phox 
(protein of the NADPH oxidase complex) transcript in GTN skeletal muscle. The PCR 
product corresponds to the amplicon size shown in table 2.1 below.  
 
Primer Name 
(ID) 
Forward Primer 
Sequence 
Reverse Primer 
Sequence 
Amplicon 
Size (bp) 
p67
phox
 
 
gaccttaaagaggccttgacg 
 
 
atgccaactgctcttctgct 
 
 
160 
 
 
Table 2.1 Sequences of the specific primers used for RT-PCR amplification of p67phox 
in GTN skeletal muscle. 
 
2.11 ASSESSING CHANGES IN REDOX STATUS OF TISSUES 
2.11.1 Assessing changes in the 3-nitrotyrosine (3-NT) content of proteins 
Peroxynitrite was assessed via changes in the level of nitration of tyrosine 
residues of proteins in muscle. Previous studies have indicated that the 3-nitrotyrosine 
(3-NT) content of the major muscle protein, carbonic anhydrase III  (CAIII), is a 
relatively sensitive marker of muscle oxidative stress (Vasilaki et al., 2007), and this 
100	  bp	  	  200	  bp	  
300	  bp	  400	  bp	   55	  o C	   55.6	  o C	   56.5	  o C	   57.8	  o C	   59.5o C	   60.8	  o C	   61.7	  o C	   62	  o C	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was examined using the techniques described by Vasilaki et al. (2007). Skeletal muscles 
were ground under liquid nitrogen as described in section 2.6 and total cellular protein 
(50 µg) was separated on 1D SDS-PAGE followed by western blotting as described in 
section 2.8. The content of 3-NT was analyzed by using a mouse monoclonal antibody 
(Cayman Chemical Co., Ann Arbor, Michigan, USA), and the bands were visualized 
using a Biorad Chemi-Doc System (Biorad Laboratories Ltd, Hemel Hempstead, UK). 
Densitometric quantification of the CAIII band was undertaken, and the protein content 
was normalized to the GAPDH content of the same sample. Comparisons were made 
between samples on the same gel ⁄ western blot. 
 
2.11.2 Assessing changes in protein oxidation 
Protein oxidation was assessed via changes in protein carbonyls. Cellular 
proteins (50 µg) were separated on 1D SDS-PAGE and transferred on a PVDF 
membrane as per the manufacturer’s instructions.   
Derivatization 
1. Following the electroblotting step, PVDF membranes were immersed in 
100% methanol for 15 seconds, and then allowed to dry at room temperature 
for 5 minutes.  
2. Membranes were equilibrated in TBS containing 20% Methanol for 5 
minutes and were washed in 2N HCl for 5 minutes. 
3. Membranes were incubated with 1X DNPH solution (a solution used to 
derivatize the carbonyl groups) for exactly 5 minutes and were washed three 
times in 2N HCl, 5 minutes each time, followed by five minute washes in 
100% methanol, 5 minutes each time. 
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Immunoblotting 
Membranes were blocked and probed for 2h using a freshly diluted 1:1000 Rabbit Anti-
DNP Antibody (Cell Biolabs, San Diego, CA, USA). Secondary HRP conjugated 
antibody was applied as described in paragraph 2.8. 
 
2.11.3 Assessing changes in lipid peroxidation 
Lipid peroxides are unstable indicators of oxidative stress that decompose to 
form more complex and reactive compounds such as Malondialdehyde (MDA) and 4-
hydroxynonenal (4-HNE), natural bi-products of lipid peroxidation. Lipid peroxidation 
was assessed via changes in 4-HNE protein conjugates and MDA - protein adducts. 
Both markers were assessed using the same protocol as for 3-NT (section 2.11.1). 
Rabbit Anti-MDA primary antibodies (Cell Biolabs, San Diego, CA, USA) and rabbit 
anti 4-HNE (Abcam, Cambridge, UK) were used. 
 
2.12 HISTOLOGICAL ANALYSIS OF SKELETAL MUSCLE  
2.12.1 Preparation of muscle blocks  
Anterior tibialis (AT) and GTN skeletal muscles were fixed as described below.  
Reagents 
All reagents were purchased from Merck Ltd. (Dorset, U.K) 
• O.C.T. mounting compound  
• Iso-pentane  
 
	   75	  
AT and GTN muscles were orientated with fibres running transversely on cork 
discs, surrounded by O.C.T. mounting compound and frozen in iso-pentane pre-cooled 
in liquid nitrogen. Blocks were stored at –70oC prior to histological analysis. Sections 
(10µm) from the centre of the muscles were taken onto glass cover slips using a cryostat 
(Bright Instrument Co., Huntingdon, UK) and stained with haematoxylin and eosin. 
 
2.12.2 Haematoxylin and eosin (H&E) staining 
 
Reagents 
All reagents were purchased from (Merck Ltd., Dorset, U.K) 
• Harris’ Haematoxylin: 5% solution  
• Eosin: 1% solution  
• DPX mountant  
 
Sections were placed in Harris’ Haematoxylin for 3-5 min, rinsed in distilled H2O 
and counterstained in eosin for 30 sec. Sections were then dehydrated in 3x Absolute 
alcohol and cleaned in xylene. Cover slips were mounted onto microscope slides using 
DPX mountant. Sections were analysed with the use of an inverted miscroscope (Zeiss 
Axiovert 200M microscope). 
 
 
 
	   76	  
2.13 STATISTICAL ANALYSES 
Data are presented as mean ± SEM for each experiment. For each experiment, n 
number of fibres (minimum 6-7 fibres) were taken from a minimum of 4 different mice. 
When more than 1 fibre studies were undertaken from the same mouse, the mean value 
of the fibres studied/mouse was considered for the statistical analyses. For multiple 
comparisons at any time point, analysis was by one-way ANOVA followed by the post 
hoc LSD test. Single comparisons between two experimental conditions at a time point 
were undertaken using the unpaired Student’s t test. Comparisons between data from 
individual fibres at different time points were undertaken using Student’s paired t test. 
Data were analysed using SPSS 18 and p values of less than 0.05 were considered 
statistically significant. 
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CHAPTER 3 
DEVELOPMENT OF TECHNIQUES TO 
EXAMINE CYTOSOLIC AND 
MITOCHONDRIAL SUPEROXIDE IN SINGLE 
ISOLATED MATURE SKELETAL MUSCLE 
FIBRES  
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3.1 INTRODUCTION 
Skeletal muscle produces reactive oxygen and nitrogen species (RONS) from a 
variety of cellular locations and it is widely accepted that nitric oxide (NO) and 
superoxide are the primary radical species (Jackson, 2011). Superoxide and NO are the 
precursors for the generation of a number of secondary species (Chapter 1, Section 
1.2.2) and their production is augmented during periods of contractile activity (Close et 
al., 2005; Palomero et al., 2008).  
 
Monitoring specific radical species in sub-cellular compartments may have 
widespread implication for the understanding of diverse scientific areas, including the 
responses of muscle to exercise training (Vasilaki et al., 2006), age-related loss of 
muscle mass and function (Vasilaki et al., 2010), as well as inflammatory or 
degenerative muscle diseases, such as the muscular dystrophies that are associated with 
increased levels of oxidative damage and muscle weakness (Wallace and McNally, 
2009). However, direct measurement of radical species in living cells is inherently 
difficult because of the short half-life and the labile and reactive nature of these species. 
 
Early studies examining changes in RONS production in skeletal muscle, 
assessed changes in end-point indicators of the reactions of oxidants in tissues (Davies 
et al., 1982; Dillard et al., 1978; Jackson et al., 1985) and although assessment of 
oxidatively modified molecules might provide a useful tool to assess changes in muscle 
redox status, this approach however is not suitable to determine real-time changes in 
RONS at discrete subcellular sites. 
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Studies from this group have established techniques to examine intracellular NO 
changes in single muscle fibres (Pye et al., 2007), but no technique for direct real-time 
monitoring of superoxide formation in muscle cells is available.  
 
3.2 AIMS 
The aim of the current chapter was to develop reliable techniques to assess 
mitochondrial and cytosolic changes in superoxide in single isolated mature skeletal 
muscle fibres.  
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3.3 EXPERIMENTAL PROCEDURES 
3.3.1 Mice  
Female C57Bl/6 mice, 4-8 months old were used in this study. All experiments 
were performed in accordance with UK Home Office guidelines under the UK Animals 
(Scientific Procedures) Act 1986. Mice were killed by cervical dislocation and the 
flexor digitorum brevis (FDB) muscles were rapidly removed for isolation of single 
muscle fibres. 
 
3.3.2 Chemicals and Reagents  
Unless stated otherwise, all chemicals used in this study were obtained from 
Sigma Chemical Company, Dorset, UK. 
 
3.3.3 Isolation of single mature skeletal muscle fibres  
Single muscle fibres were isolated from the FDB muscles of mice as described 
in Section 2.2. Briefly, FDB muscles were dissected and incubated for 1.5 h in 
collagenase to digest the connective tissue. Muscles were agitated every 30 min during 
the digestion period and single myofibres were released by gentle trituration with a 
wide-bore pipette. Fibres were washed three times in MEM containing 10% FBS and 
were plated onto precooled culture dishes precoated with Matrigel (BD Biosciences) 
and were allowed to attach for 45 min before adding 1 mL MEM containing 10% FBS.  
Analyses were only performed on fibres that displayed good morphology and prominent 
cross-striations. 
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3.3.4 Use of dihydroethidium (DHE) and MitoSOX Red to monitor cytosolic and 
mitochondrial changes in superoxide in isolated fibres  
A detailed description of the ROS sensitive dyes used in this study is presented 
in Section 2.3. Briefly, single isolated mature fibres were loaded by incubation in 2mL 
Dulbecco’s phosphate-buffered saline (D-PBS) containing 5µM dihydroethidium 
(DHE) or 250nM MitoSOX Red (Invitrogen) for 30 min at 37oC. Cells were then 
washed twice with D-PBS and the fibres were maintained in MEM without Phenol Red 
during the experimental protocol. 
 
3.3.5 Use of 4-Amino-5-Methylamino-2’, 7’-Difluorofluorescein Diacetate (DAF-
FM DA) and 5- (and 6-) chloromethyl-2’,7’-dichlorodihydrofluorescein 
diacetate (CM-DCFH DA) to monitor NO and H2O2 changes in isolated 
fibres  
A detailed description of DAF-FM DA and CM-DCFH DA dyes used in this 
study is presented in Section 2.3. Briefly, single isolated mature fibres were loaded by 
incubation in 2mL Dulbecco’s phosphate-buffered saline (D-PBS) containing 10µM 4-
amino-5-methylamino-2′,7′-difluorofluorescein diacetate (DAF-FM DA) or 10µM 5- 
(and 6-) chloromethyl-2’,7’-dichlorodihydrofluorescein diacetate (CM-DCFH DA) 
(Molecular Probes, OR, USA) for 30 min at 37oC. Cells were then washed twice with 
D-PBS and the fibres were maintained in MEM without Phenol Red during the 
experimental protocol. 
 
3.3.6 Microscopy and fluorescent imaging  
For details see Section 2.4. Briefly, the image capture system consisted of a 
Zeiss Axiovert 200M microscope equipped with 500/20 nm excitation, 535/30 nm 
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emission filter set for DAF-FM fluorescence, a 510–560 nm excitation/590 nm emission 
filter set for ethidium (E+) and MitoSOX Red fluorescence and a 450–490 nm 
excitation/515–565 nm emission filter set for the detection of CM-DCF fluorescence. 
Using a X20 objective, fluorescence images were captured with a computer-controlled 
Zeiss MRm charged-coupled device (CCD) camera (Carl Zeiss GmbH) and analyzed 
with Axiovision 4.0 image capture and analysis software (Carl Zeiss Vision GmbH). 
 
3.3.7 Contractile activity induced by electrical stimulation  
Contractions in single isolated muscle fibres were induced by electrical field 
stimulation using established techniques (Palomero et al., 2008; Pye et al., 2007). 
Following loading, fibres remained at rest for 10 min and were then exposed to trains of 
bipolar square wave pulses of 2 ms in duration for 0.5 sec at 50 Hz and 30 V/well. The 
contraction protocol has been used in previous studies and shown to increase ROS 
activities in single isolated muscle fibres (Palomero et al., 2008; Pye et al., 2007). A 
video of contracting FDB fibres was presented in previous work by Palomero et al 
(Palomero et al., 2008). For details see Section 2.5.  
 
3.3.8 Use of pharmacological agents  
Increased superoxide generation was induced by menadione (5µM). Incubation 
of fibres with the superoxide scavengers; 4, 5-dihydroxy-1, 3-benzenedisulphonic acid 
(Tiron, 1mM), or 4-hydroxy-2, 2, 6, 6- tetramethylpiperidine 1-oxyl (Tempol, 100µM) 
was commenced at 1h prior to loading the fibres with DHE. Hydrogen peroxide (H2O2) 
was used at a concentration of 2µM. Generation of NO was induced by the NO donor 3-
(2-hydroxy-1-methyl-2-nitrosohydrazino)-N-methyl-1-propanamine (NOC-7, 125µM). 
Mitochondrial superoxide production was induced by treatment of fibres with Rotenone 
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(Rot; 250nM) or Antimycin A (Ant A; 10µM). The mitochondria-targeted SS-31 
peptide (10µM) was obtained from W.M. Keck Fdn. Biotechnology Resource 
Laboratory at Yale, 77 University, New Haven, CT, USA. SS-31 (D-Arg-Dmt-Lys-Phe-
NH2) has a positive charge of 3+ at physiological pH which makes it targeted to 
mitochondria (inner mitochondrial membrane) and its antioxidant property is due to 
incorporation of a dimethyl tyrosine (Dmt) residue (Szeto, 2006a; Szeto, 2006b). 
Incubation of fibres with SS-31 peptide commenced at 4h prior to the start of 
fluorescence measurements. All reagents were maintained in the incubation medium 
during the loading and experimental periods. Most of the pharmacological agents have 
previously been used in skeletal muscle studies (Nethery et al., 2000; Nethery et al., 
1999; Whitehead et al., 2010; Pye et al., 2007) at similar concentrations to the ones used 
in this study. The final drug concentrations were defined following preliminary studies 
in which cell viability was determined by assessment of propidium iodide exclusion and 
control experiments were undertaken to examine any potential effects of the drugs on 
muscle contractions.  
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3.4 RESULTS 
3.4.1 Development of a technique to examine cytosolic changes in superoxide 
3.4.1.1 Representative images of DHE loaded fibres  
Figures 3.1 A (i) and B (i) show bright-field images of single muscle fibres 
displaying good morphology and well-defined striations along the sarcolemma. The 
unreacted form of DHE “blue fluorescence” appeared to accumulate in the cytosol 
(Figure 3.1 A ii & iii) but upon reaction with superoxide, the oxidised form of DHE 
indicated by ethidium (E+) fluorescence was predominantly localized to nuclei, shown 
by the co-localization of DAPI with E+ fluorescence (Figure 3.1 B iv).  
(A) 
  
 
 
(B) 
 
 
 
i ii iii 
i ii iii 
iv 
	   85	  
Figure 3.1 (A) Confocal images of a single isolated fibre from the FDB muscle after 16 
hours in culture. Bright field (i), fluorescent image showing blue fluorescence from 
non-oxidized DHE (ii), merged image of i and ii (iii). (B) Confocal images of a single 
isolated fibre under bright field (i), fluorescent image showing 4’,6-diamidino-2-
phenylindole dihydrochloride (DAPI) staining (ii), fluorescent image showing ethidium 
(E+), the oxidized form of DHE (iii) and a merged image of ii and iii (iv). 60x original 
magnification (bar = 30 µm). 
 
3.4.1.2 Effect of menadione, a superoxide anion generator on DHE oxidation 
Menadione, a redox cycling agent	   mediates the transfer of electrons from 
NADPH or NADH to 02 generating a flux of superoxide in a process called redox 
cycling (Greenberg et al., 1990). Figure 3.2 shows the effect of addition of menadione 
on resting FDB muscle fibres at 30 min of the experimental period (Figure 3.2). 
Menadione caused an increase in the rate of change in DHE oxidation that was 
significantly higher than in untreated fibres within 20 min following exposure (Figure 
3.2). No changes in fibre viability were observed following addition of menadione.  
 
 
 
Figure 3.2 Rate of change in DHE oxidation from DMSO treated fibres (control group) 
and fibres treated with menadione (5µM) at 30 minutes. *P<0.05 compared with values 
from control non-treated fibres at the same time point. Data are presented as mean 
(±SEM), n = 5–7 fibres in each group (from 5-6 mice). 
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3.4.1.3 Effect of superoxide scavengers (Tiron/Tempol) on DHE oxidation following 
contractile activity  
To further assess the specificity of DHE oxidation to monitor changes in 
superoxide in muscle in response to a physiological stimulus such as contractile 
activity, fibres were incubated with the superoxide scavengers Tiron or Tempol, and 
were subjected to a 10 min period of contractile activity (Figure 3.3). Emission 
fluorescence significantly increased by the contraction protocol, but this increase was 
abolished in the presence of either compound (Figure 3.3). 
 
 
 
 
Figure 3.3 Relative change in DHE oxidation from FDB fibres over 30 minutes at rest, 
following 10 minutes of contractile activity without treatment, and from fibres subjected 
to contractions following pre-treatment with the superoxide scavengers Tiron (1mM) or 
Tempol (100µM). *P<0.05 compared with values from previous time point from fibres 
of the same group; #P<0.05 compared with resting non-contracted fibres and fibres 
subjected to contractile activity in the presence of Tiron or Tempol. Data are presented 
as mean (±SEM), for 7 fibres in each group (from 5-6 mice). Black bar indicates the 
contractile activity period. 
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3.4.1.4 Effect of hydrogen peroxide (H2O2) and NO on DHE oxidation  
Further experiments were undertaken to examine the specificity of DHE towards 
superoxide, by examining the capacity of H2O2 and NO to oxidize DHE in muscle fibre. 
DHE oxidation was unaffected following exposure of fibres to H2O2 or the NO donor 3-
(2-hydroxy-1-methyl-2-nitrosohydrazino)-N-methyl-1-propanamine (NOC-7) at 10 min 
of the experimental period (Figures 3.4 and 3.5).  
 
 
 
 
 
Figure 3.4 Relative change in DHE oxidation from PBS vehicle-treated fibres (V 
control) and fibres treated with H2O2 (2µM) at 10 min. Data are presented as mean 
(±SEM), n = 4-5 fibres in each group (from 4 mice).  
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Figure 3.5 Relative change in DHE oxidation from PBS vehicle-treated fibres (V 
control) and fibres treated with the NO donor 3-(2-hydroxy-1-methyl-2-
nitrosohydrazino)-N-methyl-1-propanamine (NOC-7, 125µM) at 10 min. Data are 
presented as mean (±SEM), n = 4-5 fibres in each group (from 4 mice). 
 
In contrast, positive control experiments using 5- (and 6-) chloromethyl-2’,7’-
dichlorodihydrofluorescein diacetate (CM-DCFH DA) and 4-amino-5-methylamino-
2’,7’-difluorofluorescein diacetate (DAF-FM DA) loaded fibres showed a marked 
increase in DCF fluorescence following addition of H2O2 or DAF-FM fluorescence 
following NOC-7 indicating an intracellular increase in H2O2 and NO (Figures 3.6 and 
3.7, respectively). CM-DCFH DA fluorescent probe has been used as a general 
indicator of ROS changes and H2O2 has been reported to induce CM DCFH oxidation in 
single muscle fibres (Palomero et al., 2008). DAF-FM DA is a relatively specific probe 
which reacts with NO and application of the technique to the study of NO changes in 
single isolated mature skeletal muscle fibres has been reported in previous work from 
Pye et al. (2007).  
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Overall, these data imply that the technique based on monitoring DHE oxidation 
from single muscle cells, is capable of detecting changes in superoxide at rest but also 
in response to a physiological stimulus such as contractile activity. 
 
 
Figure 3.6 Relative change in CM-DCF fluorescence from CM-DCFH DA loaded FDB 
fibres either PBS treated (V control) or treated with H2O2 (2µM) at 10 min. *P<0.05 
compared with values from the control vehicle-treated fibres at the corresponding time 
points. Data are presented as mean (±SEM), n = 5-6 fibres in each group. 
 
 
 
 
Figure 3.7 Relative change in DAF-FM fluorescence from DAF-FM DA loaded FDB 
fibres either PBS treated (V control) or treated with NOC-7 (125µM) at 10 min. 
*P<0.05 compared with values from the control vehicle-treated fibres at the 
corresponding time points. Data are presented as mean (±SEM), n = 4-5 fibres in each 
group. 
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3.4.2 Development of a technique to examine mitochondrial changes in 
superoxide 
MitoSOX Red is a fluorescent probe, commonly used to assess changes in 
mitochondrial superoxide. The difference between DHE and MitoSOX Red is that 
MitoSOX Red has a triphenylphosphonium cation that facilitates its preferential 
accumulation and retention within mitochondria (Robinson et al., 2006), which after 
oxidation interacts with mitochondrial DNA\RNA enhancing its fluorescence to enable 
the detection of superoxide. 
 
3.4.2.1 Representative images of MitoSOX Red loaded fibres   
MitoSOX Red selectively accumulated in the mitochondria of single muscle 
fibres as shown by the co-localization of MitoTracker Green FM with MitoSOX Red 
fluorescence (Figure 3.8 v), co-localization coefficients; Pearson’s correlation 
(Rr)=0.51, Mander’s overlap (R)=0.78, Manders’s co-localization coefficient for 
channel1 (Mred)=0.91, Manders’s co-localization coefficient for channel2 
(Mgreen)=0.99. MitoSOX Red fluorescence was not detectable in the nuclei of 
MitoSOX Red loaded muscle fibres (Figure 3.8 v). 
 
 
	   91	  
 
 
 
Figure 3.8 Confocal images of a single isolated fibre under bright field (i), fluorescent 
image following loading with DAPI (ii), fluorescence image following loading with 
MitoTracker Green FM (15nM) (iii), fluorescent image from MitoSOX Red (iv) and a 
merged image of ii, iii and iv (v). 60x original magnification. (bar = 30 µm). 
 
 
3.4.2.2 Effect of the mitochondrial electron transport chain inhibitors Antimycin A     
(Ant A) and Rotenone (Rot) on MitoSOX Red fluorescence 
Previous studies have shown that skeletal muscle mitochondria produce 
superoxide from both complexes I and III of the electron transport chain (Muller et al., 
2004). Superoxide generated at complex I appears to be released into the mitochondrial 
matrix, but complex III releases superoxide to both sides of the inner mitochondrial 
membrane; the matrix and the MIS (Muller et al., 2004).  
Figures 3.9 and 3.10 show the effect of Ant A and Rot electron transport chain 
inhibitors on MitoSOX Red fluorescence of resting FDB muscle fibres. Treatment of 
fibres with either compound at 30 min induced a significant increase in fluorescence 
indicating an increase in superoxide within the mitochondrial matrix of the muscle 
fibres. 
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Figure 3.9 Relative change in MitoSOX Red fluorescence from ethanol vehicle-treated 
fibres (V control) and fibres treated with Ant A (10µM) at 30 min. *P<0.05 compared 
with values from the control vehicle-treated fibres at the same time point (n = 6-8 fibres 
in each group).  
 
 
 
 
 
Figure 3.10 Relative change in MitoSOX Red fluorescence from DMSO vehicle-
treated fibres (V control) and fibres treated with Rot (250nM) at 30 min. *P<0.05 
compared with values from control vehicle-treated fibres at the same time point. (n = 6-
9 fibres in each group). 
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3.4.2.3 Effect of SS-31 peptide, a mitochondrial targeted antioxidant peptide on 
MitoSOX Red fluorescence following addition of Rot  
To further assess the specificity of MitoSOX Red to monitor mitochondrial 
changes in superoxide in muscle, fibres were pretreated with the SS-31 peptide, a 
mitochondrial targeted antioxidant peptide that accumulates on the inner mitochondrial 
membrane (IMM) and can scavenge superoxide to form tyrosine hydroperoxide (Dai et 
al., 2011; Maack and Bohm, 2011). SS-31 attenuated the anticipated increase in 
MitoSOX Red fluorescence following addition of Rot in single muscle fibres (Figure 
3.11). 
 
 
 
 
 
 
Figure 3.11 Relative change in MitoSOX Red fluorescence from DMSO vehicle-
treated fibres (V control) and fibres treated with Rot at 30 min. A group of Rot-treated 
fibres was also pre-treated with SS-31 peptide (10µM). #P<0.05 compared with values 
from rotenone-treated fibres incubated in the presence of SS-31 peptide at the 
corresponding time point (n = 6-9 fibres in each group). 
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3.4.2.4 Effect of H2O2 and NO on MitoSOX Red fluorescence 
Further experiments were undertaken to examine the specificity of MitoSOX 
Red towards superoxide, by examining the ability of H2O2 and NO to oxidise MitoSOX 
Red in fibres. Both H2O2 and the NO donor 3-(2-hydroxy-1-methyl-2-
nitrosohydrazino)-N-methyl-1-propanamine (NOC-7) failed to oxidise the probe 
(Figures 3.12 and 3.13, respectively).  
These data imply that the technique based on monitoring MitoSOX Red from 
single muscle cells, is capable of selectively detecting changes in superoxide within the 
mitochondrial matrix of muscle fibres.  
 
 
 
 
 
Figure 3.12 Relative change in MitoSOX Red fluorescence from PBS vehicle-treated 
fibres (V Control) and fibres treated with H2O2 (2µM) at 10 min (n = 4-6 fibres in each 
group). 
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Figure 3.13 Relative change in MitoSOX Red fluorescence from PBS vehicle-treated 
fibres (V Control) and fibres treated with NOC-7 (125µM) at 10 min (n = 4-6 fibres in 
each group). 
 
 
3.5 DISCUSSION 
The work described in this chapter has examined the use of DHE and MitoSOX 
Red superoxide sensitive florescent dyes to determine changes in superoxide within the 
cytosolic and mitochondrial compartment of mature single muscle fibres. Oxidation of 
dihydroethidium (DHE) and MitoSOX Red fluorescence has been used as a means of 
monitoring cytosolic and mitochondrial changes in superoxide by following ethidium 
(E+) and 2-hydroxyethidium (2-OH-E+) formation (Zielonka and Kalyanaraman, 2010). 
This technique has only been rarely used to examine skeletal muscle (Zuo et al., 2000; 
Zuo and Clanton, 2002), and hence the objectives of the current study were to examine 
the reliability of this approach as a means of monitoring intracellular cytosolic and 
mitochondrial superoxide changes in muscle fibres. 
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3.5.1 Methodological considerations 
Multiple approaches including electron-spin resonance spectroscopy (Pattwell et 
al., 2003), fluorescence-based microscopic assays (Palomero et al., 2008; Pye et al., 
2007), microdialysis (Close et al., 2007) and HPLC techniques (Pattwell et al., 2003) 
have been used to assess intracellular and extracellular changes in RONS produced by 
skeletal muscle. In the current study, the aim was to develop a technique with the use of 
fluorescence imaging microscopy, which would enable monitoring of real-time changes 
in superoxide in single isolated muscle fibres both at rest and during contractile activity.  
 
For the purposes of this study we utilized an ex vivo single muscle fibre 
approach in which we isolated single skeletal muscle fibres from the flexor digitorum 
brevis muscle. The merit of this approach is that it enables the analysis of superoxide in 
the absence of non-myogenic cells such as lymphocytes, endothelial cells and 
fibroblasts. The single muscle fibres used in this study were isolated from adult muscle 
and hence more closely reflect the situation in muscle in vivo in comparison with 
immature skeletal myotubes in culture.	  	  
 
3.5.2 DHE and MitoSOX Red oxidation by single muscle fibres 
The assessment of E+ fluorescence following MitoSOX Red and DHE loading as 
a measure of superoxide anion radical in cellular compartments has been criticised and 
recent studies have identified 2-hydroxyethidium (2-OH-E+) as a specific product of the 
reaction of DHE with superoxide (Zielonka and Kalyanaraman, 2010). In the present 
study the use of DHE oxidation to assess cytosolic superoxide changes by monitoring 
changes in E+ fluorescence was evaluated in single skeletal muscle fibres. To assess the 
specificity of this method, DHE loaded fibres were initially exposed to menadione, a 
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known inducer of intracellular superoxide generation, which caused an increase in E+ 
fluorescence. To further assess the specificity of E+ fluorescence to monitor changes in 
superoxide in muscle in response to contractile activity, fibres were incubated with the 
superoxide scavengers Tiron or Tempol, and the anticipated increase in fluorescence 
following contractions was completely abolished with either compound. Similarly, 
MitoSOX Red loaded fibres showed an increase in the emission florescence following 
addition of Rot and Ant A indicating an increase in superoxide within the mitochondrial 
matrix. The anticipated increase in Rot-induced MitoSOX Red fluorescence was 
inhibited in fibres pretreated with the mitochondrial targeted antioxidant SS31 peptide 
further implying that MitoSOX Red selectively reacts with ROS generated within the 
mitochondrial matrix. Finally, the specificity of DHE and MitoSOX Red towards 
superoxide, was examined by treatment of fibres with exogenous H2O2 and NO and 
examining whether this oxidized the superoxide sensitive fluorescent probes. Both 
compounds failed to oxidise the probes. These data imply that the technique developed 
in this study based on monitoring E+ fluorescence from single muscle cells following 
loading with DHE and MitoSOX Red, is capable of detecting changes in superoxide 
production at rest but also in response to a physiological stimulus such as contractile 
activity.  
 
3.5.3 Physiological implications 
The production of reactive oxygen and nitrogen species by skeletal muscle is 
important as it underlies oxidative damage in many degenerative muscle diseases and 
plays multiple regulatory roles by fulfilling important cellular functions (Section 1.6). 
With the development of techniques to assess real-time changes in superoxide within 
the mitochondrial and cytosolic sites of single muscle fibres, this would provide a useful 
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tool to examine potential sub-cellular pathways that are involved in the regulation of 
cytosolic and mitochondrial superoxide content at rest and during contractile activity. 
Techniques established in this study might also be utilized as an approach to determine 
the sub-cellular superoxide producing sources that might be implicated in pathological 
muscle diseases such as the muscular dystrophies.  
 
3.6 CONCLUSION 
In conclusion, these data imply that techniques based on use of single mature 
skeletal muscle fibres loaded with DHE and MitoSOX Red are capable of detecting 
cellular changes in superoxide within the cytosolic and mitochondrial compartment that 
occur in response to a pharmacological stimulant or in response to a physiological 
stimulus such as contractile activity.  
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CHAPTER 4 
IDENTIFYING THE SUB-CELLULAR SITES 
THAT REGULATE CYTOSOLIC 
SUPEROXIDE IN SKELETAL MUSCLE AT 
REST AND DURING CONTRACTILE 
ACTIVITY  
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4.1 INTRODUCTION 
Since the initial observations that skeletal muscles produce free radicals (Davies 
et al., 1982; Jackson et al., 1983), a great deal of research has been undertaken to 
identify the sources that are responsible for the increased generation of RONS during 
contractions. As mentioned in the introduction (Section 1.2), it is now clear that 
superoxide and NO are the primary reactive oxygen and nitrogen species generated 
within skeletal muscle both at rest and during contractile activity. Although the 
production of NO by the nitric oxide synthases has been well described (Stamler and 
Meissner, 2001; Palomero and Jackson, 2010), there is still considerable debate over the 
prime cytosolic source(s) of superoxide in skeletal muscle.  
 
Early studies suggested that the mitochondrial respiratory chain was the 
predominant source that accounted for the increased superoxide production following 
contractions (Boveris and Chance, 1973; Loschen et al., 1974; Davies et al., 1982), but 
recent data from our group (McArdle et al., 2005; Palomero et al., 2008) and others 
(Michaelson et al., 2010; St-Pierre et al., 2002; Di Meo and Venditti, 2001; Herrero and 
Barja, 1997; Aydin et al., 2009) have cast considerable doubt on this theory. 
Reassessment of the rate of oxidant production by mitochondria has shown that only 
0.15% of the total amount of oxygen is reduced with the production of superoxide (St-
Pierre et al., 2002), a value that is an order of magnitude lower than the original 
estimate of 2-3% (Chance et al., 1979; Naqui et al., 1986). In addition, growing 
evidence indicates that mitochondrial superoxide generation is higher during state 4 
respiration compared with state 3 (Di Meo and Venditti, 2001; Herrero and Barja, 
1997), implying that skeletal muscle mitochondria are not the major sources of oxidant 
production during contractions.  
	  	   101	  
Work presented in my MPhil thesis “Factors influencing the intracellular 
generation of ROS by skeletal muscle fibres, 2009”, showed that contractile activity 
induced a significant increase in dihydroethidium (DHE) oxidation, indicating an 
increase in superoxide within the cytoplasmic compartment of the muscle cells (I have 
described these findings in more detail in the results section of this chapter, Section 
4.4). In contrast, other studies investigating mitochondrial superoxide production failed 
to observe changes in MitoSOX Red fluorescence upon tetanic stimulation of single 
FDB muscle fibres suggesting that mitochondrial superoxide production was not 
increased with increased contractile activity (Aydin et al., 2009). Recent findings have 
supported this proposal by showing no changes in the mitochondrial redox potential 
from single muscle fibres subjected to a tetanic stimulation protocol (Michaelson et al., 
2010). Taken together, these data argue against major formation of ROS within skeletal 
muscle mitochondria during increased contractile activity.  
 
Skeletal muscle mitochondria produce superoxide from both complexes I and III 
of the electron transport chain (Muller et al., 2004). While complex I-generated 
superoxide is exclusively released into the matrix, complex III can release superoxide to 
both sides of the inner mitochondrial membrane; the mitochondrial matrix and the 
mitochondrial intermembrane space (MIS) (Muller et al., 2004). Studies investigating 
mitochondrial superoxide formation or mitochondrial changes in redox potential 
commonly use MitoSOX Red and mito-roGFP constructs. However, due to their 
chemical structure, these probes preferentially accumulate in the mitochondrial matrix, 
thus they do not reflect changes in superoxide within the MIS. Although superoxide is a 
relatively membrane impermeant anion (Powers and Jackson, 2008), studies using 
isolated mitochondria have provided evidence that channels of the outer mitochondrial 
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membrane (OMM) can permit diffusion of superoxide from the MIS to the cytosol (Han 
et al., 2003; Budzinska et al., 2009). Thus the increase in cytoplasmic superoxide 
observed during contractile activity might be related to superoxide released into the 
cytosol across the OMM. However, the role of the OMM in mediating the diffusion of 
superoxide from the intermembrane space to the cytosol of skeletal muscle has not been 
studied.  
 
Additional extramitochondrial sites for superoxide production within skeletal 
muscle have been identified including the nicotinamide adenine dinucleotide phosphate 
(NADPH) oxidase enzymes (Espinosa et al., 2006; Hidalgo et al., 2006; Mofarrahi et 
al., 2008; Xia et al., 2003), enzymes of the phospholipase A2 family (Gong et al., 2006; 
Nethery et al., 1999), and xanthine oxidase (Gomez-Cabrera et al., 2010) but their 
contribution to the cytosolic production of superoxide in skeletal muscle has not been 
evaluated.   
 
4.2 AIMS 
The aim of this chapter was to identify, by using a variety of different 
approaches, the potential pathways that are involved in the regulation of cytosolic 
superoxide both at rest and during contractile activity in single isolated mature skeletal 
muscle fibres.  
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4.3 EXPERIMENTAL PROCEDURES 
4.3.1 Mice  
Female C57Bl/6 mice, 4-8 months old were used in this study. All experiments 
were performed in accordance with UK Home Office guidelines under the UK Animals 
(Scientific Procedures) Act 1986. Mice were killed by cervical dislocation and the 
flexor digitorum brevis (FDB) muscles were rapidly removed for isolation of single 
muscle fibres. Other muscles and tissues were harvested and stored at -70oC until 
analysis. 
 
4.3.2 Chemicals and Reagents  
Unless stated otherwise, all chemicals used in this study were obtained from 
Sigma Chemical Company, Dorset, UK. 
 
4.3.3 Isolation of single mature skeletal muscle fibres  
Single muscle fibres were isolated from the FDB muscles of mice as described 
in Section 2.2. Briefly, FDB muscles were dissected and incubated for 1.5 h in 
collagenase to digest the connective tissue. Muscles were agitated every 30 min during 
the digestion period and single myofibres were released by gentle trituration with a 
wide-bore pipette. Fibres were washed three times in MEM containing 10% FBS and 
were plated onto precooled culture dishes precoated with Matrigel (BD Biosciences) 
and were allowed to attach for 45 min before adding 1 mL MEM containing 10% FBS. 
Analyses were only performed on fibres that displayed good morphology and prominent 
cross-striations. 
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4.3.4 Use of dihydroethidium (DHE) and MitoSOX Red to monitor cytosolic and 
mitochondrial changes in superoxide in isolated fibres  
A detailed description of the ROS sensitive dyes used in this study is presented 
in Section 2.3. Briefly, single isolated mature fibres were loaded by incubation in 2mL 
Dulbecco’s phosphate-buffered saline (D-PBS) containing 5µM dihydroethidium 
(DHE) or 250nM MitoSOX Red (Invitrogen) for 30 min at 37oC. Cells were then 
washed twice with D-PBS and the fibres were maintained in MEM without Phenol Red 
during the experimental protocol. 
 
4.3.5 Microscopy and fluorescent imaging  
For details see Section 2.4. Briefly, the image capture system consisted of a 
Zeiss Axiovert 200M microscope equipped with a 510–560 nm excitation/590 nm 
emission filter set for the detection of ethidium (E+) and MitoSOX Red fluorescence. 
Using a X20 objective, fluorescence images were captured with a computer-controlled 
Zeiss MRm charged-coupled device (CCD) camera (Carl Zeiss GmbH) and analyzed 
with Axiovision 4.0 image capture and analysis software (Carl Zeiss Vision GmbH). 
 
4.3.6 Contractile activity protocols  
Contractions in single isolated muscle fibres were induced by electrical field 
stimulation using established techniques (Palomero et al., 2008; Pye et al., 2007). 
Following loading, fibres remained at rest for 10 min and were then exposed to trains of 
bipolar square wave pulses of 2 ms in duration for 0.5 sec at 50 Hz and 30 V/well. The 
duty cycle, (i.e. proportion of time that the fibre was stimulated) was varied to modify 
the intensity of the contraction protocol. Contractile activity protocols are shown 
schematically below (Scheme 4.1). The High contraction protocol consisted of a 2.5 sec 
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stimulation cycle (20% duty cycle), the Moderate a 5 sec stimulation cycle (10% duty 
cycle) and the Low protocol a 10 sec stimulation cycle (5% duty cycle). The Moderate 
intensity protocol has been used in previous studies and shown to increase ROS 
activities in single isolated muscle fibres (Palomero et al., 2008; Pye et al., 2007). A 
video of contracting FDB fibres was presented in previous work by Palomero et al 
(Palomero et al., 2008). 
 
 
	  
	  
Scheme 4.1 Schematic illustration of the protocols for electrical stimulations at 
different intensities. The stimuli train was constant in all contraction protocols. The time 
at rest between repetitions varied according to the intensity of each protocol. 
 
4.3.7 Use of pharmacological agents to identify sources of superoxide  
Mitochondrial superoxide production was induced by treatment of fibres with 
Rotenone (Rot; 250nM) or Antimycin A (Ant A; 5 or 10µM). The mitochondria-
targeted SS-31 peptide (10 or 100µM) was obtained from W.M. Keck Fdn. 
Biotechnology Resource Laboratory at Yale, 77 University, New Haven, CT, USA. 
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Cyclosporin A (CsA; 0.5µM), 4’-Chlorodiazepam (4Cl-DZP; 12µM), Dextran sulphate 
Mr 6,500 - 10,000 (DS; 0.1mM) and the BAX channel blocker (Bax CB; (±)-1-(3,6-
dibromocarbazol-9-yl)-3-piper azin-1-yl-propan-2-ol; 5µM; Merck Chemicals Ltd, 
Nottingham, UK) were used to assess the role of specific pathways in superoxide 
release from mitochondria. The contribution of NADPH oxidase enzymes was assessed 
using the NADPH oxidase inhibitors; Apocynin (APO; 0.5mM), Diphenyleneiodonium 
chloride (DPI; 10µM; Enzo Life Sciences, Exeter, UK), gp91ds-tat and the control 
peptide scrambled-tat (5µM; Anaspec, Fremont, USA). The calcium-independent 
phospholipase A2 enzyme (iPLA2) was blocked by the selective inhibitor bromoenol 
lactone (BEL; 0.6µM; Enzo Life Sciences). Incubation of fibres with inhibitors was 
commenced at 30 min prior to the start of fluorescence measurements, with the 
exception of the SS-31 peptide, which was added 4 h prior to measurements. Most of 
the pharmacological agents have previously been used in skeletal muscle studies 
(Nethery et al., 2000; Nethery et al., 1999; Whitehead et al., 2010; Pye et al., 2007) at 
similar concentrations to the ones used in this study. Cell viability following treatments 
was determined by assessment of propidium iodide exclusion and control experiments 
were undertaken to examine any potential effects of the drugs on muscle contractions. 
Contractile activity was monitored and fibres that did not visibly contract during the 
entire contractile activity period were excluded. 
 
4.3.8 RNA isolation and RT-PCR analysis  
For details see Section 2.10. Briefly, RNA from single muscle cells was 
extracted using Tri Reagent (Qiagen, Sussex, UK). All RNA samples were DNase-
treated and purified using the RNeasy MinElute cleanup-kit (Qiagen). Purified RNA 
was utilized to generate first-strand cDNA using the iScript cDNA synthesis kit (Bio-
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Rad, Hertfordshire, UK). The primers for real-time PCR analyses used in this study are 
shown below in Table 4.1. GAPDH was used as the only reference gene, this might be a 
limitation since evidence has shown that contractile activity but also RONS can alter 
GAPDH mRNA expression in skeletal muscle (Brownson et al., 1988).  
 
	  
Table 4.1 Sequences of the specific primers used for RT-PCR amplification of NADPH 
oxidase subunits in isolated fibres from the FDB muscle. 
  
4.3.9 Western blotting of muscle proteins 
For details see Section 2.8. Briefly, 30-100µg of total protein was applied to a 8-
15% polyacrylamide gel with a 4% stacking gel. Proteins were separated by 
electrophoresis and were transferred to a nitrocellulose membrane by a Multiphore 
continuous blotting system (Pharmacia, Uppsala, Sweden). Membranes were blocked 
for 2h in a 3% milk solution at room temperature and probed overnight using antibodies 
shown in Table 4.2. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) protein 
content was also determined and served the control-loading sample. Horseradish 
peroxidase conjugated anti-mouse IgG, anti-rabbit IgG (Cell Signaling, Hitchin, UK), 
anti-goat IgG, or anti-chicken IgY (Thermo Scientific, Loughborough, UK) were used 
Amplicon	  Size 
	  (bp) 151 
Forward	  	  Primer	   
Sequence 
Reverse	  Primer	  
Sequence 
Primer	  Name 
(ID)	   cctgaatttcaactgtatgctga	   NOX2	  	   cctgaatttcaactgtatgctga	   ggatttgctactgcctccat	   	  	  	  	  	  	   163 NOX4 agtgactccaatgcctccag	   p67phox gaccttaaagaggccttgacg 	  	  	  	  	  	   atgccaactgctcttctgct	   160 p47phox gtccctgcatcctatctgga 	  	  	  	  	  	   atgacctcaatggcttcacc	   155 p40phox tgacttcactgggaacagca	   	  	  	  	  	  	   tagccagttggtggtgtcct	   184 p22
phox gccattgccagtgtgatcta 	  	  	  	  	  	   tggtaggtggttgcttgatg	   118 
Rac	  1 gccaatgttatggtagatggaaa	   	  	  	  	  	  	   tttcaaatgatgcaggactca	   	  	  	  	  	  	   151 
GAPDH ccgtagacaaaatggtgaagg	   	  	  	  	  	  	   tcgttgatggcaacaatctc	   	  	  	  	  	  	   109 
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as the secondary antibody. Peroxidase activity was detected using an ECL kit 
(Amersham International Cardiff, UK), and band intensities were analysed using 
Quantity One Software (Biorad, US). The specificity of the bands were identified in 
comparison with a sample that had not been exposed to the primary antibody and the 
molecular weight was determined by using rainbow coloured protein markers 
(Amersham International). 
 
Antibody Company Catalogue No Species Dilution 
GAPDH Abcam Ab8245-100 Mouse 1:5000 
COXIV Abcam Ab59426 Mouse 1:4000 
VDAC1 Abcam Ab40747 Rabbit 1:3000 
VDAC2 Abcam Ab37985 Goat 1:500 
VDAC3 
Thermo 
Scientific 
PA1-959 Chicken 1:500 
BAX Santa Cruz Sc-493 Rabbit 1:500 
iPLA2 Cayman 160507 Rabbit 1:500 
NOX2 Abcam Ab80508 Rabbit 1:1000 
NOX4 Abcam Ab61248 Rabbit 1:1000 
Rac1 Cytoskeleton ARC03 Mouse 1:500 
P67phox 
BD 
Transduction 
610913 Mouse 1:1000 
P47phox Santa Cruz Sc-14015 Rabbit 1:500 
P22phox Abcam Ab75941 Rabbit 1:1000 
P40phox Santa Cruz Sc-30087 Rabbit 1:500 
MPO Abcam Ab45977 Rabbit 1:1000 
 
Table 4.2 Antibodies used for western blotting. 
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4.3.10 Subcellular fractionation   
Mitochondrial and cytosolic fractions from GTN skeletal muscle were isolated 
as described in Section 2.9. Briefly, GTN muscles were dissected and minced on ice and 
homogenized in STM buffer (comprising: 250mM sucrose, 50mM Tris-HCl pH 7.4, 
5mM MgCl2), protease and phosphatase inhibitor cocktails. The homogenate was 
decanted into a centrifuge tube and maintained on ice for 30 minutes and then 
centrifuged at 800g for 15 minutes at 4°C. The supernatant was kept (labeled as S1) and 
centrifuged at 800g for 10 minutes at 4°C for subsequent isolation of mitochondrial and 
cytosolic fractions. The supernatant (S2) was then centrifuged at 11,000g for 10 minutes 
at 4°C. The resulting pellet following S2 centrifugation was resuspended in 50-100μL 
SOL buffer (comprising: 50mM Tris HCl pH 6.8, 1mM EDTA, 0.5% Triton-X-100, 
protease and phosphatase inhibitors) by sonication on ice and labelled as “mitochondrial 
fraction” whereas the supernatant (S3) was precipitated in cold 100% acetone at -20°C 
for 1 hour followed by centrifugation at 12,000g for 5 minutes, the pellet was then 
resuspended in 100-300μL STM buffer and labelled as “cytosolic fraction”. 
 
4.3.11 Immunoprecipitation of p40phox  
Single isolated muscle fibres from the FDB muscle, powdered frozen muscle 
tissue from GTN, and liver tissue were homogenised and lysed in CelLytic-M 
Mammalian Cell Lysis/Extraction Reagent. Protein extracts (~1mg protein/sample) 
were incubated with 2µg of anti-p40phox antibody (Santa Cruz Biotechnology, 
Middlesex, UK) overnight at 4°C. The mixture was added to 30µL of protein G-
Sepharose beads and was further incubated for 2 h at 4°C. Beads were centrifuged and 
washed five times with immunoprecipitation buffer and bound proteins were eluted by 
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boiling in loading buffer (National Diagnostics, Hessle, UK) before being resolved by 
electrophoresis and identified by western blotting.  
 
4.3.12 Immunocytochemistry of NADPH oxidase subunits in single isolated muscle 
fibres  
Single skeletal muscle fibres from the FDB muscle were isolated and plated on 
culture dishes. Cells were rinsed with warm PBS and immediately fixed in 4% 
paraformaldehyde for 20 min at room temperature. After three washes with PBS, fibres 
were permeabilised and blocked in PBS containing 0.1% Triton X-100 and 1% bovine 
serum albumin (BSA). After 10 h incubation, fibres were washed with PBS and 
incubated overnight at 4oC with primary antibodies (see Table 4.3) diluted in PBS and 
1% BSA.  Fibres were washed with PBS plus 1% BSA three times for 5 min, followed 
by incubation with appropriate secondary antibodies (Alexa Fluor 488 and 532; 
Invitrogen, diluted 1:800) for 1.5 h at room temperature.  
 
Fluorescence images were obtained using a C1 confocal laser-scanning 
microscope (Nikon Instruments Europe BV, Surrey, UK) equipped with a 405nm 
excitation diode laser, a 488nm excitation argon laser and a 543nm excitation helium-
neon laser. Emission fluorescence was detected through a set of 450/35, 515/30 and 
605/15-emission filters. Using a ×60 objective, fluorescence images were captured and 
analysed with the EZC1 V.3.9 (12bit) acquisition software. To quantify sub-cellular 
(cytosolic and membrane) fluorescent distribution and the degree of co-localization of 
proteins and fluorescent probes in muscle fibres, NIH Image J software was used. Co-
localization coefficients: Pearson’s correlation (Rr) coefficient (correlation of intensity 
distribution between channels), Mander’s overlap (R) coefficient and Manders’s co-
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localization coefficient for each image (proportion of one channel signal coincident 
with the signal in other channel); channel 1 (Mred) and channel 2 (Mgreen) were 
calculated over the entire confocal image.   
 
Antibody Company Catalogue No Species Dilution 
Rac1 Cytoskeleton ARC03 Mouse 1:40 
P40phox Santa Cruz Sc-30087 Rabbit 1:50 
P47phox Santa Cruz Sc-14015 Rabbit 1:20 
P67phox 
BD 
Transduction 
610913 Mouse 1:50 
NOX2 Abcam Ab80508 Rabbit 1:50 
NOX4 Abcam Ab61248 Rabbit 1:50 
P22phox Abcam Ab75941 Rabbit 1:30 
α1s DHPR 
Thermo 
Scientific 
MA3-920 Mouse 1:50 
Caveolin-3 Santa Cruz Sc-55518 Mouse 1:50 
 
Table 4.3 Antibodies used to immunostain single FDB muscle fibres. 
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4.4 RESULTS 
To define the sources that modulate cytosolic changes in superoxide at rest and 
during contractile activity, single muscle fibres were loaded with the superoxide 
sensitive fluorescent probes DHE and MitoSOX Red as previously described (Section 
2.3). The experiments presented in chapter 3 indicated that techniques based on use of 
single mature skeletal muscle fibres loaded with DHE and MitoSOX Red appeared 
capable of detecting cellular changes in superoxide that occur in response to drug-
stimulants or in response to the physiological stimulus such as contractile activity. In 
the present study, specific inhibitors of potential pathways and immunolocalization 
techniques were also used to identify sub-cellular sites contributing to cytosolic 
superoxide. 
Previous work from my MPhil thesis “Factors influencing the intracellular 
generation of ROS by skeletal muscle fibres” showed that DHE oxidation in fibres 
increased in an intensity dependent manner following muscle contractions (Sakellariou, 
2009). The contractile activity protocols used in that study are shown in Scheme 4.1 
(Section 4.3.6), with fibres subjected to the High, Moderate and Low contracted groups 
showing a 5.8, 4.1 and 2.8 fold increase following contractions compared with resting 
fibres (Figure 4.1, data taken from MPhil). The experiments undertaken at that time 
implied that contractile activity increased in an intensity dependent manner the 
cytosolic superoxide content of single muscle fibres since DHE oxidation reflects 
changes in superoxide within the cytoplasmic compartment of the muscle fibres. These 
data are reproduced here for completeness. The following new data focus on identifying 
the sites that contribute to cytosolic superoxide changes both at rest and following 
contractile activity.  
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Figure 4.1 Rate of change in DHE oxidation from resting FDB fibres and fibres 
subjected to a 10 min period of contractile activity with different intensities. *P<0.05 
compared with fibres from the resting group. #P<0.05 compared with fibres subjected to 
the Low contractile activity protocol (n = 7-8 fibres in each group), (Figure taken from 
MPhil; Sakellariou, 2009). 
 
Intracellular sources of superoxide production that have been proposed include 
mitochondria, NADPH oxidase enzymes (Hidalgo et al., 2006; Mofarrahi et al., 2008), 
and enzymes of the phospholipase A2 family (Gong et al., 2006; Nethery et al., 1999), 
but their contribution to cytosolic changes in superoxide in skeletal muscle during 
contractions has not been fully evaluated. The results of this chapter aim to evaluate the 
contribution of these sources to superoxide production both at rest and during 
contractile activity in skeletal muscle.  
 
4.4.1 Contribution of mitochondria to cytosolic superoxide in single skeletal 
muscle fibres at rest and during contractile activity  
Changes in superoxide within the mitochondrial matrix were monitored with 
MitoSOX Red. As shown in previous chapter (Figure 3.8), MitoSOX Red selectively 
accumulates in the mitochondria of single muscle fibres and can react with superoxide, 
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formed within the mitochondrial matrix as indicated by the increase in MitoSOX Red 
fluorescence following addition of Rot and Ant A (Figures 3.9 and 3.10).  
 
4.4.1.1 Skeletal muscle mitochondria release superoxide to the cytosol of fibres 
following treatment with Antimycin A 
To examine mitochondria as a potential source of superoxide detected in the 
cytosol, DHE loaded fibres were treated with 5 or 10 µM Ant A at 30 min. Treatment of 
fibres with Ant A induced a dose dependent increase in DHE oxidation compared with 
control untreated fibres, indicating extramitochondrial superoxide release (Figure 4.2).  
 
 
 
 
Figure 4.2 Relative change in DHE oxidation from ethanol vehicle-treated fibres (V 
control) and fibres treated with Ant A (5 or 10µM) at 30 min. *P<0.05 compared with 
values from fibres treated with 5µM Ant A or control vehicle-treated fibres at the same 
time point (n = 7-8 fibres in each group). 
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4.4.1.2 Release of superoxide from mitochondria following treatment with Ant A 
does not occur through the mitochondrial permeability transition pore 
(mPTP) or the inner membrane anion channel (iMAC) 
 
4.4.1.2.1 The effect of Ant A on DHE oxidation in SS31 loaded fibres  
Treatment of isolated skeletal muscle mitochondria with Ant A increases 
superoxide on both sides of the inner mitochondrial membrane; the MIS and 
mitochondrial matrix (Muller et al., 2004). It has previously been reported that both of 
these compartments can release superoxide into the cytosol through the mitochondrial 
permiablility transition pore (mPTP) - that spans the inner (IMM) and outer (OMM) 
mitochondrial membrane (Gomez-Cabrera et al., 2010), the inner membrane anion 
channel (iMAC) (Maack and Bohm, 2011; Pouvreau, 2010) or through channels located 
on the OMM which allow the passage of solutes and proteins between the MIS and 
cytosplasm (Budzinska et al., 2009; Han et al., 2003).To identify if either the mPTP or 
iMAC contributed to the extramitochondrial superoxide release seen following 
treatment with Ant A, fibres were pretreated with the SS-31 peptide, the mitochondrial 
targeted antioxidant peptide which was shown in previous chapter to scavenge 
superoxide within the mitochondrial matrix (Figure 3.11) .  
 
Treatment of fibres with SS-31 at either 10 or 100µM had no effect on DHE 
oxidation with the treated fibres showing a similar increase in fluorescence compared 
with vehicle-control fibres following addition of Ant A (Figure 4.3) suggesting that the 
extramitochondrial superoxide release seen following treatment with Ant A was not 
derived from the matrix through the mPTP or the iMAC. 
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Figure 4.3 Relative change in DHE oxidation from ethanol vehicle-treated fibres (V 
control) and fibres loaded with Ant A (5µM) at 30 min. Two groups of Ant A-treated 
fibres were also pre-treated with the mitochondrial targeted SS-31 peptide (dissolved in 
PBS) at 10 or 100µM (n = 6 fibres in each group). 
 
4.4.1.2.2 The effect of iMAC and mPTP inhibitors on DHE oxidation following 
treatment with Ant A  
 The potential role of the mPTP and iMAC in release of superoxide was further 
examined using the mPTP - cyclosporin A (CsA) and iMAC - 4 chlorodiazepam (4Cl-
DZP) inhibitors. Neither CsA or 4CL-DZP was found to affect DHE oxidation in Ant 
A-treated fibres (Figure 4.4) providing further evidence that superoxide formed within 
the mitochondrial matrix does not diffuse to the cytosplasm of single muscle fibres.  
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Figure 4.4 Relative change in DHE oxidation from ethanol vehicle-treated fibres (V 
control) and fibres loaded with Ant A (5µM) at 30 min. Two groups of Ant A-treated 
fibres were also pre-treated with the mPTP (CsA, 0.5µM) or iMAC (4Cl-DZP, 12µM) 
inhibitors (both inhibitors were dissolved in ethanol). *P<0.05 compared with values 
from fibres in all other Ant A treated groups and control vehicle-treated fibres at the 
corresponding time points (n = 6-8 fibres in each group). 
 
4.4.1.2.3 The effect of rotenone on DHE oxidation  
The role of matrix superoxide was also examined by treatment of fibres with the 
complex I inhibitor, Rot. This was previously (Chapter 3) shown to increase MitoSOX 
Red oxidation (Figure 3.11), but no effect was seen on DHE oxidation (Figure 4.5) 
indicating that complex I-dependent superoxide is exclusively released into the matrix 
and does not release superoxide to the cytoplasm from intact mitochondria.   
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Figure 4.5 Relative change in DHE oxidation from control DMSO vehicle-treated 
fibres (V control) and fibres treated with rotenone at 30 min (n = 5-7 fibres in each 
group). 
 
 
4.4.1.3 Channels of the outer mitochondrial membrane mediate the diffusion of 
superoxide from the MIS to the cytosol of skeletal muscle fibres 
Taken together the data presented in Figures 4.3, 4.4 & 4.5 suggest that the 
diffusion of superoxide from the mitochondria to the cytosol of single muscle fibres 
following treatment with Ant A did not derive from the mitochondrial matrix but was 
likely to originate from the MIS.  
 
4.4.1.3.1 Purity of cytosolic and mitochondrial fractions  
In order to identify the channels that might play a role in the diffusion of 
superoxide from the MIS to the cytosol in single muscle fibres, mitochondrial and 
cytosolic fractions from GTN muscles were prepared. Figure 4.6 shows the relative 
purity of the mitochondrial and cytosolic fractions obtained. GAPDH was only present 
in the cytosolic fractions and COXIV in the mitochondrial fractions.  
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Figure 4.6 Example western blots for GAPDH and cytochrome oxidase IV (COXIV) to 
illustrate the purity of the extracted mitochondrial (Mito F) and cytosolic (Cyto F) 
fractions obtained from GTN muscle. 
 
 
4.4.1.3.2 Protein expression of VDAC isoforms in skeletal muscle  
Previous studies in isolated cardiac mitochondria have shown that the voltage 
dependent anion channels (VDACs) located on the OMM can mediate the release of 
superoxide from the MIS. We initially assessed the protein expression of all three 
isoforms of VDAC in cytosolic and mitochondrial fractions from GTN muscle and 
lysates from single skeletal muscle fibres (Figure 4.7). All three isoforms were highly 
expressed in the skeletal muscle mitochondrial fractions (Figure 4.7). 
 
 
Figure 4.7 Representative western blots of VDAC1, VDAC2 and VDAC3 proteins in 
cytosolic (Cyto F) and mitochondrial (Mito F) fractions from GTN muscle, in lysate 
from single isolated fibres from the FDB muscle (fibres) and whole GTN muscle.   
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4.4.1.3.3 Effect of VDAC inhibition by dextran sulfate (DS) at rest and following 
exposure to Ant A  
In the presence of dextran sulfate (DS), a VDAC inhibitor, the anticipated 
increase in DHE oxidation following treatment with Ant A at 30 min was partially 
inhibited over the first 20 minutes following addition of Ant A, but by the end of the 
experiment the level was comparable with those from fibres loaded with Ant A only 
(Figure 4.8). These data support the possibility that i) VDACs play a key role in 
mitochondrial superoxide release and ii) channels of the OMM other than VDACs 
might also mediate the diffusion of superoxide from the MIS to the cytosol of single 
muscle fibres. No effect on baseline DHE oxidation was observed following treatment 
of fibres with DS alone at 30 min (Figure 4.9) implying that intact skeletal muscle 
mitochondria do not release superoxide to the cytosol of resting muscle fibres. 
 
 Effects of inhibition of VDAC by 4,4'-diisothiocyano-2,2'-disulfonic acid 
stilbene (DIDS) inhibitor could not be assessed as this agent was found to affect fibre 
viability at IC50 values of 0.2mM.  
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Figure 4.8 Relative change in DHE oxidation from ethanol vehicle-treated fibres (V 
control) and fibres loaded with Ant A (5µM) at 30 min. A group of Ant A-treated fibres 
was also pre-treated with DS (0.1mM). DS was dissolved in PBS. *P<0.05 compared 
with fibres treated with DS at the corresponding time point (n = 7 fibres in each group). 
 
 
 
 
 
Figure 4.9 Relative change in DHE oxidation from PBS vehicle-treated fibres (V 
control) and fibres treated with DS (0.1mM) at 30 min (n = 7-8 fibres in each group). 
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4.4.1.3.4 Effect of a Bax channel blocker and/or VDAC inhibitors following 
exposure to Ant A  
Further experiments were undertaken to identify whether the Bax channel, an 
additional channel located on the OMM (Martinou, 1999), would play a role in the 
release of superoxide following treatment of fibres with Ant A. The protein expression 
of the Bax channel in mitochondrial fractions and lysate from single muscle cells is 
shown in (Figure 4.10). Following inhibition of the Bax channel with the Bax channel 
blocker (Bax CB), fibres showed a reduction in DHE oxidation during the 40-50 minute 
period following addition of Ant A (Figure 4.11). Fibres pretreated with the Bax 
channel blocker and VDAC inhibitor together, showed a further reduction in 
fluorescence, with the relative change in DHE oxidation being statistically lower 
(~13%) during the 20-50 min period following Ant A treatment compared with fibres 
treated with Ant A only (Figure 4.11). The increase in DHE oxidation in the Bax CB 
and DS group was lower over the 30-90 min time course compared with the Ant A 
treated fibres (Figure 4.11) but this did not occur in fibres treated with DS only (Figure 
4.8), suggesting that both channels play a synergistic role in mediating the diffusion of 
superoxide from the MIS across the OMM. Inhibition or blocking of these two OMM 
channels did not completely prevent extramitochondrial superoxide release following 
treatment of fibres with Ant A (Figure 4.11). To ensure that data were not influenced by 
any direct interactions between Ant A and DHE, that were unrelated to effects of Ant A 
on the electron transport chain, control experiments were conducted in a cell-free 
medium but these showed no effect of Ant A on DHE or MitoSOX Red oxidation. 
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Figure 4.10 Representative western blot of Bax protein in cytosolic (Cyto F) and 
mitochondrial (Mito F) fractions from GTN muscle, in lysate from single isolated FDB 
muscle fibres and whole GTN muscle. 
 
 
 
 
 
Figure 4.11 Relative change in DHE oxidation from ethanol vehicle-treated fibres (V 
control) and fibres loaded with Ant A (5µM) at 30 min. Two groups of Ant-A treated 
fibres were also pre-treated with Bax CB (5µM) or with Bax CB (5µM) and DS 
(0.1mM). *P<0.05 compared with values from Ant A treated fibres preincubated with 
Bax CB and DS at the same time point. #P<0.05 compared with values from fibres 
treated with Ant A in the presence of Bax CB at the same time point (n = 6-7 fibres in 
each group). 
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4.4.1.3.5 Effect of a Bax channel blocker and/or VDAC inhibitors on DHE 
oxidation during contractile activity  
Data in Figures 4.8 and 4.11 suggest that mitochondria in single skeletal muscle 
fibres can release superoxide from the MIS to the sarcoplasm of muscle cells. To 
investigate the possibility that skeletal muscle mitochondria release superoxide from the 
MIS to the cytosol during contractions, muscle fibres were subjected to a 10 min 
contractile activity period following treatment with the Bax and VDAC inhibitors 
(Figure 4.12). Contractile activity induced a significant increase in DHE oxidation in 
the presence or absence of the inhibitors compared with values from fibres from the 
resting group (Figure 4.12). No differences in the rate of change in DHE oxidation were 
observed between untreated fibres and fibres treated with VDAC and/or Bax inhibitors 
following contractions (Figure 4.12) indicating that the increase in superoxide in 
response to contractions was unlikely to derive from the MIS and likely originated from 
non-mitochondrial sources.  
 
 
Figure 4.12 Rate of change in DHE oxidation from resting fibres and fibres subjected 
to the Moderate contraction protocol for a period of 10 min. Contracted fibres were 
either untreated, treated with DS or treated with DS and Bax CB. *P<0.05 compared 
with values from fibres at rest (n = 9-11 fibres in each group). 
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4.4.2 The contribution of iPLA2 enzymes to cytosolic superoxide   
4.4.2.1 Expression of iPLA2 in skeletal muscle  
Previous studies have reported that iPLA2 enzymes can modulate the cytosolic 
oxidant activity in skeletal muscle cells indicated by a reduction in 2', 7'- 
dichlorodihydrofluorescin (DCFH) oxidation following inhibition of iPLA2 (Gong et 
al., 2006). The present study initially assessed the expression of iPLA2 and Figure 4.13 
shows the presence of iPLA2 in cytosolic fractions from GTN muscle and in lysate from 
single muscle fibres.  
 
 
 
Figure 4.13 Representative western blot of iPLA2 protein in cytosolic fraction (Cyto F) 
from GTN muscle, in lysate from single isolated FDB muscle fibres and whole GTN 
muscle. 
 
 
4.4.2.2 Effect of inhibition of iPLA2 enzymes on cytosolic superoxide at rest and 
during contractile activity  
To identify the contribution of iPLA2 enzymes to cytosolic superoxide 
production at rest, quiescent muscle fibres were treated with the selective iPLA2 
inhibitor Bromoenol lactone (BEL) at 30 min of the experimental period (Figure 4.14). 
No differences in the relative change in DHE oxidation were observed between the 
treated and non-treated groups of fibres (Figure 4.14). The same pattern was observed 
following a period of contractions, with fibres from all contracted groups showing a 
similar increase in DHE oxidation following contractions (Figure 4.15). 
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Figure 4.14 Relative change in DHE oxidation from DMSO vehicle-treated fibres (V 
control) and fibres treated with BEL (0.6µM) at 30 min (n = 7-10 fibres in each group). 
 
 
 
 
 
Figure 4.15 Relative change in DHE oxidation from resting FDB fibres and fibres 
subjected to the Moderate contraction protocol over the 10 - 20 min period. Fibres were 
either untreated or treated with BEL (0.6µM). *P<0.05 compared with values from 
fibres of the same group prior to contractions (n = 7-8 fibres in each group). 
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4.4.3 Contribution of NADPH oxidase(s) to cytosolic superoxide   
 
Expression of NADPH oxidase(s) in skeletal muscle 
 
4.4.3.1 mRNA expression in single FDB muscle fibres 
There is evidence that skeletal muscles express NADPH oxidase(s) (Whitehead 
et al., 2010; Mofarrahi et al., 2008; Hidalgo et al., 2006; Espinosa et al., 2006), but little 
information is available regarding the role and regulation of this complex in generation 
of superoxide in skeletal muscles. As mentioned previously in Chapter 1 (Section 1.2), 
NADPH oxidases are a family of enzymes, which consist of both catalytic and 
regulatory subunits. Other studies have identified various NADPH oxidase subunits in 
mouse and rabbit skeletal muscles (Whitehead et al., 2010; Hidalgo et al., 2006), but to 
our knowledge no studies have examined the expression in pure skeletal muscle, devoid 
of all non-myogenic cells. To assess the expression of the NADPH oxidase components 
in a pure skeletal muscle preparation, RNA was extracted from single isolated FDB 
muscle fibres. The optimal annealing temperature for each primer set was determined as 
described in hapter 2 “Experimental Methods” and the primer sets used in this study are 
depicted in Table 1, Section 4.3.8. The mRNA expression of NOX2 and NOX4 
catalytic subunits as well as Rac1, p67phox, p47phox, p22phox, p40phox regulatory 
components is shown in Figure 4.16. GAPDH was used as the control.  
 
 
 
 
 
	  	   128	  
 
 
Figure 4.16 RT-PCR amplification of NOX2, NOX4, Rac1, p67phox, p47phox, p22phox, 
p40phox and GAPDH transcripts in single isolated fibres from the FDB muscle. The PCR 
products correspond to the amplicon sizes shown in Table 4.1 in the Experimental 
procedures (Section 4.3.8). 
 
 
 
4.4.3.2 Protein expression in single FDB muscle fibres 
Further experiments were undertaken to determine the protein expression of the 
NADPH oxidase subunits in single FDB muscle fibres. Figure 4.17 shows the protein 
expression of NOX2, NOX4, Rac1, p67phox, p47phox, p22phox and p40phox in lysates from 
single muscle fibres and whole GTN skeletal muscles. p40phox was immunoprecipitated, 
for details see Section 4.3.11. Appropriate positive controls were included for each 
antibody.   
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Figure 4.17 Representative western blots of NOX2, NOX4, Rac1, p67phox, p47phox, 
p22phox and p40phox proteins in lysate from single isolated FDB muscle fibres and whole 
GTN muscle. Appropriate positive controls (PC) are shown: lysate from mouse heart for 
NOX2, NOX4 and p40phox; lysate from mouse liver for p67phox and p22phox; Human 
platelet extract for Rac1 and Raw macrophage 264.7 whole cell lysate for p47phox. 
*p40phox was immunoprecipitated, see Section 4.3.11 for details. 
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4.4.3.3 Protein expression of NOX isoforms in mitochondrial fractions 
Recent evidence has shown that cardiac (Ago et al., 2010; Dai et al., 2011; 
Kuroda et al., 2010) and liver (Block et al., 2009) mitochondria express NOX4. To 
identify if either NOX2 or NOX4 oxidases are present in skeletal muscle mitochondria, 
further experiments were undertaken in mitochondrial fractions from GTN muscles and 
demonstrated the presence of NOX4 in this fraction (Figure 4.18). 
 
 
(A) 
 
 
 
(B) 
 
 
 
Figure 4.18 Representative western blots of NOX2 (A) and NOX4 (B) proteins in 
mitochondrial (Mito F) fractions from GTN muscle compared with lysate from whole 
GTN muscle. 
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Effect of inhibition of NADPH oxidase(s) on cytosolic superoxide at rest and 
during contractile activity 
 
4.4.3.4 Effect of diphenyleneiodonium chloride (DPI) inhibitor on DHE oxidation 
The role of NADPH oxidase complexes in producing superoxide under resting 
conditions was initially assessed by use of the non-specific inhibitor, 
Diphenyleneiodonium chloride (DPI) (Figure 4.19). Resting muscle fibres treated with 
DPI at 30 min of the experimental period showed an unexpected increase in DHE 
oxidation compared with control non-treated fibres (Figure 4.19). In addition, this 
flavoprotein inhibitor DPI also prevented the fibres from contracting. An alternative 
NADPH oxidase inhibitor, 4-(2-aminoethyl)-benzenesulfonyl fluoride (AEBSF) 
inhibitor also could not be assessed since this agent also influenced muscle contractions. 
 
 
 
 
 
Figure 4.19 Relative change in DHE oxidation from DMSO vehicle-treated fibres (V 
control) and fibres treated with DPI (10µM) at 30 min. *P<0.05 compared with values 
from control vehicle-treated fibres at the same time points (n = 6-8 fibres in each 
group).  
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4.4.3.5 Effect of apocynin (APO) inhibitor on DHE oxidation 
Fibres were incubated in the presence of apocynin (APO), a non-specific 
NADPH oxidase inhibitor, with the quiescent muscle fibres showing a reduction in 
fluorescence by a mean of 10% over the 50-90 min time course compared with vehicle-
treated fibres (Figure 4.20). APO was also found to decrease DHE oxidation following 
a period of contractile activity. The contraction–induced increase in fluorescence was 
reduced by a mean of 70% compared with untreated fibres (Figures 4.21 and 4.22).  
 
 
 
 
Figure 4.20 Relative change in DHE oxidation from PBS vehicle-treated fibres (V 
control) and fibres treated with APO (0.5mM) at 30 min. *P<0.05 compared with values 
from control vehicle-treated fibres at the same time points (n = 9 fibres in each group). 
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Figure 4.21 Relative change in DHE oxidation from resting FDB fibres and fibres 
subjected to the Moderate contraction protocol over the 10 - 20 min period. Fibres were 
either untreated or treated with APO (0.5mM). *P<0.05 compared with values from 
fibres of the same group prior to contractions. #P<0.05 compared with contracted fibres 
treated with APO at the corresponding time point (n = 14-17 fibres in each group). 
 
 
 
 
 
Figure 4.22 Rate of change (net change in fluorescence following the contractile 
activity period) in DHE oxidation from resting fibres and fibres subjected to a 10 min 
period of contractile activity. Fibres were either untreated or treated with APO 
(0.5mM). *P<0.05 compared with fibres from both resting groups. #P<0.05 compared 
with contracted fibres treated with APO (n = 14-17 fibres in each group). 
0.5 
0.8 
1.1 
1.4 
1.7 
0 10 20 30 
Contracted + Apo 
Resting + Apo 
Contracted 
Resting 
	  
* # 
* 
Time (min) 
R
el
at
iv
e 
D
H
E 
ox
id
at
io
n 
(a
rb
itr
ar
y 
un
its
) 
-0.2 
0 
0.2 
0.4 
Res2ng	   Res2ng	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
+	  Apo	  
Contracted	   Contracted	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
+	  Apo	  
* 
* # 
R
at
e 
of
 c
ha
ng
e 
in
 D
H
E 
 
ox
id
at
io
n 
(a
rb
it
ra
ry
	  u
ni
ts
) 
	  	   134	  
Recent work suggests that APO may act as a scavenger for reaction products of 
H2O2, excluding superoxide, in vascular cells that lack myeloperoxidase (MPO) or 
produce low amounts of ROS (Heumuller et al., 2008). MPO is an enzyme that 
catalyses the production of hypochlorous acid (Spickett et al., 2000) and 
immunoblotting experiments failed to identify any MPO in skeletal muscle cells (Figure 
4.23). Hence the potential inhibitory effect of gp91ds-tat, a specific peptide inhibitor of 
NADPH oxidases, was also examined. 
 
 
 
Figure 4.23 Representative western blot of myeloperoxidase (MPO) in cytosolic (Cyto 
F) and mitochondrial (Mito F) fractions from GTN muscle, in lysate from whole GTN 
muscle and single isolated FDB muscle fibres. Human Jurkat cells and HeLa cells were 
used as positive controls. 
 
4.4.3.6 Effect of gp91ds-tat inhibitor on DHE oxidation  
Resting fibres incubated in the presence of gp91ds-tat showed a decline in 
fluorescence by a mean of 18% compared with vehicle-treated fibres and fibres treated 
with the control peptide, scrambled-tat (Figure 4.24). Treatment of fibres with gp91ds-
tat also prevented the increase in DHE oxidation in response to a 10 min period of 
contractions (Figure 4.25). DHE oxidation was significantly increased by contractions 
in both the vehicle control and scrambled-tat treated fibres, but the scrambled-tat treated 
fibres also showed a lower rate of increase in DHE oxidation than the vehicle-treated 
control group (Figure 4.25). 
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Figure 4.24 Relative change in DHE oxidation from PBS vehicle-treated (V control) 
fibres, gp91ds-tat (5µM) treated fibres and scrmb-tat (5µM) treated fibres at 30 min. 
*P<0.05 compared with values from control vehicle-treated fibres and fibres treated 
with scrmb-tat at the corresponding time points (n = 6-7 fibres in each group). 
 
 
Figure 4.25 Rate of change in DHE oxidation from resting FDB fibres and fibres 
subjected to the Moderate contraction protocol for a period of 10 min. Contracted fibres 
were either untreated or treated with gp91ds-tat (5µM) or scrmb-tat (5µM). *P<0.05 
compared with values from fibres of the resting group. #P<0.05 compared with 
contracted fibres treated with gp91ds-tat. †P<0.05 compared with values from 
contracted fibres treated with scrmb-tat (n = 7 fibres in each group). 
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Identifying the sub-cellular location of the NADPH oxidase components in single 
muscle fibres. 
 
4.4.3.7 Identifying the sub-cellular location of the regulatory NADPH oxidase 
components in single muscle fibres 
To determine the cellular location of NADPH oxidase subunits, 
immunocytochemistry of single isolated fibres from the FDB muscle was undertaken. 
Figure 4.26 shows the expression of the regulatory subunits (p40phox, p47phox, p67phox 
and Rac1) of the NADPH oxidase complex. These proteins were found to be localized 
on, or in close proximity to the sarcolemma, but immunofluorescence from p40phox and 
p67phox was also observed in the cytosolic compartment of the muscle fibres (Figure 
4.26). 
 
 
 
Figure 4.26 Immunocytochemistry of single isolated fibres from the FDB muscle 
showing the expression of p40phox, p47phox, p67phox and Rac1 subunits of the NADPH 
oxidase complex. 
p40phox p47phox 
p67phox Rac	  1 
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4.4.3.8 Identifying the sub-cellular location of the catalytic NADPH oxidase 
components in single muscle fibres 
The catalytic subunits (NOX2 and NOX4) and the small membrane-bound 
integral subunit (p22phox) were found to be localised on the plasma membrane of the 
muscle fibres, as indicated by co-localisation (yellow staining) with caveolin-3, the 
muscle-specific caveolin isoform, present in sarcolemmal caveolae (Whitehead et al., 
2010), (Figure 4.27). A striated pattern of staining for all three subunits was also 
observed in close proximity to the sarcolemma, potentially due to expression in the T-
tubules (Figure 4.27). 
 
 
 
	  	   138	  
 
 
Figure 4.27 Immunocytochemistry for the NOX2, NOX4 and p22phox NADPH oxidase 
components. Fibres were co-immunostained with an antibody to Caveolin-3 (red 
staining) to demonstrate sarcolemmal co-localisation (yellow staining). 
 
 
4.4.3.9 Examining the T-Tubular expression of NOX2, NOX4 and p22phox in single 
muscle fibres 
To examine the possibility of at T-tubular NOX2, NOX4 and p22phox expression, 
the membrane bound subunits of the NADPH oxidase complex from single muscle 
fibres were co-immunostained with the α1s subunit of the dihydropyridine receptor (α1s 
DHPR), that is located on the T-tubule membrane (Hidalgo et al., 2006) (Figure 4.28). 
Confocal images showed a high degree of co-localization (yellow staining) strongly 
Caveolin-­‐3 NOX	  2 Merged 
Caveolin-­‐3 NOX	  4 Merged 
Caveolin-­‐3 p22phox Merged 
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suggesting that the NADPH oxidase components; NOX2 (Rr=0.60, R=0.67, Mred=0.85, 
Mgreen=0.96), NOX4 (Rr=0.98, R=0.98, Mred=0.98, Mgreen=1) and p22phox (Rr=0.92, 
R=0.97, Mred=1, Mgreen=0.92) were also expressed on the T-tubule membrane in 
skeletal muscle fibres (Figure 4.28). 
 
 
 
Figure 4.28 Fibres were immunostained using antibodies against NOX2, NOX4 and 
p22phox and co-immunostained with an antibody to α1s DHPR (red staining) to 
demonstrate T-Tubular co-localisation (yellow staining). 
 
 
 
α1s	  DHPR NOX	  4 Merged 
α1s	  DHPR NOX	  2 Merged 
α1s	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4.4.3.10 The effect of contractions on p40phox and p67phox translocation in single  
skeletal muscle fibres. 
Activation of the NADPH oxidase complex in phagocytic cells requires 
translocation of the cytosolic components; p40phox, p47phox and p67phox to the cell 
membrane (Babior, 1995; Dusi et al., 1996; Kuribayashi et al., 2002). The confocal 
images in Figure 4.26 showed that p40phox and p67phox regulatory subunits were present 
in the cytosolic compartment of quiescent muscle cells. To determine whether the 
increase in cytosolic superoxide following contractions was associated with 
translocation of the regulatory subunits to the plasma membrane of the muscle cells, 
resting and contracted muscle fibres were immunostained-using antibodies against 
p40phox and p67phox (Figure 4.29). Confocal images showed no evidence for contraction-
induced translocation of the p67phox protein, with resting fibres showing a similar 
intensity of fluorescence at the membrane and in the cytosol compared with fibres 
subjected to contractions (Figure 4.29). Fibres probed against p40phox showed a different 
pattern, with the contracted fibres exhibiting a more intense fluorescence at the 
sarcolemma compared with resting non-contracted fibres (Figure 4.29). 
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Figure 4.29 Immunocytochemistry of single isolated fibres showing the sub-cellular 
location of the cytosolic NADPH oxidase subunits; p40phox and p67phox, at rest and 
following a 10 min period of moderate contractions. Nuclei (blue staining) were stained 
with DAPI. 
 
4.4.3.11 Fluorescence distribution analysis of p40phox in contracted and resting single 
skeletal muscle fibres. 
To examine the possible translocation of p40phox following contractions, shown 
in images of Figure 4.29 quantification of sub-cellular fluorescent distribution analysis 
for p40phox (Figure 4.30) was undertaken by utilizing the NIH Image J software. 
Quantification of sub-cellular fluorescent distribution analysis for p40phox (Figure 4.30) 
showed an increased proportion of the fibre fluorescence at the sarcolemma and a 
relative reduction in the cytosolic compartment of contracted fibres compared with 
quiescent fibres, suggesting that NADPH oxidase activation in skeletal muscle fibres 
during contractions involves translocation of p40phox to the plasma membrane.   
p40phox Resting Contracted 	  
p67phox Resting Contracted 	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Figure 4.30 Profile of the distribution of fluorescence from immunostaining for p40phox 
across the single resting and contracted fibres shown in Figure 4.29.   
 
4.5 DISCUSSION 
Since the initial observations that skeletal muscle produces free radicals, a great 
deal of research has been undertaken to identify potential sources that are responsible 
for the increased generation of RONS during contractions. It is now clear that 
superoxide and NO are the primary reactive oxygen and nitrogen species generated 
within skeletal muscle both at rest and during contractile activity and although the 
production of NO by the nitric oxide synthases has been well described, there is still 
considerable debate over the prime cytosolic source(s) of superoxide in skeletal muscle. 
The work described in this chapter has examined potential pathways that are involved in 
the regulation of cytosolic superoxide content both at rest and during contractile activity 
in single isolated mature skeletal muscle fibres by monitoring real time changes in DHE 
and MitoSOX Red oxidation using fluorescence microscopy.  
 
4.5.1 Potential cytosolic sources of superoxide in single skeletal muscle fibres 
Many studies have demonstrated an increase in end-point indicators of the 
reactions of RONS in tissues during and following exercise, and the increase in RONS 
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appears to be in major part due to generation by contracting skeletal muscle (Jackson, 
2005). The main objective of the present study was to determine the major sites that 
contribute to changes in cytosolic superoxide in skeletal muscle both at rest and 
following contractile activity.  
 
Previous work from my MPhil thesis (Figure 4.1) showed that the contraction-
induced increase in superoxide in response to contractions is proportional to the 
intensity of the contraction protocol/frequency of contractions. This finding is in 
agreement with previous studies which demonstrated that intracellular (Silveira et al., 
2003) and extracellular ROS (Kolbeck et al., 1997; Reid et al., 1992) generation in 
myotubes and diaphragm tissue was higher following an intense electrical stimulation 
protocol than with a moderate stimulation protocol.  
 
4.5.2 Contribution of mitochondria to cytosolic superoxide in single skeletal 
muscle fibres 
It has been well described that the increase in ATP production via oxidative 
phosphorylation is associated with elevated O2 consumption that occurs with increased 
mitochondrial activity and early studies examining the sources of superoxide production 
reported that 2-5% of the total O2 consumed by mitochondria may undergo one electron 
reduction with the generation of superoxide (Boveris and Chance, 1973; Loschen et al., 
1974; Halliwell and Gutteridge, 2007). Although recent assessments of the rate of 
superoxide production by mitochondria indicate that only ~0.15% of the total O2 
consumed is reduced to superoxide (St-Pierre et al., 2002), this might imply that the 
contraction intensity-dependent increase in cytosolic superoxide assessed via changes in 
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DHE oxidation (Figure 4.1) might be a result of increased mitochondrial superoxide 
increase due to a greater demand for ATP production.  
 
However, the rapid increase in superoxide observed following contractions 
(Figure 4.1) likely originated from non-mitochondrial sources since the change in DHE 
oxidation reflects reaction with superoxide within the cytosolic compartment of the 
muscle cells (Johnson-Cadwell et al., 2007). Superoxide is a membrane impermeant 
anion, but recent evidence has indicated that superoxide can diffuse out of isolated 
mitochondria through the mitochondrial permeability transition pore (mPTP) (Abou-
Sleiman et al., 2006), the inner mitochondrial anion channel (iMAC) (Dai et al., 2011) 
and through channels located on the outer mitochondrial membrane (OMM) (Budzinska 
et al., 2009; Han et al., 2003).  
 
Studies have shown that isolation techniques can severely disturb mitochondrial 
structural integrity, associated with marked impairments of mitochondrial function. 
Reports indicate that skeletal muscle mitochondria exhibit a markedly diverse 
architecture (Kirkwood et al., 1986; Kayar et al., 1988) with some mitochondria 
exhibiting elongated tubular branched structures (Ogata and Yamasaki, 1997) and 
extensive functional connections (Fang et al., 2011). However, electron microscopy 
images of isolated mitochondria from healthy tissues show disrupted architecture such 
as lower electron density of the matrix space, dysmorphic and irregular inner 
mitochondrial membrane structure and swelling of the inter-membrane (Schwerzmann 
et al., 1989). Mitochondrial morphology is closely associated to aspects of 
mitochondrial function and recent evidence has shown that isolation techniques can 
cause striking adverse effects such as loss of soluble matrix enzymes (Schwerzmann et 
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al., 1989; Picard et al., 2010), increased mitochondrial permeability transition pore 
(mPTP) sensitivity to Ca2+ (Picard et al., 2011b), altered respiratory responses and 
increased H2O2 production (Picard et al., 2011a; Picard et al., 2011b). 
 
These findings demonstrate that mitochondrial isolation techniques can 
profoundly impact several aspects of mitochondrial function, which raises concerns 
regarding the interpretation of results obtained in studies using isolated mitochondria. 
Hence, the current study examined mitochondrial superoxide release from intact 
mitochondria within single muscle fibres, thus preserving the mitochondrial 
morphology, maintaining the functional interactions with other cellular compartments 
(such as sarcoplasmic reticulum, lipid droplets and cytoskeleton) (Goodman, 2008; Saks 
et al., 2010) and keeping the organelles in their native intracellular and systemic 
environment. 
 
In order to induce an increase in superoxide generation by mitochondria and 
examine the potential release of superoxide to the cytosol, two approaches were used. 
Fibres were either treated with Ant A which is reported to increase superoxide 
generation at complex III leading to release to both the matrix and MIS (Muller et al., 
2004), or fibres were treated with Rot which is reported to increase superoxide 
generation at complex I leading to release to the matrix only (Muller et al., 2004). Both 
of these treatments were found to increase the oxidation of matrix-localised MitoSOX 
Red, but only Ant A caused an increase in cytosolic DHE oxidation supporting the 
possibility that only superoxide within the intermembrane space can contribute to 
cytosolic superoxide.   
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The lack of any role for matrix superoxide in oxidation of DHE in the cytoplasm 
was supported by the lack of effect of the SS-31 peptide on DHE oxidation. The 
mitochondrial targeted SS-31 peptide accumulates on the IMM and recent reports have 
shown that it can directly scavenge superoxide produced within the mitochondrial 
matrix (Dai et al., 2011; Maack and Bohm, 2011). The lack of effect observed in this 
study provides evidence that superoxide generated by complex III and released into the 
matrix, does not escape from intact mitochondria in muscle fibres. These findings are 
consistent with previous reports that failed to show any extramitochondrial superoxide 
release from mitochondria in response to the addition of rotenone (Muller et al., 2004; 
Gao and Wolin, 2008), indicating that complex I-dependent superoxide is exclusively 
released into the matrix. Inhibitors of iMAC or mPTP were also ineffective in reducing 
cytosolic DHE oxidation in Ant A-treated fibres, which argues against a role for these 
channels in release of superoxide from the mitochondrial matrix to the cytosol of 
muscle fibres.    
 
A role for OMM channels in release of superoxide from the MIS to the 
cytoplasm was supported by the effects of VDAC and Bax inhibitors. The three VDAC 
isoforms (VDAC1, VDAC2 and VDAC3) and the Bax channel were detected in 
mitochondrial fractions and lysates from single muscle fibres. Both VDAC and Bax 
channel inhibitors (DS and Bax CB) attenuated the anticipated increase in DHE 
oxidation following treatment with Ant A indicating that VDAC and Bax can 
potentially act as superoxide channels. This observation is consistent with early studies 
(Lynch and Fridovich, 1978) and with recent reports examining superoxide release from 
isolated cardiac mitochondria which confirmed VDAC can mediate the release of 
superoxide from the MIS across the OMM (Han et al., 2003). Inhibition of VDAC 
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reduced DHE oxidation to a greater extent than Bax inhibition, potentially since 
VDACs are the major channels of the OMM responsible for the passage of proteins and 
solutes between the OMM and cytosplasm (Mannella, 1998). Neither DS nor Bax CB 
fully inhibited the extramitochondrial superoxide release suggesting that either the 
inhibitors failed to completely close the respective channels or other channels, such the 
peptide-sensitive channel (Juin et al., 1995) or the translocase of outer membrane 
(Budzinska et al., 2009) may also mediate the release of superoxide across the OMM.  
 
Single muscle fibres were also incubated in the presence of VDAC and/or Bax 
channel inhibitors to attempt to inhibit the increase in DHE oxidation following a 10 
min period of contractile activity, but no significant effects were seen. These data 
strongly suggest that the increase in cytosolic superoxide during contractions does not 
derive from mitochondrial sources. Interestingly, DHE oxidation following contractions 
increased by 20% whereas, the relative change in fluorescence in response to Ant A 
increased by 90%. Thus, the observed increase in superoxide following addition of Ant 
A may be considered “non physiological” compared with that following a period of 
contractile activity. Hence, it is argued that intact mitochondria do not release 
superoxide to the cytosplasm of skeletal muscle fibres at rest or in response to a 
physiological stimulus such as contractile activity, but can release superoxide under 
pathological conditions, where mitochondrial superoxide production is grossly 
excessive.   
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4.5.3 Contribution of iPLA2 enzymes to cytosolic superoxide in skeletal muscle 
fibres 
Recent work by Reid and colleagues demonstrated that iPLA2 enzymes can 
modulate the cytosolic oxidant activity in skeletal muscle cells as indicated by a 
reduction in 2', 7'- dichlorodihydrofluorescin (DCFH) oxidation following inhibition of 
iPLA2 (Gong et al., 2006). DCFH oxidation is considered to be a general indicator of 
ROS activities (Palomero et al., 2008). Western blots for iPLA2 confirmed the presence 
of this enzyme in the cytosolic compartment of skeletal muscles and lysates from single 
fibres, but no effect of the iPLA2 inhibitors on DHE oxidation was seen. In the study by 
Reid and colleagues (Gong et al., 2006), the iPLA2 selective inhibitor BEL was used at 
concentration of 10 µM, a concentration that exceeds the IC50 by more than three fold 
(Hazen et al., 1991), whereas in the present study, single muscle cells were incubated 
with 0.6 µM since in preliminary studies higher concentrations were found to affect the 
viability of muscle fibres. Concentrations as low as 0.6 µM have previously shown to 
inhibit iPLA2 activity by 100% (Ackermann et al., 1995). Overall, our data imply that 
that the cytosolic superoxide levels either at rest or during contractions in single skeletal 
muscle fibres are not modulated by the activity of the iPLA2 enzymes. In relation to 
this, work from Zuo and colleagues showed that the PLA2 enzymes do not specifically 
produce superoxide but can release arachidonic acid, which is a substrate for superoxide 
generating enzyme systems such as the lipoxygenases (Zuo et al., 2004). 
 
4.5.4 Expression of NADPH oxidase and its contribution to cytosolic superoxide 
in skeletal muscle fibres 
Skeletal muscles have previously been shown to express NADPH oxidase(s) 
(Espinosa et al., 2006; Hidalgo et al., 2006; Mofarrahi et al., 2008; Whitehead et al., 
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2010), but little information has been published regarding the role and regulation of this 
complex in generation of superoxide in muscles. Our initial results show mRNA and 
protein expression of NADPH oxidase subunits in single isolated fibres from the FDB 
muscle. Others have identified various NADPH oxidase subunits in mouse and rabbit 
skeletal muscles (Whitehead et al., 2010; Hidalgo et al., 2006), but this appears to be the 
first report to demonstrate the expression of all NADPH oxidase components in a pure 
muscle fibre preparation devoid of all non-myogenic cells.  
 
Inhibitor studies support a role for NADPH oxidase in contributing to cytosolic 
superoxide production. Resting fibres treated with APO and gp91ds-tat inhibitors 
showed a decrease in DHE oxidation compared with control fibres, suggesting that the 
complex is active and modulates superoxide generation under resting conditions. 
Similarly, fibres subjected to contractile activity showed a significantly lower increase 
in DHE oxidation following treatment with APO whereas gp91ds-tat treatment 
abolished the increase in response to contractions. Scrambled-tat pretreated fibres also 
showed a decrease in fluorescence following contractions, but some previous studies 
have also observed this (Rey et al., 2001). Gp91ds-tat appeared to be more effective 
than APO, which can be attributed to the different inhibitory properties of the 
compounds.  
 
Recent evidence suggests that APO might require activation by peroxidases 
(Wind et al., 2010) and can additionally act as an antioxidant scavenger for ROS, 
excluding superoxide, in cellular systems that lack myeloperoxidase, or produce low 
amounts of ROS (Heumuller et al., 2008). The proposed inhibitory mechanism of action 
of APO on NADPH oxidase is to prevent the translocation of p47phox and p67phox to the 
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membrane-located catalytic subunits (Muijsers et al., 2000) whereas gp91ds-tat peptide, 
the most potent inhibitor (IC50: 3 µM) selectively inhibits NOX2-oxidase (Csanyi et al., 
2011), although early studies suggested the possibility that the peptide may additionally 
inhibit NOX1 and NOX4 homologues (Brandes, 2003; Rey et al., 2001) by preventing 
their interaction with p47phox (Rey et al., 2001). The inhibitory effects of both APO and 
gp91ds-tat imply that p47phox is a critical component of the NADPH oxidase complex 
and can regulate the activity of the enzyme in skeletal muscle. 
 
Treatment of resting fibres with the non-specific inhibitor DPI showed a 
paradoxical increase in DHE oxidation. Lack of specificity of DPI in inhibiting 
flavoenzymes besides NADPH oxidase, such as nitric oxide synthase, xanthine oxidase 
and NADPH-cytochrome P450 reductase (Balcerczyk et al., 2005; Longpre and Loo, 
2008; Park et al., 2007) imply that this compound can affect multiple cellular processes 
unrelated to NADPH oxidase. Data on the regulation of intracellular ROS by DPI are 
controversial, with both inhibitory and stimulatory actions of DPI being reported. 
Studies have shown that DPI can induce the production of reactive oxygen (Li et al., 
2003; Riganti et al., 2004) and nitrogen species (Balcerczyk et al., 2005), thus affecting 
the cellular redox status as indicated by increased levels of lipid peroxidation (Riganti et 
al., 2004) and DNA damage (Longpre and Loo, 2008; Park et al., 2007), an increase in 
glutathione disulfide (Riganti et al., 2004) and apoptosis (Balcerczyk et al., 2005; 
Longpre and Loo, 2008; Park et al., 2007), as well as increased nitration of tyrosine 
residues of cellular proteins (Balcerczyk et al., 2005). Previous studies have also 
reported an increased oxidation of ROS-sensitive probes including dHR 123 (Park et al., 
2007) and H2DCF-DA (Balcerczyk et al., 2005; Park et al., 2007) following addition of 
DPI. Potential mechanisms through which DPI can stimulate RONS production have 
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been reported including mitochondrial superoxide production via inhibition of complex 
I (Li et al., 2003; Li and Trush, 1998), but also due to the inhibitory mechanism of DPI 
which incudes formation of phenyl radicals (O'Donnell et al., 1993; Longpre and Loo, 
2008). However, the data presented in this chapter argue that the increase in DHE 
oxidation following addition of DPI is not related to complex I mitochondrial 
superoxide production since other experiments indicate that complex I-dependent 
superoxide production within the mitochondrial matrix (Figure 3.10) does not diffuse to 
the cytoplasmic compartment of the muscle fibres (Figure 4.5). 
 
The data presented imply that NOX2 is likely to be the predominant oxidase 
system contributing to cytosolic superoxide generation in muscle fibres since most 
recent data indicate that the gp91ds-tat peptide selectively inhibits the assembly of 
NOX2 oxidase (Csanyi et al., 2011). Immunocytochemistry of single isolated fibres 
from the FDB muscle revealed that NOX isoforms and subunits were localized on, or in 
close proximity to the plasma membrane of muscle fibres although p40phox and p67phox 
were also present in the cytosolic compartment of quiescent muscle fibres. Further 
experiments supported previous findings (Espinosa et al., 2006; Hidalgo et al., 2006) of 
apparent localization of these subunits to the T-Tubules. In addition, NOX4 was found 
to be present in skeletal muscle mitochondria. Recent reports have shown NOX4 
localized to cardiac (Ago et al., 2010; Dai et al., 2011; Kuroda et al., 2010) and liver 
(Block et al., 2009) mitochondria. NOX4 has been predicted to localize on the inner 
mitochondrial membrane (Block et al., 2009) and produce hydrogen peroxide (von 
Lohneysen et al., 2008) but recent reports have shown that it can also regulate changes 
in superoxide within the mitochondrial matrix (Ago et al., 2010; Block et al., 2009; Dai 
et al., 2011; Kuroda et al., 2010). These findings however, have not been examined in 
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skeletal muscle, thus future studies are warranted to examine the role of NOX4 in 
skeletal muscle mitochondria. Updated schematic figures that show the cytosolic and 
mitochondrial RONS sources in skeletal muscle were produced to highlight these 
findings (Figures 4.31 and 4.32). 
 
In phagocytic cells, NADPH oxidase activation requires the translocation of the 
cytosolic-regulatory subunits to cytochrome b558, the catalytic core of the enzyme (Dusi 
et al., 1996; Kuribayashi et al., 2002). Fluorescent distribution analysis showed no 
evidence for translocation of the p67phox protein following contractions but p40phox 
immunostained fibres showed an increased proportion of fluorescence at the membrane 
and a reduction in the cytoplasmic compartment following contractions, which suggests 
that NADPH oxidase activation in single skeletal muscle fibres from young mice in 
response to contractions may involve translocation of the p40phox regulatory subunit to 
the plasma membrane. Although the role of p40phox has been controversial, studies in 
phagocytes indicate that on stimulation, p40phox translocates to cytochrome b558 (Dusi et 
al., 1996) and functions as a positive regulator of the superoxide–producing phagocyte 
oxidase by enhancing recruitment of p67phox and p47phox to the membrane (Kuribayashi 
et al., 2002). In addition, lack of p40phox in homozygotic knockout mice has been 
reported to reduce superoxide production in both in vivo and in vitro models (Ellson et 
al., 2006) and decrease the expression of p67phox (Ellson et al., 2006; Tian et al., 2008).  
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Figure 4.31 Schematic representation of the non-mitochondrial sites for superoxide and 
nitric oxide production in skeletal muscle. Superoxide (O2-) is produced by 
multicomponent NAD(P)H oxidase 2 (NOX2), xanthine oxidase (XO) and the 
lipoxygenases (LOX) which activity is regulated by the phospholipase A2 enzymes. 
Arachidonic acid (AA) release by the membrane bound calcium-dependent 
phospholipase A2 enzymes (sPLA2) facilitates extracellular O2- release by the 
membrane bound LOX. It is uncertain whether the cytosolic LOX enzymes contribute 
to intracellular O2- changes which substrate availability might be regulated by the 
cytosolic calcium-independent phospholipase A2 enzymes (iPLA2). NAD(P)H oxidase 4 
(NOX4) also contributes to ROS changes, though the primary ROS product, O2- or 
hydrogen peroxide (H2O2) of NOX4 is uncertain. Cytosolic and extracellular O2- is 
dismuted into H2O2 by superoxide dismutase (SOD), SOD1 and SOD3 respectively, or 
reacts rapidly with membrane permeant nitric oxide (NO) produced by the endothelial 
and neuronal nitric oxide synthase (eNOs and nNOS) to form peroxynitrite (ONOO-). 
H2O2 formed within the extracellular space is reduced into H2O by the action of 
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glutathione peroxidase 3 (GPX3) or peroxiredoxin IV (PRX4), while cytosolic H2O2 is 
reduced into H2O by glutathione peroxidase 1 (GPX1), catalase (CAT) or 
peroxiredoxins (PRXs). ONOO- can be reduced predominantly into nitrite (NO2-) by 
peroxiredoxin V (PRX5), (Sakellariou et al., 2013b) 
 
 
 
Figure 4.32 Schematic representation of the mitochondrial sites for superoxide 
production and the channels that mediate the release to the cytosolic compartment in 
skeletal muscle. Superoxide (O2-) is produced by complex I and complex III of the 
mitochondrial ETC of the inner mitochondrial membrane (IMM) and released into the 
matrix and the mitochondrial intermembrane space (MIS). NAD(P)H oxidase 4 (NOX4) 
also contributes to ROS changes, though the primary ROS product, O2- or hydrogen 
peroxide (H2O2) of NOX4 is uncertain. Arachidonic acid (AA) release by the calcium-
dependent phospholipase A2 enzymes (sPLA2) interacts with complex I and enhances 
superoxide generation by this complex. O2- released into the matrix and MIS is 
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dismuted into H2O2 by superoxide dismutase (SOD), SOD2 and SOD1 respectively, or 
reacts rapidly with nitric oxide (NO) produced by the endothelial nitric oxide synthase 
(eNOS) to form peroxynitrite (ONOO-). H2O2 is reduced into H2O by the action of 
glutathione peroxidase 4 (GPX4) or peroxiredoxins (PRXs), ONOO- can be reduced 
predominantly into nitrite (NO2-) by peroxiredoxin V (PRX5). O2- is essentially 
membrane impermeable while H2O2 is readily diffusible. Matrix O2- can diffuse to the 
cytosol through the inner membrane anion channel (iMAC) that spans the IMM and the 
outer mitochondrial membrane (OMM) or via the mitochondrial permeability transition 
pore (mPTP) comprised of the voltage dependent anion channels (VDAC) on the OMM, 
the adenine-nucleotide translocator (ANT) located on the IMM and cyclophilin D (Cyclo 
D) located in the matrix. Channels of the OMM including VDAC, BAX and possibly 
the translocase of outer membrane 40 (TOM40) can also mediate the release of O2- from 
the MIS to the cytosol, (Sakellariou et al., 2013b) 
 
4.5.5 Physiological implications 
Previous studies indicated that myotube depolarisation induced superoxide 
generation through activation of NADPH oxidase (Espinosa et al., 2006) and data 
presented here support this proposal. The electrical field stimulation used to induce 
contractile activity results in membrane depolarisation and the generation of action 
potentials which are transmitted to the interior of the muscle fibres along the T-tubules 
(Mougios, 2006). The presence of T-Tubule-localised NADPH oxidase expression 
reported by Hidalgo et al (Hidalgo et al., 2006) and observed in the present study in 
conjunction with the effect of increasing frequency of contractions on superoxide 
content presented in Figure 4.1, imply that repeated membrane depolarisation may 
regulate the activity of skeletal muscle NADPH oxidase. Data from the present study 
showed that NADPH oxidase-dependent superoxide production was directly related to 
the frequency of contractions of the fibre, with the greatest intensity of contractions 
causing the highest cytosolic DHE oxidation. A possible physiological role was 
proposed by Hidalgo and colleagues who suggested that superoxide generated by 
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NADPH oxidase can stimulate calcium release from the sarcoplasmic reticulum through 
oxidative modification of the ryanodine receptor (Hidalgo et al., 2006).  
 
There is also emerging evidence of interplay between ROS generated by 
NADPH oxidases and that by mitochondria. Studies in vascular tissue have shown that 
NOX derived cytosolic superoxide can trigger mitochondrial ROS formation (Brandes, 
2005) by opening the mitochondrial ATP-sensitive potassium channels, leading to 
changes in the mitochondrial membrane potential (Doughan et al., 2008). Conversely, 
increased mitochondrial H2O2 release has been reported to activate NADPH oxidase via 
a protein kinase C dependent pathway, resulting in increased cytosolic superoxide 
production (Doughan et al., 2008; Daiber, 2010), supporting the concept that NADPH 
oxidase can trigger mitochondrial ROS formation and vise-verse. In relation to this, 
pharmacological studies which induced mild mitochondrial dysfunction (Wosniak et al., 
2009) but also transgenic approaches including thioredoxin 2 overexpressing mice 
(Widder et al., 2009) have shown that both experimental models attenuated angiotensin-
II mediated increase in mRNA (Wosniak et al., 2009) and protein (Widder et al., 2009) 
NADPH oxidase expression implying that mitochondrial ROS can regulate the 
expression of the NADPH oxidase components. Although, the cross-talk between 
mitochondrial and Nox-derived ROS in skeletal muscle remains unclear, the presence of 
NOX4 in skeletal muscle mitochondria observed in the present study further supports 
the concept of interplay between the NADPH oxidases and mitochondrial ROS sources. 
However, further research is warranted to examine the relationship between cytosolic 
and mitochondria ROS sources in skeletal muscle at rest and during contractile activity.  
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4.6 CONCLUSION 
In conclusion, this is the first study to report the relative contribution of potential 
mitochondrial and cytosolic sources to superoxide production within the cytosolic 
compartment of single muscle fibres both at rest and during contractile activity. Data 
indicated that contractile activity increased superoxide content in an intensity dependent 
manner. Experiments with intact mitochondria in isolated mature skeletal muscle fibres 
support the conclusion that mitochondrial sources do not contribute to cytosolic 
superoxide increase either at rest or following a physiological stimulus such as 
contractile activity. In contrast, under pathological conditions when mitochondrial 
superoxide production is grossly excessive, channels of the outer mitochondrial 
membrane such as VDAC and Bax appear to be able to release superoxide from the 
MIS to the cytosol of skeletal muscle fibres. Cytosolic superoxide levels were not 
modulated by the activity of the iPLA2 enzymes in single skeletal muscle fibres, but 
inhibition of NADPH oxidase activity induced a significant decrease in DHE oxidation 
at rest and following contractions. Our data suggest that NADPH oxidase is the major 
contributor to superoxide production both at rest and during contractile activity in 
skeletal muscle.  
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CHAPTER 5 
IDENTIFYING THE REACTIVE SPECIES 
INVOLVED IN THE ACCELERATED AGE-
RELATED LOSS OF MUSCLE MASS IN MICE 
LACKING CU, ZN SUPEROXIDE 
DISMUTASE AND TO EXAMINE THE 
CHANGES IN REDOX STATUS AND 
ADAPTIVE RESPONSES THAT OCCUR IN 
SKELETAL MUSCLES FROM THESE MICE  
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5.1 INTRODUCTION 
Ageing skeletal muscle is characterized by a progressive loss of mass and 
contractile force and has a profound impact on the quality of life of older people. The 
loss of muscle mass and strength that occurs during ageing contributes to frailty and 
loss of independence (Marcell, 2003) and by the age of 70, the cross-sectional area of 
skeletal muscle is reduced by 25-30%, inducing a subsequent decrease in muscle 
strength and power by 30-40% (Porter et al., 1995). As mentioned in the introduction 
(Section 1.5), oxidative damage has been claimed to be involved in the loss of tissue 
function that occurs during ageing and it is well recognised that skeletal muscle of aged 
rodents contains increased amounts of the products of oxidative damage to 
biomolecules such as lipids, DNA and proteins in comparison with young or adult 
rodents (Sastre et al., 2003; Broome et al., 2006; Vasilaki et al., 2007; Kaneko et al., 
1996). 
 
The mechanisms by which the age-related loss of muscle mass and function 
occur are poorly understood and the hypothesis that an increased generation of oxidants 
in vivo plays a key role in age-related tissue dysfunction has been examined in a number 
of transgenic studies with inconsistent results (Huang et al., 2000; Schriner et al., 2005; 
Muller et al., 2006; Vasilaki et al., 2010; Elchuri et al., 2005). Studies from this group 
have examined skeletal muscle of mice lacking various key regulatory enzyme systems 
involved in the detoxification of ROS to determine whether specific defects in 
antioxidant protection and the resultant changes in ROS influence the onset and/or rate 
of age-related muscle dysfunction (Broome et al., 2006; McArdle et al., 2004; Vasilaki 
et al., 2007; Vasilaki et al., 2010). In collaboration with colleagues from the 
Universities of Texas and Michigan, USA it has been identified that a lack of 
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CuZnSOD (SOD1) in homozygotic SOD1 knockout (SOD1KO) mice induced a rapid 
acceleration of the age-related loss of skeletal mass which resembles an acceleration of 
normal age-related sarcopenia and potentially provides a useful model to study the role 
of chronic oxidative stress in loss of skeletal muscle (Muller et al., 2006; Vasilaki et al., 
2010; Jang et al., 2010). 
 
As mentioned in the introduction (chapter 1, Section 1.2.2), superoxide and 
nitric oxide (NO) are the primary radical species generated by skeletal muscle and 
increased during periods of contractile activity (Balon and Nadler, 1994; Close et al., 
2005; Jackson, 2011; Jackson et al., 2007; Kobzik et al., 1994; Reid et al., 1992). The 
production of NO has been well described by the nitric oxide synthases (NOS) 
including the neuronal (nNOS), endothelium (eNOS) and inducible (iNOS) isoforms 
(Stamler and Meissner, 2001) whereas the sources of intracellular superoxide 
generation that occur in skeletal muscles include the mitochondrial respiratory chain 
(Muller et al., 2004) and, as presented in chapter 3 and by others (Mofarrahi et al., 
2008; Whitehead et al., 2010; Espinosa et al., 2006; Xia et al., 2003), the nicotinamide 
adenine dinucleotide phosphate (NADPH) oxidase enzymes.  
 
Superoxide and NO are the precursors for the generation of a number of 
secondary species and muscle and other tissues have developed sophisticated enzymatic 
systems that control the cellular activities of these species. Intracellular superoxide is 
regulated by the activities of the superoxide dismutases (SODs); SOD1 (Cu, Zn SOD, 
located in the cytosol and mitochondrial inter-membrane space), SOD2 (MnSOD, 
located in the mitochondrial matrix) and SOD3 (ecSOD, which is present in the 
extracellular space) (Powers and Jackson, 2008), for a detailed description of the SOD 
	  	   161	  
enzymes see chapter 1, Section 1.3. When superoxide and NO are both present, their 
chemical reaction to form peroxynitrite is likely and competes with the dismutation of 
superoxide to hydrogen peroxide (H2O2) by SODs (Beckman and Koppenol, 1996), but 
there is little direct evidence for formation of peroxynitrite in skeletal muscle. 
 
In mice lacking SOD1, the general assumption has been that the toxicity and 
tissue damage that contributes to the accelerated muscle ageing phenotype may be 
associated with excess superoxide within the sarcoplasm of the muscle cells, but it is 
possible that alternative species play important roles in the initiation of degeneration. 
Thus peroxynitrite, or a reduction in NO bioavailability due to reaction with excess 
superoxide might both affect tissue function. In recent studies from this group, it was 
demonstrated that resting muscle fibres from FDB muscle of SOD1KO mice show a 
higher rate of increase in oxidation of the non-specific intracellular ROS probe, 5- (and 
6-) chloromethyl-2’, 7’-dichlorodihydrofluorescin diacetate (CM-DCFH DA), 
compared with fibres from WT mice (Vasilaki et al., 2010), but surprisingly show no 
further increase in oxidation following contractile activity whereas in fibres from WT 
mice, the increase was evident (Vasilaki et al., 2010). DCFH is reported to be relatively 
insensitive to oxidation by superoxide, but to be oxidised by H2O2, hydroxyl radicals, 
peroxynitrite and NO (Murrant and Reid, 2001; Palomero et al., 2008). 
 
Monitoring of the amounts of specific ROS in cells is inherently difficult due to 
the labile and reactive nature of these species. Techniques for examination of 
intracellular NO in single muscle fibres have been published (Pye et al., 2007) but no 
reliable technique for monitoring of peroxynitrite formation in muscle cells is available 
and evidence for peroxynitrite formation is usually implied from the presence of 3-
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nitrotyrosine (3-NT) groups in proteins and from changes in superoxide and/or NO 
(Beckman and Koppenol, 1996; Close et al., 2005; Pattwell et al., 2004; Vasilaki et al., 
2006b). A validated technique for assessment of real-time cytosolic superoxide changes 
in skeletal muscle fibres both at rest and following contractions was developed as part 
of the current work (Chapter 3) and is based on monitoring changes in dihydroethidium 
(DHE) oxidation.  
 
5.2 AIMS 
The current study was therefore designed to: (i) characterise the changes in 
redox status that occur in skeletal muscles from SOD1KO mice by assessing changes in 
the amounts of the products of oxidative damage to biomolecules, (ii) assess the 
potential changes in the protein expression of the regulatory enzymes for the primary 
radical species (SODs and NOS), (iii) determine whether a lack of SOD1 in muscle was 
associated with an increase in superoxide, a change in NO availability or an increase in 
peroxynitrite formation and (iv) determine whether the experimental manipulation of 
intracellular NO availability (through transgenic overexpression of nNOS) would 
induce changes in peroxynitrite formation and modify the expression of the main 
regulatory enzymes (SODs and NOS). It was hypothesised that when enzymatic 
dismutation of superoxide in muscle was reduced due to a lack of SOD1, the muscle 
would have increased cytosolic superoxide, decreased intracellular NO content and 
increased formation of 3-NT groups on muscle proteins due to increased formation of 
peroxynitrite.  
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5.3 EXPERIMENTAL PROCEDURES 
5.3.1 Mice  
5.3.1.1 Generation of SOD1KO mice  
These studies used male adult (5–11 months) mice lacking SOD1 (C57Bl⁄6 
SOD1KO) and their control (C57Bl⁄6 WT) mice. SOD1KO mice used in this study were 
generated by Dr. Charles Epstein's laboratory at the University of California San 
Francisco and obtained from Dr Harlan Richardson (University of Texas Health Science 
Center, San Antonio, Texas, USA). Details of the generation and characterization of the 
knockout mouse model have been reported previously (Elchuri et al., 2005; Muller et 
al., 2006; Huang et al., 1997). Using homologous recombination in embryonic stem 
cells the entire coding sequence of the mouse SOD1 gene was removed. The mutant 
embryonic cells were in turn used to create the homozygous SOD1KO mice. To 
confirm the targeted disruption of the SOD1 gene, muscles and tissues were dissected 
and assayed for SOD1 protein (Figure 5.1). Mice were supplied by Dr Holly Van 
Remmen (University of Texas Health Science Center, San Antonio, Texas, USA).  
 
 5.3.1.2 Generation of nNOS transgenic mice  
These studies used male adult (5–11 months) muscle specific transgenic mice 
overexpressing nNOS (C57Bl⁄6 nNOSTg) and their control (C57Bl⁄6 WT) mice. Details 
of the generation and characterization of the transgenic mouse model have been 
reported previously (Nguyen and Tidball, 2003). Rat brain nNOS in pCMV5 was 
cloned downstream of the 2.2-kb human skeletal actin promoter and the vp1 intron. The 
NOS cDNA was followed by the SV-40 large T poly-A site. The Clal-Dral–digested 
DNA was injected to the pronucleus of F2 hybrid zygotes of C57 Bl6 C3H parents. To 
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confirm the overexpression of nNOS in skeletal muscle, muscles were dissected and 
assayed for nNOS protein (see results Section, Figure 5.28). Mice were supplied by Dr 
Holly Van Remmen (University of Texas Health Science Center, San Antonio, Texas, 
USA). 
All experiments were performed in accordance with the UK Home Office 
guidelines and under the UK Animals (Scientific Procedures) Act 1986. Mice were 
killed by cervical dislocation and the flexor digitorum brevis (FDB) muscles were 
rapidly removed for isolation of single muscle fibres, other muscles and tissues were 
harvested and stored at -70oC until analysis.  	  
5.3.2 Chemicals and Reagents  
Unless stated otherwise, all chemicals used in this study were obtained from 
Sigma Chemical Company, Dorset, UK. 
 
5.3.3 Haematoxylin and eosin (H&E) staining 
For details see Section 2.12. Briefly, transverse sections from AT and GTN 
muscles were taken onto glass cover slips using a cryostat (Bright Instrument Co., 
Huntingdon, UK) and were placed in Harris’ Haematoxylin reagent for 3-5 min. 
Sections were rinsed in distilled H2O and counterstained in eosin for 30 sec. Sections 
were then dehydrated in 3x Absolute alcohol and cleaned in xylene. Cover slips were 
mounted onto microscope slides using DPX mountant and sections were analysed with 
the use of an inverted miscroscope (Zeiss Axiovert 200M microscope). 
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5.3.4 Isolation of single mature skeletal muscle fibres  
Single muscle fibres were isolated from the FDB muscles of mice as previously 
described in Section 2.2. Briefly, FDB muscles were dissected and incubated for 1.5 h 
in collagenase to digest the connective tissue. Muscles were agitated every 30 min 
during the digestion period and single myofibres were released by gentle trituration with 
a wide-bore pipette. Fibres were washed three times in MEM containing 10% FBS and 
were plated onto precooled culture dishes precoated with Matrigel (BD Biosciences) 
and were allowed to attach for 45 min before adding 1 mL MEM containing 10% FBS.  
Analyses were only performed on fibres that displayed good morphology and prominent 
cross-striations. 
 
5.3.5 Use of dihydroethidium (DHE) and 4-Amino-5-Methylamino-2’, 7’-
Difluorofluorescein Diacetate (DAF-FM DA) to monitor superoxide and NO 
changes in isolated fibres  
A detailed description of the ROS sensitive dyes used in this study is presented 
in Section 2.3. Briefly, single isolated mature fibres were loaded by incubation in 2mL 
Dulbecco’s phosphate-buffered saline (D-PBS) containing 5µM dihydroethidium 
(DHE) or 10µM 4-amino-5-methylamino-2′,7′-difluorofluorescein diacetate (DAF-FM 
DA) for 30 min at 37oC. Cells were then washed twice with D-PBS and the fibres were 
maintained in MEM without Phenol Red during the experimental protocol. 
 
5.3.6 Microscopy and fluorescent imaging  
For details see Section 2.4. Briefly, the image capture system consisted of a 
Zeiss Axiovert 200M microscope equipped with 500/20 nm excitation, 535/30 nm 
emission filter set for DAF-FM fluorescence and a 510–560 nm excitation/590 nm 
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emission filter set for the detection of ethidium (E+) fluorescence. Using a X20 
objective, fluorescence images were captured with a computer-controlled Zeiss MRm 
charged-coupled device (CCD) camera (Carl Zeiss GmbH) and analysed with 
Axiovision 4.0 image capture and analysis software (Carl Zeiss Vision GmbH). 
 
5.3.7 Contractile activity induced be electrical stimulation  
Contractions in single isolated muscle fibres were induced by electrical field 
stimulation using established techniques (Palomero et al., 2008; Pye et al., 2007). For 
details see Section 2.5. Briefly, fibres were electrically stimulated with trains of bipolar 
square wave pulses of 2ms in duration for 0.5 of a sec every 5 sec at 50 Hz and 30 
V/well. A schematic illustration of the standard contractile activity protocol is shown in 
Figure 2.1. 
 
5.3.8 Western blotting of muscle proteins 
For details see Section 2.8. Briefly, 30-100µg of total protein was applied to a 8-
15% polyacrylamide gel with a 4% stacking gel. Proteins were separated by 
electrophoresis and were transferred to a nitrocellulose membrane by a Multiphore 
continuous blotting system (Pharmacia, Uppsala, Sweden). Membranes were blocked 
for 2h in a 3% milk solution at room temperature and probed overnight using antibodies 
shown in Table 5.1. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) protein 
content was also determined and served the control-loading sample. Horseradish 
peroxidase conjugated anti-mouse IgG, or anti-rabbit IgG (Cell Signaling, Hitchin, UK), 
were used as the secondary antibody. Peroxidase activity was detected using an ECL kit 
(Amersham International Cardiff, UK), and band intensities were analysed using 
Quantity One Software (Biorad, US). The specificity of the bands were identified in 
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comparison with a sample that had not been exposed to the primary antibody and the 
molecular weight was determined by using rainbow coloured protein markers 
(Amersham International). 
 
Table 5.1 Antibodies used for western blotting. 
 
Antibody Company Catalogue No Species Dilution 
GAPDH Abcam Ab8245 Mouse 1:5000 
SOD1 Enzo Life Sciences ADI-SOD-100-F Rabbit 1:1000 
SOD2 Enzo Life Sciences ADI-SOD-111-F Rabbit 1:1000 
SOD3 Enzo Life Sciences SOD-105 Rabbit 1:500 
nNOS Abcam Ab76067 Rabbit 1:500 
eNOS Abcam Ab76198 Mouse 1:500 
iNOS Abcam Ab49999 Mouse 1:500 
PRX1 Abcam Ab15571 Rabbit 1:1000 
PRX2 Abcam Ab59539 Rabbit 1:1000 
PRX3 Abcam Ab16751 Mouse 1:1000 
PRX4 Abcam Ab16943 Mouse 1:1000 
PRX5 Abcam Ab16944 Mouse 1:1000 
PRX6 Abcam Ab59543 Rabbit 1:1000 
4-HNE Abcam Ab46545 Rabbit 1:1000 
MDA Cell Biolabs STA-331 Rabbit 1:1000 
3-NT Cayman 189542 Rabbit 1:1000 
Prot. Carbonyls Cell Biolabs STA-308 Rabbit 1:1000 
GPX1 Abcam Ab22604 Rabbit 1:500 
Catalase Sigma C 0979 Mouse 1:1000 
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5.3.9 Analyses of the 3-nitrotyrosine (3-NT) content of muscle carbonic 
anhydrase III (CAIII). 
Changes in the 3-nitrotyrosine (3-NT) content of the major muscle protein, 
carbonic anhydrase III (CAIII) were assessed as described in Section 2.11. Briefly, 
50µg of total protein was separated on 1D SDS-PAGE followed by western blotting as 
described in Section 2.8. The content of 3-NT was analyzed by using a mouse 
monoclonal antibody (Cayman Chemical Co., Ann Arbor, Michigan, USA), and the 
bands were visualized using a Biorad Chemi-Doc System (Biorad Laboratories Ltd, 
Hemel Hempstead, UK). Densitometric quantification of the CAIII band was 
undertaken, and the protein content was normalized to the GAPDH content of the same 
sample. Comparisons were made between samples on the same gel ⁄ western blot. 
 
5.3.10 Determination of protein oxidation and lipid peroxidation. 
Changes in protein oxidation and lipid peroxidation were assessed as described 
in Section 2.8. Following the electroblotting step, proteins were derivatized and 
membranes were blocked and probed for 2h using an Anti-DNP antibody (Cell Biolabs, 
San Diego, CA, USA). Secondary HRP conjugated antibody was applied as described 
in Section 2.8. 
Lipid peroxidation was assessed via changes in 4-hydroxynonenal (4-HNE) protein 
conjugates and malondialdehyde (MDA) - protein adducts. Both markers were assessed using 
the same protocol as for 3-NT (Section 5.3.9). Rabbit Anti-MDA primary antibodies (Cell 
Biolabs, San Diego, CA, USA) and rabbit anti 4-HNE (Abcam, Cambridge, UK) were used. 
 
 
 
	  	   169	  
5.4 RESULTS 
AIM I:IDENTIFYING THE INTRACELLULAR CHANGES IN RONS AND 
ADAPTIVE RESPONSES IN SKELETAL MUSCLE FROM 
HOMOZYGOTIC SOD1 KNOCKOUT (SOD1KO) MICE.  
5.4.1 SOD1 in muscles/tissues from SOD1KO mice 
To confirm the lack of SOD1 in the SOD1KO mice, mice were culled by 
cervical dislocation and a variety of tissues including: anterior tibialis (AT), 
gastrocnemius (GTN), soleus (SOL) and extensor digitorum longus (EDL), kidneys, 
heart, liver, spleen, lungs, brain and also nerves were dissected and their protein content 
of SOD1 was examined. A representative western blot of the SOD1 protein content is 
shown in Figure 5.1. SOD1 was not detectable in any of the tissues from the SOD1KO 
mice (Figure 5.1) 
 
 
 
 
Figure 5.1 Representative western blots of superoxide dismutase 1 and 2 (SOD1 and 
SOD2) proteins from gastrocnemius (GTN), anterior tibialis (AT), extensor digitorum 
longus (EDL), soleus (SOL), sciatic nerve, brain, kidney, spleen, lung, liver and heart of 
WT and SOD1KO mice.  
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5.4.2 Comparison of muscle/tissue weights in WT and SOD1KO mice 
Previous studies have shown that SOD1KO mice show an age dependent loss in 
muscle mass (Muller et al., 2006; Jang et al., 2010) and Figure 5.2 shows the gross 
morphology of skinned hindlimb muscles of a 20-month-old SOD1KO and WT mouse. 
In the present study, to further assess whether the loss in muscle mass in the SOD1KO 
mice was specific to skeletal muscle, the absolute mass of other tissues/organs was 
studied (Table 5.2). The age-related decrease in mass was observed in specific skeletal 
muscle tissues (AT and GTN muscles), as the mass of the EDL, SOL, heart, liver, 
kidney, spleen, lung, and brain was similar to tissues of the age-matched WT littermates 
(Table 5.2).  
 
 
 
Figure 5.2 Gross morphology of skinned hindlimb muscles of 20-month-old SOD1KO 
and WT mice. (Image from Jang et al. 2010) 
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Table 5.2 Comparison of tissue weights from WT and SOD1KO mice (10±1 months of 
age). Values are presented as the mean ± SEM. Bold values represent statistically 
significant differences among groups, P < 0.05.  
 
5.4.3 Changes in muscle structure in muscles from SOD1KO mice 
To assess whether the accelerated muscle ageing phenotypic changes observed 
in the AT and GTN muscles of the SOD1KO mice was associated with changes in 
muscle structure, transverse sections of the GTN muscles from WT and SOD1KO mice 
were stained with Haematoxylin and Eosin (Figure 5.3). Muscles from the SOD1KO 
mice showed minor changes in structure, such as greater variability in fibre size and the 
presence of occasional central nuclei compared with muscles from WT mice, implying 
that the loss of mass observed in the muscles of the SOD1KO mouse model is likely 
primarily due to a complete loss of muscle fibres.  
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(i)                (ii) 
 
 
 
Figure 5.3 Example Haematoxylin and Eosin stained 8-micron transverse sections of 
the GTN muscle from WT (i) and SOD1KO (ii) mice. Asterisks (*) represent fibres with 
centrally located nuclei, (bar = 200 µm).  
 
 
5.4.4 Changes in oxidative damage in muscles from SOD1KO mice 
5.4.4.1 Changes in protein oxidation 
Several assays were carried out to determine changes in muscle redox status by 
assessing the level of oxidative damage in muscles of SOD1KO mice. The overall level 
of oxidative modification of proteins in GTN muscles of SOD1KO mice was assessed 
with Western blot analyses and the protein carbonyl immunoblot kit (Figure 5.4). A 
consistent increase in protein oxidation was detected in GTN homogenates from the 
knockout group, suggesting that protein oxidation is a prominent feature in SOD1KO 
mice (Figure 5.4). 
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Figure 5.4 Oxidative modification of proteins. Oxyblot analysis of the protein carbonyl 
level in GTN muscles from WT and SOD1KO mice, along with densitometric 
quantification of the blot, *P < 0.05 compared to values for muscles from WT mice.  
 
5.4.4.2 Changes in lipid peroxidation 
To determine the extent of lipid peroxidation, 4-hydroxynonenal (4-HNE) 
protein conjugates and malondialdehyde (MDA) protein adducts were measured in GTN 
muscles from SOD1KO and age-matched controls (Figures 5.5 and 5.6). Both 
compounds increased in skeletal muscles from the knockout group suggesting that the 
lack of SOD1 leads to an increase in oxidative modifications of lipids (Figures 5.5 and 
5.6). 
 
 
Figure 5.5 Oxidative modification of lipids. Representative Western blots of 4-
hydroxynonenal (4-HNE) protein conjugates in GTN muscles from WT and SOD1KO 
mice and densitometric quantification of the blots for 4-HNE, *P < 0.05 compared to 
values for muscles from WT mice. 
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Figure 5.6 Oxidative modification of lipids. Representative Western blots of 
Malondialdehyde (MDA) protein adducts in GTN muscles from WT and SOD1KO 
mice and densitometric quantification of the blots for MDA protein adducts. 
 
5.4.4.3 Changes in DNA damage 
To determine if there was an increase in DNA damage, the protein expression of 
the oxidative DNA repair enzyme; 8-Oxoguanine glycosylase (OGG1) was studied. 
Reports have shown that OGG1 is a base excision repair protein which activity 
increases following exposure to oxidative stress (Mirbahai et al., 2010). Lack of SOD1 
in GTN muscles from SOD1KO mice significantly increased the expression of OGG1 
indicating a potential increase in DNA damage (Figure 5.7).  
 
 
 
Figure 5.7 Representative western blots of 8-Oxoguanine glycosylase (OGG1) protein 
in GTN muscles of WT and SOD1KO mice and densitometric quantification of the blots 
for OGG1, *P < 0.05 compared with values for muscles from WT mice. 
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5.4.5 Changes in superoxide in single isolated muscle fibres from SOD1KO mice 
To identify the reactive species that are responsible for the increased oxidative 
damage in muscles from the SOD1KO mice, fluorescent microscopic techniques were 
applied. To examine ROS changes in muscle fibres in the absence of non-myogenic 
cells, single fibres from the flexor digitorum brevis (FDB) muscle were isolated as 
previously described (Section 2.2). Changes in superoxide were assessed by monitoring 
dihydroethidium (DHE) oxidation, a technique that was developed and optimised in 
chapter 3. 
 
 Images of a single isolated fibre from an adult WT mouse loaded with DHE and 
4’,6-diamidino-2-phenylindole dihydrochloride (DAPI) to visualize nuclei are  shown in 
Figure 5.8. As shown in chapter 3 (Figure 3.1), the predominant ethidium (E+) 
fluorescence from the DHE-loaded fibre was from nuclei indicated by the co-
localization of DAPI with E+ fluorescence (Figure 5.8) and measurements from nuclei 
were therefore used for all further studies, because fluorescence values were much 
higher from this site, and hence, the sensitivity of the method might be optimized. 
  
 
 
Figure 5.8 Images of a single isolated fibre from the FDB muscle after 24 hours in 
culture photographed under bright field (i), fluorescent image following loading with 
DAPI (ii), fluorescent image showing ethidium (E+) fluorescence following loading 
with DHE (iii) and a merged image of ii and iii (iv), (bar = 30 µm). 
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Single muscle fibres from the FDB muscle from WT and SOD1KO mice were 
loaded with DHE and changes in E+ fluorescence were monitored in resting fibres 
(Figure 5.9) and fibres subjected to a period of contractions (Figure 5.10). Surprisingly, 
data showed that E+ fluorescence from fibres of the two groups did not differ at rest 
although the mean values from fibres of the SOD1KO mice tended to be higher, 
indicating that the content of superoxide did not vary significantly between fibres of the 
two groups (Figure 5.9). The effect of 10 min period of contractions on DHE oxidation 
from FDB fibres of WT and SOD1KO mice is shown in Figure 5.10. Following 
contractile activity, a significant increase in fluorescence was seen from muscle fibres 
of both the WT and SOD1KO mice (Figure 5.10). However, the overall increase 
following contractions was much smaller and significantly less in fibres from the 
knockout group than that seen from fibres of WT mice indicating a lower rate of 
increase in superoxide with contractions (Figure 5.10). 
 
 
 
Figure 5.9 Relative change in DHE oxidation from resting DHE-loaded FDB fibres of 
WT and SOD1KO over 30 minutes at rest, (n = 9–10 fibres in each group). 
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Figure 5.10 Relative change in DHE oxidation from DHE-loaded FDB fibres of WT 
and SOD1KO mice at rest and following 10 minutes of contractions between 10 and 20 
minutes of the experimental period. *P<0.05 compared with values for fibres from the 
same group at the previous time point; #P<0.05 compared with contacted fibres from 
SOD1KO mice at the same time point, (n = 10–11 fibres in each group). 
 
 
5.4.6 Changes in NO in single isolated muscle fibres from SOD1KO mice 
To monitor changes in NO, single muscle fibres from WT and SOD1KO mice 
were loaded with 4-amino-5-methylamino-2′,7′-difluorofluorescein diacetate (DAF-FM 
DA), a method developed and described in detail by Pye et al. (Pye et al., 2007). Images 
of DAF-FM fluorescence from a resting fibre from an adult WT mouse appeared to be 
homogeneous across the cell, indicating a lack of any sub-cellular localisation of this 
fluorescent probe (Figure 5.11 ii & iii).  
The DAF-FM fluorescence from quiescent fibres of WT and SOD1KO mice is 
shown in Figure 5.12. Fibres from WT mice showed a significant increase in DAF-FM 
fluorescence over time at rest, but this rate of increase was significantly lower in fibres 
from SOD1KO mice (Figure 5.12). Following contractions, a small increase in DAF-
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FM fluorescence was observed in both groups (Figure 5.13). However, the increase did 
not reach statistical significance for either group (Figure 5.13).  
 
 
 
Figure 5.11 Image of a single isolated fibre from the FDB muscle after 24 h in culture 
under bright field (i), fluorescent image following loading with 4-amino-5-
methylamino-2’,7’-difluorofluorescein diacetate (DAF-FM DA) (ii) and merge image 
of i and ii (iii), (bar = 30 µm).  
 
 
 
 
Figure 5.12 Relative change in DAF-FM fluorescence from DAF-FM DA loaded FDB 
fibres of WT and SOD1KO mice over 30 min at rest. *P < 0.05 compared with values 
for fibres from SOD1KO mice at the same time point, (n = 8–9 fibres in each group). 
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Figure 5.13 Rate of change in DAF-FM fluorescence from FDB muscle fibres of WT 
and SOD1KO mice over 30 min with 10 min of electrically stimulated contractions 
between 10 and 20 min of the experimental period, (n = 7–8 fibres in each group). 
 
 
5.4.7 Changes in peroxynitrite in single isolated muscle fibres from SOD1KO 
mice 
Specific fluorescent dyes for the detection of peroxynitrite are not available, thus 
changes in peroxynitrite were assessed via changes in nitration (3-NT) of the major 
muscle protein, carbonic anhydrase III (CAIII). Previous studies have shown that 3-NT 
of CAIII, is a relatively sensitive marker of muscle oxidative stress (Vasilaki et al., 
2007), and details on the analysis of 3-NT are described in “Experimental methods” 
(chapter 2, Section 2.11.1). An example western blot of the 3-NT content of CAIII, in 
muscles from the WT and SOD1KO mice is shown in Figure 5.14. Quantification of the 
3-NT blots showed a significant increase in the 3-NT content of CAIII in comparison 
with muscles from WT mice.  
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Figure 5.14 Representative western blots of the 3-nitrotyrosine (3-NT) content of 
carbonic anhydrase III (CAIII) in GTN muscles of WT and SOD1KO mice and 
densitometric quantification of the blots, *P < 0.05 compared with values for muscles 
from WT mice.  
 
In light of the increase in 3-NT content of muscle CAIII observed in SOD1KO 
mice, western blots were also probed for peroxiredoxin V (PRXV) as this protein is a 
peroxynitrite reductase and known to be increased in conditions where peroxynitrite is 
increased (Dubuisson et al., 2004; Trujillo et al., 2008). A typical western blot together 
with quantification of the PRXV bands is shown in Figure 5.15. These indicate a 
significant increase in the PRXV content of muscles from SOD1KO mice compared 
with WT mice implying that a lack of SOD1 induces an increase in peroxynitrite 
formation. 
 
 
Figure 5.15 Representative western blots of peroxiredoxin V (PRX V) protein in GTN 
muscles of WT and SOD1KO mice and densitometric quantification of the blots,s *P < 
0.05 compared with values for muscles from WT mice.  
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5.4.8 Changes in RONS regulatory enzymes in muscles from SOD1KO mice 
5.4.8.1 Changes in SOD protein expression  
The effect of a lack of SOD1 on the expression of the main regulatory enzymes 
for superoxide was also studied. All of the three superoxide dismutase (SOD) isoforms 
(SOD1, SOD2, and SOD3) were detected in skeletal muscles from WT mice. Figures 
5.16 and 5.17 show representative western blots from the muscles of WT and SOD1KO 
mice together with quantification of these blots by densitometry. As anticipated, SOD1 
was absent from the muscles of SOD1KO mice, but there was a small but significant 
increase in the content of SOD2 (Figure 5.16). The contents of extracellular SOD 
(SOD3) were unchanged in muscles of SOD1KO mice compared with WT mice (Figure 
5.17). 
 
 
Figure 5.16 Representative western blots of SOD1 and SOD2 proteins in GTN muscles 
of WT and SOD1KO mice and densitometric quantification of the blots for SOD2, *P < 
0.05 compared to values for muscles from WT mice. 
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Figure 5.17 Representative western blots of superoxide dismutase 3 (SOD3) protein in 
GTN muscles of WT and SOD1KO mice and densitometric quantification of the SOD3 
band (see text for explanation of the presence of two bands). 
 
 
5.4.8.2 Changes in NOS protein expression  
The possibility that the lack of SOD1 might have induced adaptations in the 
content of NOS enzymes and thus influence NO availability was examined by western 
blot analysis. All of the three NOS isoforms (nNOS, eNOS, and iNOS) were detected in 
muscles from WT and SOD1KO mice, but no significant differences in contents were 
seen (Figures 5.18, 5.19 and 5.20). 
 
 
Figure 5.18 Representative western blots of neuronal nitric oxide synthase (nNOS) 
protein in GTN muscles of WT and SOD1KO mice and densitometric quantification of 
the blots for nNOS.  
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Figure 5.19 Representative western blots of endothelium nitric oxide synthase (eNOS) 
protein in GTN muscles of WT and SOD1KO mice and densitometric quantification of 
the blots for eNOS.  
 
 
 
 
Figure 5.20 Representative western blots of the inducible nitric oxide synthase (iNOS) 
protein in GTN muscles of WT and SOD1KO mice and densitometric quantification of 
the blots for iNOS.  
 
 
5.4.8.3 Changes in PRX protein expression  
PRXV was unregulated in muscles from SOD1KO mice (Figure 5.15). The 
possibility that the lack of SOD1 might have led to adaptive changes in the contents of 
the other PRX enzymes was further examined. All of the six PRX isoforms including 
PRXI, PRXII, PRXIII, PRXIV, PRXV (see Figure 5.15) and PRXVI were detected in 
muscles from WT and SOD1KO mice. Figures 5.21, 5.22, 5.23, 5.24, and 5.25 show 
representative western blots of PRX isoforms from the muscles of WT and SOD1KO 
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mice together with quantification of these blots by densitometry. Muscles from 
SOD1KO mice showed an upregulation in the protein expression of all PRX protective 
enzymes apart from PRXI, a cytosolic isoform of the PRX family (Jarvis et al., 2012). 
 
Figure 5.21 Representative western blots of peroxiredoxin I (PRX I) protein in GTN 
muscles of WT and SOD1KO mice and densitometric quantification of the blots for 
PRX I.  
 
 
 
Figure 5.22 Representative western blots of peroxiredoxin II (PRX II) protein in GTN 
muscles of WT and SOD1KO mice and densitometric quantification of the blots for 
PRX II,  *P < 0.05 compared to values for muscles from WT mice. 
 
 
Figure 5.23 Representative western blots of peroxiredoxin III (PRX III) protein in GTN 
muscles of WT and SOD1KO mice and densitometric quantification of the blots for 
PRX III,  *P < 0.05 compared to values for muscles from WT mice. 
 
	  	   185	  
 
 
Figure 5.24 Representative western blots of peroxiredoxin IV (PRX IV) protein in GTN 
muscles of WT and SOD1KO mice and densitometric quantification of the blots for 
PRX IV,  *P < 0.05 compared to values for muscles from WT mice. 
 
 
 
 
Figure 5.25 Representative western blots of peroxiredoxin VI (PRX VI) protein in GTN 
muscles of WT and SOD1KO mice and densitometric quantification of the blots for 
PRX VI,  *P < 0.05 compared to values for muscles from WT mice. 
 
 
5.4.8.4 Changes in protein expression of the main H2O2 reducing enzymes  
In light of the increase in PRXII, PRXIII, PRXIV & PRXVI content observed in 
muscles from SOD1KO mice (see Figures 5.22, 5.23, 5.24 and 5.25), western blots 
were also probed for catalase (CAT) and glutathione peroxidase I (GPX1) as these 
proteins are the main H2O2 reducing systems (the activity and regulation of CAT and 
GPX1 have been described in detail in Section 1.3). Both CAT and GPX1 protein levels 
were significantly upregulated in muscles from the SOD1KO mice compared to WT 
mice (Figures 5.26 and 5.27, respectively). The increase in protein expression of CAT 
and GPX1 along with the increase in PRXII, PRXIII, PRXIV & PRXVI indicate the 
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adaptations that occur in skeletal muscles from the SOD1KO mice due to the higher 
content of H2O2 in comparison to muscles from the WT group.  
 
Figure 5.26 Representative western blots of catalase (CAT) protein in GTN muscles of 
WT and SOD1KO mice and densitometric quantification of the blots for CAT,  *P < 
0.05 compared to values for muscles from WT mice. 
 
 
Figure 5.27 Representative western blots of glutathione peroxidase 1 (GPX 1) protein 
in GTN muscles of WT and SOD1KO mice and densitometric quantification of the blots 
for GPX 1,  *P < 0.05 compared to values for muscles from WT mice. 
 
 
AIM II:IDENTIFYING THE ADAPTIVE RESPONSES IN SKELETAL 
MUSCLES OF NEURONAL NITRIC OXIDE OVEREXPRESSOR MICE.  
The first aim of this study was to determine the reactive species that are 
modulated in skeletal muscles from SOD1KO mice and data obtained from Figures 
5.10, 5.12, 5.14 and 5.15 indicate that the potential increased superoxide content due to 
the lack of SOD1 rapidly reacted with NO to generate peroxynitrite as shown by the 
reduction in NO availability (Figure 5.12), the increase in CAIII nitration (Figure 5.14) 
and the upregulation of PRXV protein (Figure 5.15). Superoxide and NO are the main 
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radical species generated by skeletal muscle and the second aim of this study was to 
examine whether manipulation of NO (through transgenic overexpression of nNOS) 
would have an effect on peroxynitrite formation in muscle specific nNOS transgenic 
(nNOSTg) mice.  
 
5.4.9 Expression of nNOS in muscles from nNOSTg mice 
To confirm the overerexpression of nNOS in the nNOSTg mice, mice were 
culled by cervical dislocation, GTN skeletal muscles were dissected and the protein 
content of nNOS was examined. A representative western blot of the protein content of 
nNOS is shown in Figure 5.28. Muscles from the nNOSTg mice showed a > 100-fold 
increase in nNOS content with the western blot showing the two nNOS bands (full-
length nNOS and a nNOS fragment) described by Nguyen & Tidball (Nguyen and 
Tidball, 2003). 
 
 
 
Figure 5.28 Representative western blots of nNOS protein in GTN muscles of WT and 
nNOSTg mice. nNOS content was increase >100 fold in the nNOSTg group. The 
immunoblot for GTN muscles of the nNOSTg mice was exposed for 10 seconds 
whereas for muscles of the WT group, the immunoblot was exposed for 10 minutes. 
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5.4.10 Effect of nNOS overexpression in peroxynitrite formation 
Previous experiments in single muscle fibres from the FDB muscles of nNOSTg 
mice (work presented in my MPhil thesis), (Sakellariou., 2009) showed that 
overexpression of nNOS is associated with increased intracellular NO content (see 
Figure 5.29) and a reduction in superoxide (see Figure 5.30) as indicated by the increase 
in DAF-FM fluorescence and the reduction in DHE oxidation. The reduction in 
superoxide in muscles from the nNOSTg mice implied the possibility of a peroxynitrite 
formation. 
 
 
 
Figure 5.29 Relative change in DAF-FM fluorescence from resting fibres of WT and 
nNOSTg mice over 30 min. *P < 0.05 compared with fibres from WT mice at the same 
time point, (n = 7–8 fibres in each group). 
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Figure 5.30 Relative change in E+ fluorescence from DHE loaded fibres of WT and 
nNOSTg mice over 30 min. *P < 0.05 compared with fibres from WT mice at the 
corresponding time point, (n = 7–8 fibres in each group). 
 
To assess changes in peroxynitrite formation, the 3-NT content of CAIII in the 
GTN muscles of WT and nNOSTg mice was examined. An example western blot of the 
3-NT content of CAIII in muscles from the WT and nNOSTg mice is shown in Figure 
5.31. Quantification of the 3-NT blots showed a significant increase in the 3-NT content 
of CAIII in the transgenic group in comparison with muscles from WT mice (Figure 
5.31). However, no significant changes in PrxV were observed (Figure 5.32) with 
muscles from the nNOSTg group showing a similar PRXV expression compared to 
GTN muscles from the WT mice.   
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Figure 5.31 Representative western blots of the 3-NT content of CAIII in GTN muscles 
of WT and nNOSTg mice and densitometric quantification of the blots, *P < 0.05 
compared with values for muscles from WT mice.  
 
 
 
Figure 5.32 Representative western blots of PRX V protein in GTN muscles of WT and 
nNOSTg mice and densitometric quantification of the blots.  
 
 
5.4.11 Changes in the protein expression of the mail regulatory enzymes for 
superoxide and NO in muscles from nNOSTg mice 
5.4.11.1 Changes in NOS protein expression  
The effect of nNOS overexpression on the muscle content of the other two NOS 
isoenzymes (eNOS & iNOS) in comparison with WT mice was also studied. Figures 
5.33 and 5.34 show representative western blots of eNOS and iNOS isoforms from the 
muscles of WT and nNOSTg mice together with quantification of these blots by 
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densitometry. Muscles from the transgenic mice showed a significant increase in iNOS 
content compared with WT mice (Figure 5.34) but no significant changes in the content 
of eNOS were seen (Figure 5.33). 
 
 
Figure 5.33 Representative western blots of eNOS protein in GTN muscles of WT and 
nNOSTg mice and densitometric quantification of the blots for eNOS.  
 
 
 
 
Figure 5.34 Representative western blots of iNOS protein in GTN muscles of WT and 
nNOSTg mice and densitometric quantification of the blots for iNOS, *P < 0.05 
compared to values for muscles from WT mice. 
 
 
5.4.11.2 Changes in SOD protein expression  
The possibility that nNOS overexpression might have induced adaptations in the 
content of SOD enzymes and thus influence superoxide availability was further 
examined by comparing the protein expression of the three SOD enzymes (SOD1, 
SOD2, and SOD3) in GTN muscles of nNOSTg mice in comparison with muscles from 
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WT mice (Figures 5.35 and 5.36). Muscles of nNOSTg mice showed a significant 
increase in all three SOD isoforms compared with muscles from the WT mice. 
 
 
 
Figure 5.35 Representative western blots of SOD1 and SOD2 proteins in GTN muscles 
of WT and nNOSTg mice and densitometric quantification of the blots for SOD1 and 
SOD2, *P < 0.05 compared to values for muscles from WT mice. 
 
 
 
 
 
 
 
Figure 5.36 Representative western blots of SOD3 protein in GTN muscles of WT and 
nNOSTg mice and densitometric quantification of the SOD3 band (see text for 
explanation of the presence of two bands), *P < 0.05 compared to values for muscles 
from WT mice. 
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5.5 DISCUSSION 
Superoxide and NO are the primary reactive oxygen and nitrogen species 
generated within skeletal muscle both at rest and during contractile activity. While 
further reaction of both species is well described with the generation of secondary ROS 
such as H2O2 and hydroxyl radicals from superoxide (Jackson, 2008) and interaction of 
NO with targets such as guanylate cyclase (Halliwell and Gutteridge, 2007), the 
reaction of superoxide with NO has been described in simple chemical and some 
biological systems (Beckman and Koppenol, 1996), but the functional effects of this 
interaction in skeletal muscle have not been defined. 
 
In nonstimulated cells, NO is present in the cytoplasm at 10-9 to 10-8 M, whereas 
superoxide is reported to be present at 10-12 to 10-13 M (Chance et al., 1979; Halliwell 
and Gutteridge, 2007). The chemical reaction of superoxide with NO to generate 
peroxynitrite has a reaction rate of ∼7 x 109 M-1 s-1 which is approximately threefold 
higher than the superoxide dismutase catalyzed conversion of superoxide to H2O2 of ∼2 
x 109 M-1 s-1 (Beckman and Koppenol, 1996). Thus, theoretically, an increase in 
superoxide generation will lead to peroxynitrite formation in preference to formation of 
H2O2 in muscle and other cells. NO is usually present in cells to at least 100-fold 
excess, but the relatively large quantity of superoxide dismutase present in cytoplasm 
(SOD1) or mitochondria (SOD2) of cells appears to ensure that H2O2 is a major product 
under normal physiological conditions. Where superoxide generation or flux is 
increased, it is unclear what proportion of the extra superoxide might generate 
peroxynitrite in the presence of excess NO. Such a situation may be present in ageing 
where increased generation of superoxide has been implicated in the loss of muscle 
mass and function that occurs (Melov et al., 2000; Sastre et al., 2003). Data from Muller 
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et al. (Muller et al., 2006) indicated that mice lacking Cu,Zn SOD (SOD1) showed an 
accelerated skeletal muscle ageing phenotype that is characterized by loss of muscle 
fibres and degeneration of the innervating motor neurons (Kostrominova et al., 2007). 
In addition, adult mice lacking SOD1 also mimic other aspects of the normal ageing 
phenotype such as an inability to activate adaptive responses to contractions (Vasilaki et 
al., 2010).  Collectively, these data support the theory that reactive species play a key 
role in skeletal muscle ageing and it is therefore essential to establish the changes in 
RONS that occur in SOD1KO mice because this may provide evidence about the 
species that are involved in the degeneration of skeletal muscle in this animal mouse 
model and also inform further mechanistic studies during normal ageing.  
 
Larger limb muscles of the SO1KO mice, such as the GTN, have been shown to 
have a decreased number of fibres (Muller et al., 2006) compared with WT mice. In the 
present study, it was further shown that muscles from SOD1KO mice show only minor 
changes in structure compared with WT mice. An increase in the variability of fibre 
sizes and numbers of fibres having central nuclei is apparent which appear to reflect 
previous cycles of degeneration and regeneration and provide further evidence that the 
observed loss of muscle mass is due to a complete loss of muscle fibres. In addition, 
recent work has also shown that the lack of SOD1 in SOD1KO mice is associated with 
the selective loss of white/fast glycolytic (Type IIb), or the conversion to either fast 
oxidative (Type IIa) or slow fibres (Type I) (Jang et al., 2010).  
 
5.5.1 DHE oxidation by single muscle fibres from SOD1KO mice 
The single isolated mature skeletal muscle fibre preparation from the mouse 
FDB muscle has been previously used with ROS-sensitive fluorescent probes (Palomero 
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et al., 2008; Pye et al., 2007; Vasilaki et al., 2010) and was applied here. Changes in 
superoxide were assessed by monitoring the rate of change in dihydroethidium (DHE) 
oxidation and application of this technique to the study of superoxide changes in single 
isolated mature skeletal muscle fibres has been reported in detail in chapter 3.  
 
Resting fibres from SOD1KO mice showed no increase in DHE oxidation 
compared with those from WT mice with no statistical differences between the groups 
over the experimental period (Figure 5.9). In fibres from WT mice, contractile activity 
induced a substantial increase in DHE oxidation, indicating an increase in superoxide in 
response to contractions, but in muscle fibres from SOD1KO mice, the contraction 
induced increase in E+ fluorescence was much smaller (Figure 5.10). Thus, these data 
indicate that any rise in superoxide in fibres from the SOD1KO mice at rest was much 
less than that which occurs during physiological contractions of skeletal muscle and that 
the SOD1KO mice generated much less superoxide in muscle than WT mice following 
contractions. A similar pattern of ROS changes following contractions was observed in 
previous work from this group in which single FDB muscle fibres from the SOD1KO 
mice failed to increase CM-DCF fluorescence following contactions (Vasilaki et al., 
2010).   
 
Failure of skeletal muscle fibres to generate superoxide to the same extent as 
fibres from the WT mice following contractions implies that that a lack of SOD1 
appears to lead to a partial lack of activation of the systems that generate superoxide 
during contractions. The experimental data obtained in chapter 4 suggest that the 
NADPH oxidase system is the major cytosolic source of superoxide both at rest and 
following contractions in skeletal muscle. This implies that the small increase in 
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superoxide observed following contractile activity in skeletal muscles from SOD1KO 
mice (Figure 5.10) might be due to a partial lack of activation of the NADPH oxidase 
system. In relation to this, work by Harraz et al. showed that SOD1 is not just a 
catabolic enzyme, catalyzing the dismutation of superoxide into O2 and H2O2, but it can 
also directly regulate the NADPH oxidase dependent superoxide production by binding 
Rac1 (a regulatory component of the NADPH oxidase complex) and inhibiting its 
GTPase activity (Harraz et al., 2008). Hence, the potential lack of activation of the 
NADPH oxidase system may be the mechanism that accounts for the smaller increase in 
superoxide observed in skeletal muscles from the SOD1KO mice in response to 
contractions. 
 
5.5.2 NO and peroxynitrite in muscles from SOD1KO mice 
DAF-FM fluorescence from fibres of SOD1KO mice at rest was decreased to a 
small but significant extent throughout the period of study compared with that from 
fibres of WT mice (Figure 5.12). These data are compatible with a reduced NO 
availability in fibres from the SOD1KO mice. The 3-NT content of CAIII in muscles 
was also increased in muscles from SOD1KO mice compared with those from WT mice 
(Figure 5.14). These data are therefore entirely compatible with an increased generation 
of peroxynitrite in the muscle fibres of SOD1KO mice. Previous studies from this 
laboratory have indicated that measurements of the 3-NT content of the major cytosolic 
protein CAIII is a more sensitive marker of oxidative modifications to muscle than 
measurements of total muscle 3-NT content (Vasilaki et al., 2007). The western blotting 
approach used to assess the 3-NT content of muscle proteins in the current study is not 
sufficiently sensitive to demonstrate any potential changes in the 3-NT content of 
relatively low abundance proteins in the cytosol or mitochondrial intermembrane space 
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of muscle (Vasilaki et al., 2006a) although such analyses might provide information on 
important sites for peroxynitrite action in the SOD1KO mice.  
 
All of the six mammalian PRX proteins act to degrade H2O2 (Wood et al., 
2003), but PRXV also has the highest reported peroxynitrite reductase activity 
(Dubuisson et al., 2004; Trujillo et al., 2008). This function appears important in vivo 
because previous studies have shown that changes in PRXV expression modulated 
peroxynitrite toxicity and the cellular content of the enzyme was found to be 
upregulated in conditions associated with increased peroxynitrite formation (Trujillo et 
al., 2008). The muscle content of PRXV was found to be increased in SOD1KO mice 
compared with WT mice (Figure 5.15), which provides further support for a substantial 
increase in peroxynitrite generation in this model. 
 
5.5.3 Muscles from SOD1KO mice show increased oxidative damage 
The increase in peroxynitrite formation observed in muscles from SOD1KO 
mice was associated with increased oxidative damage (Figures 5.4, 5.5, 5.6 & 5.7). 
Protein, lipid and DNA damage was increased in muscles lacking SOD1 as indicated by 
the higher content in protein carbonyls, 4-HNE protein conjugates, MDA protein 
adducts, and increased OGG1 protein expression. These data further suggest that an 
increase in peroxynitrite formation can oxidative modify lipids, proteins and DNA in 
skeletal muscle tissue from SOD1KO mice.  
 
5.5.4 Adaptive responses in muscles from SOD1KO mice 
To identify if the increased oxidative damage observed in muscles from 
SOD1KO mice induced changes in protective systems, the protein expression of the 
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main enzymes that regulate changes in reactive species was also assessed. Mice lacking 
SOD1 showed a small but significant increase on muscle SOD2 content (Figure 5.16) 
that may reflect the increased number of mitochondria reported to be present in muscles 
of these mice (Kostrominova et al., 2007). No significant changes in the muscle 
contents of SOD3 (Figure 5.17) or of the three NOS isoforms were seen (Figures 5.18 
5.19 & 5.20). The lack of SOD1 in SOD1KO mice was also associated with increased 
protein expression of H2O2 reducing enzymes such as PRXII, PRXIII, PRXIV, PRXVI, 
CAT, and GPX1 (Figures 5.22, 5.23, 5.24, 5.25, 5.26 & 5.27. These data imply that 
skeletal muscles from SOD1KO mice show increased H2O2 levels in comparison to WT 
mice and this finding is in agreement with previous findings from this group which 
showed that resting muscle fibres from the knockout mice showed a higher increase in 
CM-DCF fluorescence (Vasilaki et al., 2010).  
 
5.5.5 Can modification of NO availability affect changes in peroxynitrite in 
muscles from nNOSTg mice? 
To determine whether a substantial increase in NO formation might modify 
peroxynitrite, the effect of overexpression of nNOS in muscle was also examined. 
Initial studies demonstrated the substantial increase in nNOS content that occurred in 
the muscle of nNOSTg mice (Figure 5.28) and also that this was associated with an 
increase in iNOS content (Figure 5.34). All three of the SOD isoforms were found to be 
elevated in the muscle of the nNOSTg mice compared with WT (Figures 5.35 & 5.36). 
These data indicate a substantial adaptive response to the overexpression of nNOS in 
muscle and further demonstrate the close link between NO and superoxide metabolism 
in this tissue.  
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The experimental data presented in my MPhil thesis showed that, resting muscle 
fibres from nNOSTg mice showed a significant increase in DAF-FM fluorescence 
(Figure 5.29) in comparison with those from WT mice, indicating that nNOS plays a 
significant role on NO generation on muscle at rest as previously reported (Nguyen and 
Tidball, 2003). The nNOS overexpression appeared to reduce superoxide availability in 
resting fibres from the transgenic group as shown by the reduction in DHE oxidation in 
comparison to fibres from the WT mice (Figure 5.30). The possibility that this was 
because of increased reaction of NO with superoxide to generate peroxynitrite is 
supported by the increase in the 3-NT content of CAIII in the muscle of nNOSTg mice 
compared with WT mice that was seen (Figure 5.31), although the adaptive changes in 
SOD contents seen in muscles of the nNOSTg mice may also have played a role to 
reduce superoxide availability and hence DHE oxidation. 
 
 The overall increase in peroxynitrite in muscles of the nNOSTg mice appeared 
to be lower than that seen in the muscles of SOD1KO mice because the 3-NT content of 
CAIII was not increased to the same extent (Figure 5.14 compared with Figure 5.31). In 
addition, no upregulation of PRXV was seen in the nNOSTg mice (Figure 5.32), 
whereas the content of PRXV was increased significantly in muscles of the SOD1KO 
mice (Figure 5.15). It is also likely that the predominant sub-cellular sites for increased 
peroxynitrite generation differed in the muscles of SOD1KO mice compared with 
nNOSTg mice because SOD1 is found in the cytoplasm and mitochondrial 
intermembrane space, whereas endogenous nNOS is localized to the inside of the 
muscle plasma membrane (Crosbie et al., 1998). PRXV is localized predominantly to 
mitochondria (Wood et al., 2003), and hence, the increase in expression seen in muscle 
of SOD1KO mice supports a substantial increase in peroxynitrite in that compartment.  
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The western blots for SOD3 (extracellular SOD) in Figures 5.17 and 5.36 show 
two predominant bands. There is considerable discrepancy in the published literature 
concerning the pattern and molecular weight of SOD3 seen in mouse tissues. Published 
data show either a single band (Wiggers et al., 2008), a doublet (Kliment et al., 2009) or 
the two major bands reported here (Lavina et al., 2009). This pattern appears in part 
related to the nature of the antibody that was used, and detailed examination of the ∼30 
kDa band shown in Figure 5.17 indicates that it is a doublet. The two bands in the 
doublet are thought to represent the ‘full length’ and ‘proteolyzed’ forms of the protein 
in which the heparin-binding portion of the protein is removed. The higher molecular 
weight band in Figures 5.17 and 5.36 has been described as a highly glycosylated form 
of the protein (Lavina et al., 2009).  
 
5.6 CONCLUSION 
In conclusion, these data indicate that removal of SOD-catalyzed conversion of 
cytosolic superoxide to H2O2 in SOD1KO mice caused no significant increase in the 
apparent superoxide availability in muscle fibres at rest, although a substantial increase 
in superoxide availability was observed following contractile activity in muscle fibres 
of WT mice. The lack of SOD1 caused a substantial increase in peroxynitrite formation, 
which is likely to be due to the excess NO concentration that is present in the muscle 
fibres. Furthermore, the lack of SOD1 appeared to prevent the increase in generation of 
superoxide that occurs in muscle fibres during contractile activity in WT mice. The 
increase in basal peroxynitrite formation and decreased NO in muscles of SOD1KO 
mice was also associated with an accelerated age-related loss of muscle mass and 
function. An increase in superoxide has been implicated in the loss of skeletal muscle 
mass and function that accompanies ageing, and several studies have attempted to 
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modify superoxide in skeletal muscle through interventions to increase superoxide 
scavenging capacity without clear success (Martin et al., 2009; Melov, 2002; Melov et 
al., 2000). It is feasible that these studies may have been ineffective because of the 
inability of the additional superoxide scavengers to compete with NO for reaction with 
superoxide, and the data presented here indicate that alternative approaches based on 
scavenging of peroxynitrite may be more effective. Peroxynitrite has been shown to 
inactivate aconitase (Castro et al., 1994; Hausladen and Fridovich, 1994) and is 
hypothesized to decompose to generate the hydroxyl radical which can oxidize proteins, 
lipid, and DNA and hence is a potential initiator of degradative processes in muscle 
(Beckman and Koppenol, 1996). In comparison to superoxide or hydroxyl radical, 
peroxynitrite is relatively stable, and therefore, there is the opportunity to scavenge this 
molecule prior to its decomposition although efficient approaches to this have not yet 
been described (Beckman and Koppenol, 1996; Guven et al., 2008; Jiao et al., 2009). 
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CHAPTER 6 
GENERAL DISCUSSION AND FUTURE 
DIRECTIONS 
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6.1 GENERAL DISCUSSION 
The current study was designed to determine the intracellular sites that regulate 
changes in superoxide in skeletal muscle both at rest and during contractile activity 
(AIM2), to identify the reactive species that are involved in the accelerated loss of 
muscle mass observed in homozygotic SOD1 knockout mouse model and to 
characterize the changes in redox status and adaptive responses that occur in muscles 
from the SOD1 knockout mice (AIM3). For the purposes of this study, a reliable 
technique to assess specific changes in superoxide was required and the findings of this 
study are based on techniques, that were optimized and developed in the present work 
(AIM 1), which enabled real-time detection of superoxide within the mitochondrial and 
cytosolic compartment of skeletal muscle.  
 
To examine superoxide changes in a pure skeletal muscle preparation, avoiding 
any contribution to ROS generation from non-myogenic cells, an ex vivo experimental 
model, which involved the isolation of single mature skeletal muscle fibres from the 
flexor digitorum brevis muscle was utilised. This approach has significant advantages 
over current techniques, since the measurements were made from mature skeletal 
muscle fibres that had been isolated from adult muscle and hence are likely to reflect the 
situation in muscle in vivo.  
 
6.2 SUMMARY OF MAJOR FINDINGS 
The current study identified that:  
1. The techniques based on use of single mature skeletal muscle fibres loaded with 
dihydroethidium and MitoSOX Red appear capable of detecting cellular changes 
in superoxide within the cytosolic and mitochondrial compartments that occur in 
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response to a pharmacological stimulant or in response to a physiological 
stimulus such as contractile activity. The specificity of this method was 
evaluated with the use of superoxide inducers but also scavengers and the 
experimental evidence showed that menadione, a redox cycling agent, which is 
known to stimulate superoxide production,(Rosen and Freeman, 1984) caused a 
significant increase in DHE oxidation (Figure 3.2). To further assess the 
sensitivity of DHE oxidation in response to a physiological stimulus, single 
muscle fibres were subjected to a 10 min period of contractile activity, fibres 
showed a significant increase in DHE oxidation following contractions as 
assessed via changes in E+ fluorescence (Figure 3.3). The specificity of DHE 
oxidation towards superoxide was assessed with the use of superoxide 
scavengers (Tiron and Tempol) which blocked completely the anticipated 
increase in DHE oxidation following contractions suggesting that DHE 
oxidation reflects an increase in superoxide (Figure 3.3). Similarly, the electron 
transport chain inhibitors Antimycin A (Figure 3.9) and Rotenone (Figure 3.10) 
increased MitoSOX Red fluorescence indicating that the superoxide sensitive 
fluorescent probe MitoSOX Red is sensitive to changes in superoxide. The 
selective accumulatation of MitoSOX Red in the mitochondrial matrix was 
shown by the co-localization of MitoTracker Green FM with MitoSOX Red 
fluoresncence (Figure 3.8). Finally, the specificity of DHE and MitoSOX Red 
towards superoxide was examined by treatment of fibres with exogenous H2O2 
and NO. Positive control experiments using 5- (and 6-) chloromethyl-2’,7’-
dichlorodihydrofluorescein diacetate (CM-DCFH DA) and 4-amino-5-
methylamino-2’,7’-difluorofluorescein diacetate (DAF-FM DA) loaded fibres 
showed a marked increase in DCF fluorescence following addition of H2O2 or 
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DAF-FM fluorescence following NOC-7 indicating an intracellular increase in 
H2O2 and NO (Figures 3.6 and 3.7, respectively). However, DHE and MitoSOX 
Red loaded fibres showed no changes in fluorescence in response to exogenous 
H2O2 and NO (Figures 3.4, 3.5, 3.12 and 3.13) implying that the superoxide 
sensitive fluorescent dies DHE and MitoSOX Red are selective towards 
superoxide and are capable of detecting changes in superoxide at rest but also in 
response to a physiological stimulus such as contractile activity.. 
2. Contractile activity increased cytosolic superoxide, an increase that appeared to 
be related to the number of contractions to which the fibres were subjected. 
Fibres subjected to the High, Moderate and Low contraction protocols showed a 
5.8, 4.1 and 2.8 fold increase in DHE oxidation following contractions compared 
with resting fibres (Figure 4.1) implying that contractile activity increased the 
cytosolic superoxide content of single muscle fibres in an intensity dependent 
manner since DHE oxidation reflects changes in superoxide within the 
cytoplasmic compartment of the muscle fibres. This finding further imply that 
the activity of the sources that regulate cytosolic superoxide content in skeletal 
muscle is dependent on the number of contractions to which the fibres are 
subjected.  
3. Intact mitochondria in isolated mature skeletal muscle fibres produce superoxide 
from complex I and complex III of the mitochondrial electron transport chain as 
shown by the effect of Rotenone and Antimycin A, respectively (Figures 3.9 and 
3.10). Superoxide generated by complex I was exclusively released in the 
mitochondrial matrix as shown by the increase in MitoSOX Red fluorescence 
(Figure 3.9). No effect was seen on DHE oxidation indicating that complex I-
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dependent superoxide release into the mitochondrial matrix and does not diffuse 
to the cytoplasm from intact mitochondria (Figure 4.5). 
4. Superoxide generation by complex III was released to both sides of the inner 
mitochondrial membrane, the matrix and the intermembrane space. Treatment of 
fibres with Antimycin A induced a dose dependent increase in DHE oxidation 
compared with control untreated fibres, indicating extramitochondrial 
superoxide release (Figure 4.2). Reports have shown that superoxide can diffuse 
out of isolated mitochondria through the mitochondrial permeability transition 
pore (mPTP) (Abou-Sleiman et al., 2006), the inner mitochondrial anion channel 
(iMAC) (Dai et al., 2011) and through channels located on the outer 
mitochondrial membrane (OMM) (Budzinska et al., 2009; Han et al., 2003). The 
potential role of the mPTP and iMAC in release of superoxide following 
Antimycin A was examined in this study using the mPTP - cyclosporin A (CsA) 
and iMAC - 4 chlorodiazepam (4Cl-DZP) inhibitors (Figure 4.4). Neither CsA 
or 4CL-DZP were found to affect DHE oxidation in Antimycin A-treated fibres 
(Figure 4.4) providing evidence that superoxide formed within the mitochondrial 
matrix does not diffuse to the cytosplasm of single muscle fibres. These data 
further suggested that the diffusion of superoxide from the mitochondria to the 
cytosol of single muscle fibres following treatment with Antimycin A likely 
derived from the mitochondrial intermembrane space. To identify the channels 
that might play a role in the diffusion of superoxide from the mitochondrial 
intermembrane space to the cytosol in single muscle fibres, mitochondrial and 
cytosolic fractions from GTN muscles were prepared and were assessed for the 
protein expression of the voltage dependent anion channels (VDACs), the major 
outer membrane proteins known also as mitochondrial porin, which can 
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facilitate the diffusion of superoxide from the mitochondrial intermembrane 
space in isolated cardiac mitochondria (Han et al., 2003). All three isoforms of 
VDACs (VDAC1, VDAC2 & VDAC3) were highly expressed in the skeletal 
muscle mitochondrial fractions (Figure 4.7) and their contribution to the 
extramitochondrial superoxide release following in response to Antimycin A 
was confirmed in inhibition studies. Specifically, treatment of single muscle 
fibres with dextran sulfate, a VDAC inhibitor partially inhibited the anticipated 
increase in DHE oxidation following treatment with Antimycin A (Figure 4.8) 
implying that VDACs play a key role in mitochondrial superoxide release. In 
addition, further experiments showed that the Bax channel, an additional 
channel located on the outer mitochondrial membrane (Martinou, 1999), played 
a synergistic role in mediating the diffusion of superoxide from the MIS across 
the outer mitochondrial membrane, shown by the effect of the Bax channel 
blocker which partially inhibited DHE oxidation in response to Antimycin A 
(Figure 4.11).  
5. Intact mitochondria in isolated mature skeletal muscle fibres did not contribute 
to cytosolic superoxide increase either at rest or following a physiological 
stimulus such as contractile activity. Single isolated fibres incubated in the 
presence of dextran sulfate, a VDAC inhibitor, showed no effect on baseline 
DHE oxidation (Figure 4.9) implying that intact skeletal muscle mitochondria do 
not release superoxide to the cytosol of resting muscle fibres. Similarly, no 
differences in the rate of change in DHE oxidation were observed between 
untreated fibres and fibres treated with VDAC and/or Bax inhibitors following 
contractions (Figure 4.12) indicating that the increase in superoxide in response 
to contractions was unlikely to derive from the mitochondrial intermembrane 
	  	   208	  
space and likely originated from non-mitochondrial sources. However under 
“pathological” conditions when mitochondrial superoxide production was 
grossly excessive (i.e following addition of Antimycin A), channels of the outer 
mitochondrial membrane such as VDAC and Bax appear to release superoxide 
from the mitochondrial intermembrane space to the cytosol of skeletal muscle 
fibres (Figure 4.11). 
6. Cytosolic superoxide levels were not modulated by the activity of the iPLA2 
enzymes in single skeletal muscle fibres. Expression of iPLA2 was confirmed in 
cytosolic fractions from GTN muscle and in lysate from single muscle fibres 
(Figure 4.13). Selective iPLA2 inhibition with the use of bromoenol lactone 
failed to alter DHE oxidation in both quiescent and contracted fibres (Figures 
4.14 and 4.15, respectively) indicating that iPLA2 enzymes did not contribute to 
changes in superoxide either at rest or during contractile activity. 
7. mRNA and protein expression of various NADPH oxidase subunits including 
NOX2, NOX4, Rac1, p67phox, p47phox, p22phox and p40phox was identified in pure 
skeletal muscle preparations (Figures 4.16 and 4.17). Additional experiments 
were undertaken to identify if either NOX2 or NOX4 oxidases are present in 
skeletal muscle mitochondria and demonstrated the presence of NOX4 but not 
NOX2 in this fraction (Figure 4.18).  
8. The role of NADPH oxidase complexes in producing superoxide under resting 
and contracting conditions was assessed by use of specific and non-specific 
inhibitors. Inhibition of NADPH oxidase activity with the use of the non-
specific inhibitor, diphenyleneiodonium chloride (DPI) induced an unexpected 
increase in DHE oxidation compared with control non-treated fibres (Figure 
4.19). The mechanism by which DPI induced increased DHE oxidation in the 
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current study is unclear, but DPI has been reported to inhibit flavoenzymes in 
addition to NADPH oxidases, such as NOS, xanthine oxidase, and NADPH-
cytochrome P450 reductase (Balcerczyk et al., 2005; Longpre and Loo, 2008; 
Park et al., 2007), and hence it can affect cellular processes unrelated to NADPH 
oxidase. In addition, studies have indicated that DPI can stimulate the 
production of ROS (Li et al., 2003; Riganti et al., 2004) and reactive nitrogen 
species (Balcerczyk et al., 2005), affecting cellular redox status indicated by 
increased levels of lipid peroxidation (Riganti et al., 2004) and DNA damage 
(Longpre and Loo, 2008; Park et al., 2007), an increase in glutathione disulfide 
(Riganti et al., 2004) and apopoptosis (Balcerczyk et al., 2005; Longpre and 
Loo, 2008; Park et al., 2007), as well as increased nitration of tyrosine residues 
of cellular proteins (Balcerczyk et al., 2005) 
9.  NADPH oxidase contributes to changes in superoxide at rest and during 
contractile activity in skeletal muscle. Single muscle fibres incubated in the 
presence of apocynin (Figures 4.20, 4.21 and 4.22), and gp91ds-tat (Figures 4.24 
and 4.25) NADPH oxidase inhibitors, showed a significant reduction in 
fluorescence at rest and following contractions. The contraction–induced 
increase in fluorescence was reduced by a mean of 70% in apocynin-treated 
fibres compared with untreated fibres (Figure 4.21). Treatment of fibres with 
gp91ds-tat abolished the increase in DHE oxidation in response to contractions 
(Figure 4.25) indicating that NADPH oxidase is a major contributor to 
superoxide production both at rest and during contractile activity in skeletal 
muscle.  
10. The inhibitory effects of the NADPH oxidase inhibitors apocynin and gp91ds-tat 
imply that p47phox is a critical component of the NADPH oxidase complex and 
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can regulate the activity of the enzyme in skeletal muscle. The proposed 
inhibitory mechanism of action of apocynin on NADPH oxidase is to prevent 
the translocation of p47phox and p67phox to the membrane-located catalytic 
subunits (Muijsers et al., 2000) whereas gp91ds-tat peptide selectively inhibits 
NOX2-oxidase (Csanyi et al., 2011), although early studies suggested the 
possibility that the peptide may additionally inhibit NOX1 and NOX4 
homologues (Brandes, 2003; Rey et al., 2001) by preventing their interaction 
with p47phox. These finding suggests that NOX2 isoform is likely to be the major 
cytosolic regulator of superoxide in skeletal muscle in response to contractile 
activity. 
11. Immmunocolocalisation techniques showed that the regulatory subunits (p40phox, 
p47phox, p67phox and Rac1) of the NADPH oxidase complex were found to be 
localized on, or in close proximity to the sarcolemma, but immunofluorescence 
from p40phox and p67phox was also observed in the cytosolic compartment of the 
muscle fibres (Figure 4.26). The catalytic subunits (NOX2 and NOX4) and the 
small membrane-bound integral subunit (p22phox) were found to be localised on 
the plasma membrane of the muscle fibres, as indicated by co-localisation with 
caveolin-3, the muscle-specific caveolin isoform, present in sarcolemmal 
caveolae (Whitehead et al., 2010), (Figure 4.27). In addition, NOX2, NOX4 and 
p22phox proteins were also expressed on T-tubules as indicated by co-localisation 
with the α1s subunit of the dihydropyridine receptor (α1s DHPR), that is located 
on the T-tubule membrane (Hidalgo et al., 2006) (Figure 4.28). Updated 
schematic figures that show the cytosolic and mitochondrial RONS sources in 
skeletal muscle were produced to highlight these findings (Figures 4.31 and 
4.32). 
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12. Increased NADPH oxidase activity in response to contractions requires 
translocation of the p40phox cytosolic component to the muscle plasma 
membrane (Figure 4.29). Activation of the NADPH oxidase complex in 
phagocytic cells requires translocation of the p40phox, p47phox and p67phox 
components to the cell membrane and work from this study revealed that p40phox 
immunostained fibres exhibited a more intense fluorescence at the sarcolemma 
compared with resting non-contracted fibres following contractions (Figures 
4.29 and 4.30). No evidence for contraction-induced translocation of the p67phox 
protein was observed, with resting fibres showing a similar intensity of 
fluorescence at the membrane and in the cytosol compared with fibres subjected 
to contractions (Figure 4.29).  
13. Removal of SOD1 in homozygotic SOD1 knockout mice induced overt 
phenotypic changes of accelerated ageing in the anterior tibialis and 
gastrocnemius muscles of SOD1 knockout mice (Table 5.2). Other 
tissues/organs including the heart, liver, kidneys, spleen, brain and lungs were 
unaffected indicating that removal of SOD1 induces specific effects in skeletal 
muscle (Table 5.2). Muscles from SOD1 knockout mice showed minor changes 
in structure, such as greater variability in fibre size and the presence of 
occasional central nuclei compared with muscles from WT mice (Figure 5.3), 
implying that the loss of mass observed in the muscles of the SOD1 knockout 
mouse model is likely primarily due to a complete loss of muscle fibres.  
14. Skeletal muscle ageing phenotypic changes were associated with increased 
oxidative damage as shown by the increase in protein oxidation (Figure 5.4), 
lipid peroxidation (Figures 5.5 and 5.6) and DNA damage (Figure 5.7) in 
muscles form the SOD1 knockout mice.  
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15. Removal of SOD-catalyzed conversion of cytosolic superoxide to H2O2 in 
SOD1 knockout mice caused no significant increase in the apparent superoxide 
availability in muscle fibres, as indicated by changes in DHE oxidation (Figure 
5.9) but decreased nitric oxide availability shown by the reduction in DAF-FM 
fluorescence (Figure 5.12). The possibility that a lack of SOD1 lead to the 
formation of peroxynitrite was supported by the higher level of nitration of 
tyrosine residues of the major muscle protein carbonic anhydrase III (Figure 
5.14) as well as by the higher protein expression of peroxiredoxin V, a 
peroxynitrite reductase, in muscles from the SOD1 knockout mice (Figure 5.15). 
carbonic	  anhydrase	  III. 
16. Lack of SOD1 induced a compensatory up-regulation of RONS protective 
enzymes in skeletal muscles from the SOD1 knockout mice including an 
increase in SOD2, peroxiredoxin II, peroxiredoxin III, peroxiredoxin IV, 
peroxiredoxin VI, catalase and glutathione peroxidase I (Figures 5.16, 5.22, 
5.23, 5.24, 5.25, 5.26 and 5.27) which indicate the adaptations that occur in 
skeletal muscles from the SOD1 knockout mice due to higher RONS content in 
comparison to muscles from the WT group. The possibility that the lack of 
SOD1 might have induced adaptations in the content of nitric oxide synthase 
(NOS) enzymes was also examined, no significant differences in the contents of 
all the three NOS isoforms (nNOS, eNOS, and iNOS) were seen (Figures 5.18, 
5.19 and 5.20).  
17. Muscle specific nNOS transgenic mice showed a > 100-fold increase in nNOS 
protein content in comparison to WT mice (Figure 5.28). nNOS overexpression 
augmented the formation of peroxynitrite as shown by the higher 3-nitrotyrosine 
content of the carbonic anhydrase III in the transgenic group in comparison with 
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muscles from WT mice (Figure 5.31). However, no significant changes in 
peroxiredoxin V were observed with muscles from the transgenic group showing 
a similar peroxiredoxin V protein expression compared to muscles from the WT 
mice (Figure 5.32). nNOS overexpression induced adaptations in the content of 
SOD enzymes, the protein expression of the three SOD enzymes (SOD1, SOD2, 
and SOD3) was significantly upregulates in muscles of the transgenic mice in 
comparison with muscles from WT mice (Figures 5.35 and 5.36). In addition, 
the effect of nNOS overexpression on the muscle content of the other two NOS 
isoenzymes (eNOS & iNOS) was also examined, iNOS content was significantly 
upregulated in the transgenic mice compared with WT mice (Figure 5.34) but no 
significant changes in the content of eNOS were seen (Figure 5.33). 
 
6.3 LIMITATIONS 
6.3.1 Use of ethidium (E+) fluorescence to monitor changes in superoxide. 
The work described in this thesis has examined the use of dihydroethidium 
(DHE) and MitoSOX Red superoxide sensitive florescent dyes to determine changes in 
superoxide within the cytosolic and mitochondrial compartment of mature single 
muscle fibres. Oxidation of DHE and MitoSOX Red fluorescence has been used as a 
means of monitoring cytosolic and mitochondrial changes in superoxide by following 
ethidium (E+) and 2-hydroxyethidium (2-OH-E+) formation (Zielonka and 
Kalyanaraman, 2010) and the experimental findings in this current work are based on 
monitoring changes in E+ fluorescence from single muscle fibres. Though the 
experiments undertaken in chapter 3 indicate that the techniques based on monitoring E+ 
fluorescence from single muscle cells appear capable of detecting changes in superoxide 
at rest but also in response to contractile activity, assessment of E+ fluorescence as a 
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measure of superoxide anion radical in cellular compartments has been criticised and 
recent studies have identified 2-hydroxyethidium (2-OH-E+) as a specific product of the 
reaction of DHE and MitoSOX Red with superoxide (Zielonka and Kalyanaraman, 
2010). Hence, , future studies are required to assess whether 2-OH-E+ changes in 
skeletal muscle is a more reliable way of monitoring real-time changes in superoxide in 
skeletal muscle fibres.  
 
6.3.2 Oxygen tension under which single muscle fibre experiments were 
conducted. 
Molecular oxygen is one of the most abundant elements in the atmosphere 
(nearly 21% by volume), and its ability to accept electrons makes it vital for a variety of 
physiological processes. Resting and contracting skeletal muscles require energy and in 
biological systems, the energy is accumulated as ATP and released by its hydrolysis 
(Marieb and Hoehn, 2010; Martini, 2005). Skeletal muscle mitochondria are implicated 
in the processes of ATP production via mitochondrial oxidative phosphorylation, which 
results in the production of ATP by reducing oxygen to water (Scheffler, 1999). 
Although oxidative phosphorylation is a vital part of metabolism, it also produces 
reactive oxygen intermediates. Single isolated muscle fibres used in this study were 
exposed to environmental oxygen though the tension of oxygen in skeletal muscle in 
vivo varies between 2-7 %. Recent studies from Vasilaki et al. (unpublished data) have 
shown that different oxygen concentrations can modify ROS generation in skeletal 
muscle cells. Specifically, skeletal muscle myoblasts and myotubes grown in 6% 
oxygen showed a lower rate of increase in DHE oxidation as assessed via changes in 2-
OH-E+ in comparison to cells grown in 20% oxygen. These data imply that the RONS 
changes observed in the current study might be higher than the actual changes that 
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occur in skeletal muscle in vivo.  Hence, future studies are required to assess RONS 
changes in single skeletal muscle cells in the presence of 2-7% oxygen environments.  
 
6.3.3 Genders of mice used in this study. 
Male and female mice were used in this study. Specifically, results in chapter 3 
and 4 report findings in female WT mice whereas in chapter 5, male SOD1 knockout 
and male nNOS transgenic mice were used. The selection of gender of mice for each 
study was based entirely on the available mice at that time. Studies have shown that on 
average, the skeletal muscle of women typically has 60–80% of the strength, muscle 
fibre cross sectional area and whole muscle anatomical cross-sectional area of men 
(Folland and Williams, 2007). There is no evidence in the literature to suggest that 
skeletal muscles from female mice show a different pattern in RONS activation in 
comparison to skeletal muscles from male mice. However, studies that have assessed 
and compared the neurological and morphological adaptations in skeletal muscle 
following resistance exercise between men and women have shown that the relative 
improvements both in hypertrophy and strength adaptations are similar and that relative 
to the amount of muscle mass, men and women experience similar gains of strength 
(Folland and Williams, 2007). In relation to this, studies from this group have also 
shown that the loss of muscle mass that occurs in SOD1 knockout mice is similar 
between male and female mice. Though this evidence might indicate that the changes in 
RONS in skeletal muscle might not differ between male and female mice, future studies 
are required to assess directly whether there are any major differences in the subcellular 
sites that regulate RONS, but also examine the adaptations that occur in response to a 
stimulus such as contractile activity.  
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6.4 FUTURE DIRECTIONS 
6.4.1 Use of dihydroethidium and MitoSOX Red superoxide-sensitive dyes. 
The development of techniques to examine real-time changes in cytosolic and 
mitochondrial superoxide in skeletal muscle may have biologically and potentially 
clinically relevant implications for the understanding of diverse scientific areas. The 
production of reactive oxygen and nitrogen species by skeletal muscle is important as it 
underlies oxidative damage in many degenerative muscle diseases and plays multiple 
regulatory roles by fulfilling important cellular functions. Hence application of these 
techniques may provide useful information with regards to the responses of muscle to 
exercise training, age-related loss of muscle mass and function, as well as inflammatory 
or degenerative muscle diseases, such as the muscular dystrophies that are associated 
with increased levels of oxidative damage and muscle weakness.  
 
6.4.2 NAD(P)H oxidase expression in skeletal muscle. 
The experimental data from the current work indicated that NAD(P)H oxidases 
and particularly NOX2 is likely to be a major cytosolic regulator of superoxide in 
skeletal muscle in response to contractile activity. However, several aspects of NOX 
regulation remain uncertain. DUOX1 and DUOX2 have shown to be expressed in 
skeletal muscle and generate H2O2 although the precise location of these enzymes 
remains unidentified. The uncertainty regarding the primary ROS product released by 
NOX4 requires clarification and further research is required to assess the potential 
cross-talk between the mitochondrial NOX4 isoform and the superoxide generating sites 
of the mitochondrial electron transport chain in skeletal muscle. Finally, the recent 
finding that mitochondrial NOX4 can enhance H2O2 production and induce 
mitochondrial dysfunction in a cultured endothelial cell aging-induced senescence 
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model (Koziel et al., 2013; Wolin, 2013) raises the possibility that mitochondrial NOX4 
might be implicated in the processes of skeletal muscle ageing and future studies are 
required to examine the role of NAD(P)H oxidases in the loss of muscle mass that 
occurs with ageing.  
 
6.4.3 Formation of peroxynitrite in skeletal muscles from SOD1 knockout mice. 
The present finding that peroxynitrite is implicated in the processes of skeletal 
muscle ageing in SOD1 knockout mice highlights the role that this oxidant might play 
in skeletal muscle degeneration. Preliminary, unpublished data from this group have 
also shown that skeletal muscles from aged mice show an increase in the level of 
nitration of tyrosine residues of proteins in muscle implying that skeletal muscles from 
aged mice exhibit an increase in peroxynitrite formation. Peroxynitrite is a relatively 
stable RNS, in comparison to superoxide or hydroxyl radical and therefore, there is the 
opportunity to scavenge this molecule prior to its decomposition. Hence, future studies 
are required to assess whether direct reduction of peroxynitrite in skeletal muscle would 
induce changes in muscle mass or prevent the accelerated muscle atrophy observed in 
the SOD1 knockout mouse model.  
 
Finally, it should be noted that the lack of SOD1 within the mitochondrial 
intermembrane space might also play a major role in the skeletal muscle ageing 
phenotype observed in SOD1 knockout mice. Experimental evidence has shown that 
muscle atrophy in SOD1 knockout mice is associated with mitochondrial dysfunction 
including an increased elevation of mitochondrial ROS production, a progressive 
decline in mitochondrial bioenergetic function and an elevated apopoptotic potential 
(Jang et al., 2010). These data suggest that SOD1 is critically important to maintain 
	  	   218	  
mitochondrial function in skeletal muscle. It is also widely accepted that mitochondria 
from aged skeletal muscle tissues generate higher amounts of ROS in comparison to 
young tissues and that mitochondrial dysfunction is implicated in the processes of 
ageing. In the present study we identified that skeletal muscles from SOD1 knockout 
mice show an increase in peroxynitrite formation within the cytosolic compartment as 
assessed via changes in the level of nitration of tyrosine residues of carbonic anhydrase 
III. The potential increase in peroxynitrite formation within the mitochondrial 
intermembrane space was not assessed and further studies are required to assess the 
potential increase in peroxynitrite in the intermembrane space and its potential effect on 
skeletal muscle ageing. In support of this, the functional significance of SOD1 in the 
mitochondrial intermembrane space has recently been examined in transgenic studies in 
which SOD1 was exclusively expressed in the mitochondrial intermembrane space from 
SOD1 knockout mice (Fischer et al., 2011). Mitochondrial SOD1 expression was 
sufficient to prevent the biochemical and morphological defects and to rescue the motor 
axon degeneration phenotype in the SOD1 knockout mouse model (Fischer et al., 2011), 
implying that SOD1 in the mitochondrial intermembrane space is fundamental for 
motor axon maintenance.   
 
6.4.4 Which is the primary initiating factor for the accelerated muscle ageing 
phenotype observed in SOD1 knockout mice; Failure of redox homeostasis in 
motor neurons or in muscle?  
Elucidation of the primary mechanisms underlying sarcopenia has proved 
difficult, in part because of difficulty in unraveling the interplay between the loss of 
muscle mass and loss of functional motor units, both of which occur with ageing 
(Larsson and Wahlstrom, 1998). Skeletal muscle atrophy in SOD1 knockout mice is 
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associated with neuromuscular junction alterations including moton axon degeneration 
and postsynaptic endplate fragmentation (Fischer et al., 2011; Jang et al., 2010). These 
data suggest that neuromuscular junction degeneration is a critical part of the muscle 
atrophy phenotype exhibited in the SOD1 knockout mouse model. To unravel whether 
changes in redox homeostasis in motor nerves or in muscle initiates the observed 
muscle atrophy, mouse models of conditional deletion of specific RONS regulatory 
enzymes provide a valuable tool to determine whether site specific changes in redox 
homeostasis alter the processes of skeletal muscle ageing. Recent work from this 
laboratory has examined whether specific SOD1 gene deletion targeted to skeletal 
muscle leads to muscle atrophy and showed that lack of SOD1 protein expression 
within the muscle tissue alone was not sufficient to cause muscle atrophy (Zhang et al., 
2013). To further dissect the relative roles of skeletal muscle and motor neurons in the 
process of skeletal muscle ageing, current experiments are undertaken to generate a 
nerve transgenic SOD1 knockout mouse model to determine whether nerve-specific 
SOD1 expression is sufficient to prevent muscle atrophy in SOD1 knockout mice. This 
study will provide evidence as to whether a failure in redox homeostasis in motor 
neurons is the primary initiating factor for the loss of muscle mass that occurs in the 
SOD1 knockout mouse model.	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